<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">77195</article-id><article-id pub-id-type="doi">10.7554/eLife.77195</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Niche-specific genome degradation and convergent evolution shaping <italic>Staphylococcus aureus</italic> adaptation during severe infections</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-269767"><name><surname>Giulieri</surname><given-names>Stefano G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269743"><name><surname>Gu√©rillot</surname><given-names>Romain</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-182527"><name><surname>Duchene</surname><given-names>Sebastian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269740"><name><surname>Hachani</surname><given-names>Abderrahman</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8032-2154</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269741"><name><surname>Daniel</surname><given-names>Diane</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-93462"><name><surname>Seemann</surname><given-names>Torsten</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-269766"><name><surname>Davis</surname><given-names>Joshua S</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-104620"><name><surname>Tong</surname><given-names>Steven YC</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1368-8356</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94969"><name><surname>Young</surname><given-names>Bernadette C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6071-6770</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-4850"><name><surname>Wilson</surname><given-names>Daniel J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0940-3311</contrib-id><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-192423"><name><surname>Stinear</surname><given-names>Timothy P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0150-123X</contrib-id><email>tstinear@unimelb.edu.au</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-99235"><name><surname>Howden</surname><given-names>Benjamin P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0237-1473</contrib-id><email>bhowden@unimelb.edu.au</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Department of Microbiology and Immunology at the Peter Doherty Institute for Infection and Immunity, University of Melbourne</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05dbj6g52</institution-id><institution>Department of Infectious Diseases, Austin Health</institution></institution-wrap><addr-line><named-content content-type="city">Heidelberg</named-content></addr-line><country>Australia</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/005bvs909</institution-id><institution>Victorian Infectious Diseases Service, Royal Melbourne Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Microbiological Diagnostic Unit Public Health Laboratory, The University of Melbourne at the Doherty Institute for Infection and Immunity</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0187t0j49</institution-id><institution>Department of Infectious Diseases, John Hunter Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Newcastle, New South Wales</named-content></addr-line><country>Australia</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048zcaj52</institution-id><institution>Menzies School of Health Research, Charles Darwin University</institution></institution-wrap><addr-line><named-content content-type="city">Casuarina, Northern Territory</named-content></addr-line><country>Australia</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01ej9dk98</institution-id><institution>Victorian Infectious Disease Service, Royal Melbourne Hospital, and University of Melbourne at the Peter Doherty Institute for Infection and Immunity</institution></institution-wrap><addr-line><named-content content-type="city">Melbourne</named-content></addr-line><country>Australia</country></aff><aff id="aff8"><label>8</label><institution>Nuffield Department of medicine</institution><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>Big Data Institute, Nuffield Department of Population Health, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, University of Oxford</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>14</day><month>06</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e77195</elocation-id><history><date date-type="received" iso-8601-date="2022-01-19"><day>19</day><month>01</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-06-08"><day>08</day><month>06</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-02-12"><day>12</day><month>02</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.02.11.480068"/></event></pub-history><permissions><copyright-statement>¬© 2022, Giulieri et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Giulieri et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-77195-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-77195-figures-v2.pdf"/><abstract><p>During severe infections, <italic>Staphylococcus aureus</italic> moves from its colonising sites to blood and tissues and is exposed to new selective pressures, thus, potentially driving adaptive evolution. Previous studies have shown the key role of the <italic>agr</italic> locus in <italic>S. aureus</italic> pathoadaptation; however, a more comprehensive characterisation of genetic signatures of bacterial adaptation may enable prediction of clinical outcomes and reveal new targets for treatment and prevention of these infections. Here, we measured adaptation using within-host evolution analysis of 2590 <italic>S</italic>. <italic>aureus</italic> genomes from 396 independent episodes of infection. By capturing a comprehensive repertoire of single nucleotide and structural genome variations, we found evidence of a distinctive evolutionary pattern within the infecting populations compared to colonising bacteria. These invasive strains had up to 20-fold enrichments for genome degradation signatures and displayed significantly convergent mutations in a distinctive set of genes, linked to antibiotic response and pathogenesis. In addition to <italic>agr</italic>-mediated adaptation, we identified non-canonical, genome-wide significant loci including <italic>sucA-sucB</italic> and <italic>stp1</italic>. The prevalence of adaptive changes increased with infection extent, emphasising the clinical significance of these signatures. These findings provide a high-resolution picture of the molecular changes when <italic>S. aureus</italic> transitions from colonisation to severe infection and may inform correlation of infection outcomes with adaptation signatures.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>The bacterium <italic>Staphylococcus aureus</italic> lives harmlessly on our skin and noses. However, occasionally, it gets into our blood and internal organs, such as our bones and joints, where it causes severe, long-lasting infections that are difficult to treat.</p><p>Over time, <italic>S. aureus</italic> acquire characteristics that help them to adapt to different locations, such as transitioning from the nose to the blood, and avoid being killed by antibiotics. Previous studies have identified changes, or ‚Äòmutations‚Äô, in genes that are likely to play an important role in this evolutionary process. One of these genes, called accessory gene regulator (or <italic>agr</italic> for short), has been shown to control the mechanisms <italic>S. aureus</italic> use to infect cells and disseminate in the body. However, it is unclear if there are changes in other genes that also help <italic>S. aureus</italic> adapt to life inside the human body.</p><p>To help resolve this mystery, Giulieri et al. collected 2,500 samples of <italic>S. aureus</italic> from almost 400 people. This included bacteria harmlessly living on the skin or in the nose, as well as strains that caused an infection. Gene sequencing revealed a small number of genes, referred to as ‚Äòadaptive genes‚Äô, that often acquire mutations during infection. Of these, <italic>agr</italic> was the most commonly altered. However, mutations in less well-known genes were also identified: some of these genes are related to resistance to antibiotics, while others are involved in chemical processes that help the bacteria to process nutrients.</p><p>Most mutations were caused by random errors being introduced in to the bacteria‚Äôs genetic code which stopped genes from working. However, in some cases, genes were turned off by small fragments of DNA moving around and inserting themselves into different parts of the genome.</p><p>This study highlights a group of genes that help <italic>S. aureus</italic> to thrive inside the body and cause severe and prolonged infections. If these results can be confirmed, it may help to guide which antibiotics are used to treat different infections. Furthermore, understanding which genes are important for infection could lead to new strategies for eliminating this dangerous bacterium.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>within-host evolution</kwd><kwd>adaptation</kwd><kwd><italic>Staphylococcus aureus</italic></kwd><kwd>genomics</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>GNT1105525</award-id><principal-award-recipient><name><surname>Stinear</surname><given-names>Timothy P</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000925</institution-id><institution>National Health and Medical Research Council</institution></institution-wrap></funding-source><award-id>GNT1196103</award-id><principal-award-recipient><name><surname>Howden</surname><given-names>Benjamin P</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A large-scale analysis of <italic>Staphylococcus aureus</italic> within-host evolution based on a comprehensive catalogue of bacterial genetic variation reveals an excess of genome degradation signatures in infecting strains and new genetic loci of clinically relevant adaptation.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>While <italic>Staphylococcus aureus</italic> is one of the most important human pathogens (<xref ref-type="bibr" rid="bib113">Tong et al., 2015</xref>), its common interaction with the human host is colonisation, usually of the anterior nares (<xref ref-type="bibr" rid="bib122">Wertheim et al., 2005</xref>). Comparatively, severe, life-threatening infections such as bacteraemia or osteomyelitis occur very rarely. This suggests that at the macro-evolutionary level, <italic>S. aureus</italic> is primarily adapted to its natural ecological niche (the nasal cavity) and to specific selective pressures arising in this environment, such as competition with the resident microbiota (<xref ref-type="bibr" rid="bib53">Krismer et al., 2017</xref>). By contrast, during invasive infection, a new fitness trade-off needs to be achieved to adjust to environmental challenges that include innate and acquired immune responses (<xref ref-type="bibr" rid="bib90">Proctor, 2019</xref>), high-dose antibiotics (<xref ref-type="bibr" rid="bib54">Kuehl et al., 2020</xref>), and nutrient starvation (<xref ref-type="bibr" rid="bib44">Hood and Skaar, 2012</xref>). These trade-offs could occur across three potentially distinctive dynamics of micro-evolution during colonisation and infection (within the colonising population, from colonising to invasive, and within the invasive population), leading to nose-adapted, early infection-adapted, and late infection-adapted strains. Identifying infection-adapted strains might assist precision medicine strategies for infection prevention and management and refine the understanding of <italic>S. aureus</italic> pathogenesis versatility, as mutational footprints of selection mirror functions that are critically important for bacterial survival during invasion.</p><p>Emerging genomic approaches for analysis of within-host evolution are among the most powerful means to study bacterial host adaptation (<xref ref-type="bibr" rid="bib72">Marvig et al., 2015</xref>; <xref ref-type="bibr" rid="bib49">Kennemann et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Lieberman et al., 2016</xref>). Studies have shown the remarkable diversity and evolution of colonising populations of <italic>Streptococcus pneumoniae</italic> (<xref ref-type="bibr" rid="bib17">Chaguza et al., 2020</xref>) and <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib82">Paterson et al., 2015</xref>). In <italic>S. aureus</italic>, <italic>Enterococcus faecalis</italic> and <italic>Enterococcus faecium</italic> it has been shown that transition from colonisation to invasion favours strains with specific adaptive signatures (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>; <xref ref-type="bibr" rid="bib118">Van Tyne et al., 2019</xref>; <xref ref-type="bibr" rid="bib18">Chilambi et al., 2020</xref>), while evidence of niche adaptation was noted in a within-host study of bacterial meningitis due to <italic>S. pneumoniae</italic> (<xref ref-type="bibr" rid="bib59">Lees et al., 2017b</xref>). Furthermore, phenotypic and genomic adaptation (often in response to antibiotic pressure) has been investigated during selected episodes of persistent invasive infections due to <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib32">Giulieri et al., 2020</xref>; <xref ref-type="bibr" rid="bib45">Howden et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>), <italic>Pseudomonas aeruginosa</italic> (<xref ref-type="bibr" rid="bib123">Wheatley et al., 2021</xref>), <italic>Salmonella enterica</italic> (<xref ref-type="bibr" rid="bib52">Klemm et al., 2016</xref>), and <italic>Mycobacterium tuberculosis</italic> (<xref ref-type="bibr" rid="bib119">Vargas et al., 2021</xref>). To increase power, bacterial within-host evolution studies have leveraged on large collections of paired samples coupled with statistical models of genome-wide mutation rates (<xref ref-type="bibr" rid="bib72">Marvig et al., 2015</xref>; <xref ref-type="bibr" rid="bib59">Lees et al., 2017b</xref>; <xref ref-type="bibr" rid="bib29">Gatt and Margalit, 2021</xref>) and extended the analysis to include chromosomal structural variation (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>; <xref ref-type="bibr" rid="bib58">Lees et al., 2017a</xref>; <xref ref-type="bibr" rid="bib28">Gao et al., 2015</xref>) as well as intergenic mutations (<xref ref-type="bibr" rid="bib58">Lees et al., 2017a</xref>; <xref ref-type="bibr" rid="bib51">Khademi et al., 2019</xref>).</p><p>Convergent evolution among separated (independent) episode of colonisation or infection is a key indication of adaptation in evolution analyses. However, with the notable exception of one study of cystic fibrosis (<xref ref-type="bibr" rid="bib65">Long et al., 2020</xref>), the convergence has generally been weak in within-host studies of <italic>S. aureus</italic> infections, with no convergence at all (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>) or significant enrichment limited to the <italic>S. aureus</italic> master regulator <italic>agr</italic> (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>). We hypothesised that in addition to the small sample size, the extended range of bacterial functions potentially under selective pressure (each function being potentially targeted by diverse pathoadaptive mutations) has hampered the identification of important adaptation mechanisms. To overcome the limitations of studies to date, we have pooled all publicly available <italic>S. aureus</italic> within-host evolution studies, and complemented this with a new dataset from a recent <italic>S. aureus</italic> clinical trial (<xref ref-type="bibr" rid="bib114">Tong et al., 2020</xref>), in a single large-scale analysis. Rather than focussing on point mutations and small insertions/deletions alone, we leveraged multiple layers of genome annotation (encompassing coding regions, operons, intergenic regions, and functional categories) and included chromosome structural variants to compile a comprehensive catalogue of bacterial genetic variation arising during host infection. This strategy enabled the detection of convergent adaptation patterns at an unprecedented resolution. We also outline distinctive signatures of adaptation during colonisation, upon transition from colonisation to infection and during invasive infection.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The <italic>S. aureus</italic> within-host evolution analysis framework</title><p>We compiled a collection of 2251 <italic>S. aureus</italic> genomes from 267 independent episodes of colonisation and/or infection, reported in 24 genomic studies (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>; <xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Gao et al., 2015</xref>; <xref ref-type="bibr" rid="bib128">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib126">Wuthrich et al., 2019</xref>; <xref ref-type="bibr" rid="bib117">Trouillet-Assant et al., 2016</xref>; <xref ref-type="bibr" rid="bib110">Tan et al., 2019</xref>; <xref ref-type="bibr" rid="bib107">Suligoy et al., 2018</xref>; <xref ref-type="bibr" rid="bib94">Rouard et al., 2018</xref>; <xref ref-type="bibr" rid="bib93">Rishishwar et al., 2016</xref>; <xref ref-type="bibr" rid="bib85">Petrovic Fabijan et al., 2020</xref>; <xref ref-type="bibr" rid="bib75">Miller et al., 2020</xref>; <xref ref-type="bibr" rid="bib67">Loss et al., 2019</xref>; <xref ref-type="bibr" rid="bib64">Liu et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Langhanki et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Kuroda et al., 2019</xref>; <xref ref-type="bibr" rid="bib47">Ji et al., 2020</xref>; <xref ref-type="bibr" rid="bib46">Howden et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Harkins et al., 2018</xref>; <xref ref-type="bibr" rid="bib34">Golubchik et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Burd et al., 2014</xref>; <xref ref-type="bibr" rid="bib11">Benoit et al., 2018</xref>; <xref ref-type="bibr" rid="bib6">Azarian et al., 2019</xref>; <xref ref-type="bibr" rid="bib3">Altman et al., 2018</xref>; <xref ref-type="table" rid="table1">Table 1</xref>; <xref ref-type="supplementary-material" rid="table1sdata1">Table 1‚Äîsource data 1</xref>). We supplemented this dataset of publicly available sequences with unpublished sequences from 603 serial invasive isolates collected within the CAMERA-2 trial (<xref ref-type="bibr" rid="bib114">Tong et al., 2020</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Microbiological and clinical characteristics of the colonisation and infection episodes included in the within-host evolution analysis.</title><p><supplementary-material id="table1sdata1"><label>Table 1‚Äîsource data 1.</label><caption><title>List of within-host studies included in the analysis.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-77195-table1-data1-v2.zip"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom"/><th align="left" valign="bottom">Strains(n=2590)</th><th align="left" valign="bottom">Episodes(n=396)</th></tr><tr><th align="left" valign="bottom">Sequence type</th><th align="left" valign="bottom"/><th align="left" valign="bottom"/></tr></thead><tbody><tr><td align="left" valign="bottom">30</td><td align="left" valign="bottom">342 (13.2%)</td><td align="left" valign="bottom">43 (10.9%)</td></tr><tr><td align="left" valign="bottom">22</td><td align="left" valign="bottom">277 (10.7%)</td><td align="left" valign="bottom">44 (11.1%)</td></tr><tr><td align="left" valign="bottom">5</td><td align="left" valign="bottom">271 (10.5%)</td><td align="left" valign="bottom">42 (10.6%)</td></tr><tr><td align="left" valign="bottom">45</td><td align="left" valign="bottom">198 (7.6%)</td><td align="left" valign="bottom">38 (9.6%)</td></tr><tr><td align="left" valign="bottom">15</td><td align="left" valign="bottom">156 (6.0%)</td><td align="left" valign="bottom">4 (3.5%)</td></tr><tr><td align="left" valign="bottom">1</td><td align="left" valign="bottom">133 (5.1%)</td><td align="left" valign="bottom">14 (3.5%)</td></tr><tr><td align="left" valign="bottom">93</td><td align="left" valign="bottom">110 (4.2%)</td><td align="left" valign="bottom">29 (7.3%)</td></tr><tr><td align="left" valign="bottom">8</td><td align="left" valign="bottom">107 (4.1%)</td><td align="left" valign="bottom">18 (4.5%)</td></tr><tr><td align="left" valign="bottom">239</td><td align="left" valign="bottom">100 (3.9%)</td><td align="left" valign="bottom">29 (7.3%)</td></tr><tr><td align="left" valign="bottom">Other</td><td align="left" valign="bottom">896 (34.6%)</td><td align="left" valign="bottom">125 (31.6%)</td></tr><tr><td align="left" valign="bottom"><bold><italic>mecA</italic> positive</bold></td><td align="left" valign="bottom">1001 (38.6%)</td><td align="left" valign="bottom">207 (52.3%)</td></tr><tr><td align="left" valign="bottom"><bold>Infection syndrome</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Skin infection</td><td align="left" valign="bottom">204 (7.9%)</td><td align="left" valign="bottom">32 (8.1%)</td></tr><tr><td align="left" valign="bottom">Osteoarticular infection</td><td align="left" valign="bottom">77 (3.0%)</td><td align="left" valign="bottom">17 (4.3%)</td></tr><tr><td align="left" valign="bottom">Bacteraemia without focus</td><td align="left" valign="bottom">588 (22.7%)</td><td align="left" valign="bottom">152 (38.4%)</td></tr><tr><td align="left" valign="bottom">Bacteraemia with focus</td><td align="left" valign="bottom">331 (12.8%)</td><td align="left" valign="bottom">85 (21.5%)</td></tr><tr><td align="left" valign="bottom">Endocarditis</td><td align="left" valign="bottom">197 (7.6%)</td><td align="left" valign="bottom">44 (11.1%)</td></tr><tr><td align="left" valign="bottom">No invasive strains</td><td align="left" valign="bottom"/><td align="left" valign="bottom">66 (16.7%)</td></tr><tr><td align="left" valign="bottom"><bold>Colonisation syndrome</bold></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Nasal carriage</td><td align="left" valign="bottom">974 (37.6%)</td><td align="left" valign="bottom">166 (42%)</td></tr><tr><td align="left" valign="bottom">Cystic fibrosis</td><td align="left" valign="bottom">57 (2.2%)</td><td align="left" valign="bottom">9 (2%)</td></tr><tr><td align="left" valign="bottom">Atopic dermatitis</td><td align="left" valign="bottom">162 (6.3%)</td><td align="left" valign="bottom">9 (2%)</td></tr><tr><td align="left" valign="bottom">No colonising strains</td><td align="left" valign="bottom"/><td align="left" valign="bottom">212 (54%)</td></tr></tbody></table></table-wrap><p>Using genetic distance and sequence type (ST) to define within-host lineages, we estimated that coinfection was present in 4/336 (1%) of invasive episodes and co-colonisation 11/167 (7%). We removed genetically unrelated strains within the same episode and included 2590 genomes (1397 invasive and 1193 colonising) from 396 episodes in our within-host evolution analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>, <xref ref-type="table" rid="table1">Table 1</xref>, <xref ref-type="supplementary-material" rid="supp1 supp2">Supplementary files 1 and 2</xref>). The most prevalent lineages in the collection were ST 30 (342 strains, 13%), ST 22 (277 strains, 11%), and ST 5 (271 strains, 11%); 1001 strains (39%) were <italic>mecA</italic> positive. The collection was representative of the global <italic>S. aureus</italic> diversity, with an even distribution of colonising and invasive strains across the major clades (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). The most frequent infection syndrome was bacteraemia without focus (152 episodes, 38.4%), while nasal carriage (166 episodes, 42%) was the most prevalent colonisation condition (<xref ref-type="table" rid="table1">Table 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Overview of the <italic>S</italic>. <italic>aureus</italic> within-host evolution analysis framework.</title><p>(<bold>A</bold>) Simulated phylogenetic tree illustrating within-host evolution of <italic>S. aureus</italic> colonisation and infection. This model assumes two genetic bottlenecks (dotted lines); upon transmission and upon transition from colonisation to invasive infection. (<bold>B</bold>) Sites and timing of within-host samples and number of genomes per sample define five prototypes of within-host evolution studies, each with colonising-colonising (C&gt;C), colonising-invasive (C&gt;I), or invasive-invasive (I&gt;I) comparisons in different combinations: from top to the bottom: multiple colonising samples and one invasive samples; one colonising and one invasive sample; multiple colonising samples; multiple invasive samples; multiple colonising and invasive samples. (<bold>C</bold>) Approach to capture signals of adaptation across multiple independent episodes of colonisation/infection through detection of multiple genetic mechanisms of adaptation from short reads data and multi-layered functional annotation of the genetic variants using multiple databases including characterisation of intergenic regions (promoters), operon prediction, and gene ontology (GO). Statistical framework for the gene, operon, and gene set enrichment anlaysis (GSEA). Counts of independent mutations with likely impact on the protein sequence (non-synonymous substitutions, frameshifts, stop codon mutations, and insertion sequences [IS] insertions) were computed for each genes with a FPR3757 homologue. Gene counts (with the addition of intergenic mutations in promoter regions) were aggregated in operons and GOs. Gene and operon counts were used to fit Poisson regression models to infer mutation enrichment and significance of the enrichment. GOs counts and gene enrichment significance were used to run a gene-set-enrichment analysis. To illustrate the approach, the example of the gene <italic>walR</italic> is provided in italic.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig1-v2.tif"/></fig><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>(<bold>A</bold>) Maximum-likelihood phylogenetic tree of 2590 <italic>S</italic>. <italic>aureus</italic> sequences included in the study.</title><p>The tree is annotated (starting from the inner circle) with the most prevalent sequence types (ST), presence/absence of the <italic>mecA</italic> gene, compartment of isolation (colonising or invasive), and year of publication. (<bold>B</bold>) Summary of 396 independent episodes of <italic>S. aureus</italic> colonisation or infection categorised according to whether they allowed comparing colonising-colonising (C&gt;C), colonising-invasive (C&gt;I), or invasive-invasive (I&gt;I) strains, or a combination of them. (<bold>C</bold>) Evidence of a distinctive pattern of adaptation in late infection-adapted strains (type I&gt;I variants). For each type of comparison (type C&gt;C, colonising-colonising; type C&gt;I, colonising-invasive; type I&gt;I, invasive-invasive), the cumulative curves display the accrued number of intergenic mutations, truncating mutations, insertion sequences (IS) insertions, and large deletions as a function of the total number of mutations. Genetic events were counted once per episode, regardless of the number of strains with the mutation. The sequence of mutations events in the cumulative curves is random.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2‚Äîfigure supplement 1.</label><caption><title>Number of episode-specific variants in same-episode strains having the same sequence type (ST) as the internal reference vs. isolates with a different ST.</title><p>The dashed line represents the mutation threshold used to remove genetically unrelated strains with the same episode.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2‚Äîfigure supplement 2.</label><caption><title>Correlation between number of samples per episode and mean mutation counts.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2‚Äîfigure supplement 3.</label><caption><title>Within-host mutation rates within the colonising and invasive populations.</title><p>The scatter plots display the linear relationship between sampling time after the internal reference and number of mutations. Only episodes with at least two strains collected at at least 1 day apart were included. The shaded area around the fitted regression shows the 95% confidence interval (CI). The parameters shown on the top of each plot are the r-squared, p value, regression coefficient Œ≤, and the mutation rate Œº (mutations site<sup>‚Äì1</sup> year<sup>‚Äì1</sup>).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-figsupp3-v2.tif"/></fig><fig id="fig2s4" position="float" specific-use="child-fig"><label>Figure 2‚Äîfigure supplement 4.</label><caption><title>Regression diagnostics to assess linear regressions sampling time after the internal reference and number of mutations.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-figsupp4-v2.tif"/></fig><fig id="fig2s5" position="float" specific-use="child-fig"><label>Figure 2‚Äîfigure supplement 5.</label><caption><title>Distribution of new IS insertions by classification of the transposase and by major sequence types (ST).</title><p>(<bold>A</bold>) Distribution of the nine major ST among 2590 strains. (<bold>B</bold>) Number of independent insertion sequences (IS) insertions by ST group and type of transposase.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig2-figsupp5-v2.tif"/></fig></fig-group><p>Our within-host evolution analysis strategy identified 4556 genetic variants (median 3 per episode, range 0‚Äì237) (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Importantly, by investigating both point mutations and structural variation, we were able to uncover 214 large deletions (<underline>&gt;</underline>500 bp), 160 new insertion sequences (IS) insertions, and 609 copy number variants, underscoring the role of large chromosome structural variation in within-host evolution. To increase the evolutionary convergence signal by aggregating mutations in functionally consistent categories, we annotated all genetic variants using multiple datasets, including coding sequences, regulatory intergenic regions, operons and gene ontologies (<xref ref-type="fig" rid="fig1">Figure 1C</xref>).</p></sec><sec id="s2-2"><title>Distinctive evolutionary patterns define nose-adapted, early infection-adapted, and late infection-adapted strains</title><p>Based on the working hypothesis that <italic>S. aureus</italic> host adaptation patterns differ according to whether the strains are nose-colonising, collected at an early stage of infection (i.e. within the first 3 days) or at a late infection stage (i.e. associated with persistence beyond the first 3 days or recurrence), we assessed whether it was possible to define (i) general paradigms of genetic variation and (ii) specific convergence signatures. Thus, we classified within-host acquired variants into three groups according to their most likely location in the within-host phylogeny: (i) between colonising strains (colonising-colonising [type C&gt;C]); (ii) between colonising and early infection adapted strains (colonising-invasive [type C&gt;I]); and (iii) between invasive strains (invasive-invasive [type I&gt;I]). Overall, the 396 infection episodes included in the analysis allowed us to independently assess 166 type C&gt;C, 118 type C&gt;I, and 312 type I&gt;I within-host variants. In 95 cases, there were sufficient samples to assess all three types within the same episode (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Across colonisation/infection stages, sampling frequency did not seem to affect the number of variants identified with the exception of early adapted invasive strains (<xref ref-type="fig" rid="fig2s2">Figure 2‚Äîfigure supplement 2</xref>).</p><p>We first sought to explore whether the rate of mutations over time differs between colonising and invasive populations. To estimate within-host mutation rates, we fitted linear regressions using data from a subset of 109 episodes that had at least two colonising or invasive isolates collected at two different timepoints (total 701 strains). The regressions suggested that mutation rates were higher in the invasive population; however, this analysis was limited by the heterogeneity of sampling strategies and by evidence of heteroskedasticity and non-linear distribution (<xref ref-type="fig" rid="fig2s3">Figure 2‚Äîfigure supplements 3</xref> and <xref ref-type="fig" rid="fig2s4">4</xref>).</p><p>We have previously shown that invasive strains from persistent or relapsing infections exhibit a high proportion of protein-truncating mutations (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>). A similar enrichment of protein-truncating variants was identified within invasive strains as compared to strains from asymptomatically colonised individuals (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>; <xref ref-type="bibr" rid="bib128">Young et al., 2012</xref>). We reasoned that if this indicates genome degradation during infection, infecting strains might also be enriched for other loss of function (LOF) mutations caused by structural variants, such as movement of IS (<xref ref-type="bibr" rid="bib43">Hawkey et al., 2020</xref>) and large deletions, leading to complete or partial gene loss (<xref ref-type="bibr" rid="bib112">Toft and Andersson, 2010</xref>). In addition, we hypothesised that mutations and IS insertions in intergenic regions might contribute to altering gene expression or activity by interfering with the expression of key genes or operons (<xref ref-type="bibr" rid="bib73">McEvoy et al., 2013</xref>).</p><p>Therefore, we calculated the prevalence of intergenic mutations, protein-truncating mutations, IS insertions, and large deletions among all variants and compared it between type C&gt;C, type C&gt;I, and type I&gt;I variants. Strikingly, the distribution of mutations according to the predicted effect differed substantially in I&gt;I pairs when compared to mutations identified between nose-colonising and invasive strains and within colonising strains (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This can be expressed using the neutrality index (NI), which tests deviation from neutral evolution and is comparable to an odds ratio (<xref ref-type="bibr" rid="bib106">Stoletzki and Eyre-Walker, 2011</xref>). Relative to type C&gt;C variants, variants emerging within the infecting strains were enriched for intergenic mutations (NI 2.5; p=1.8 √ó 10<sup>‚Äì16</sup>) and protein-truncating mutations (NI 2.4; p=4.8 √ó 10<sup>‚Äì10</sup>) (<xref ref-type="table" rid="table2">Table 2</xref>). In contrast, no significant enrichment was observed among type C&gt;I variants.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Modified McDonald-Kreitman table displaying counts of variants (point mutations and structural variants) and the neutrality index for colonising-invasive (type C&gt;I) and invasive-invasive (type I&gt;I) variants (both compared to colonising-colonising [type C&gt;C] variants).</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Classification of variant</th><th align="left" valign="bottom" colspan="3">Number of variants <italic>(Neutrality index)</italic></th></tr><tr><th align="left" valign="bottom">Type C&gt;C</th><th align="left" valign="bottom">Type C&gt;I</th><th align="left" valign="bottom">Type I&gt;I</th></tr></thead><tbody><tr><td align="left" valign="bottom">Synonymous</td><td align="left" valign="bottom">381</td><td align="left" valign="bottom">130</td><td align="left" valign="bottom">155</td></tr><tr><td align="left" valign="bottom">Non-synonymous</td><td align="left" valign="bottom">978</td><td align="left" valign="bottom">300 <bold><italic>(0.9)</italic></bold></td><td align="left" valign="bottom">503 <bold><italic>(1.3)*</italic></bold></td></tr><tr><td align="left" valign="bottom">Intergenic</td><td align="left" valign="bottom">544</td><td align="left" valign="bottom">197 <bold><italic>(1.1)</italic></bold></td><td align="left" valign="bottom">549 <bold><italic>(2.5)</italic>**</bold></td></tr><tr><td align="left" valign="bottom">Truncating</td><td align="left" valign="bottom">197</td><td align="left" valign="bottom">58 <bold><italic>(0.9)</italic></bold></td><td align="left" valign="bottom">190 <bold><italic>(2.4)</italic>**</bold></td></tr><tr><td align="left" valign="bottom">Insertion sequences insertion</td><td align="left" valign="bottom">17</td><td align="left" valign="bottom">6 <bold><italic>(1.0)</italic></bold></td><td align="left" valign="bottom">137 <bold><italic>(19.8)</italic>**</bold></td></tr><tr><td align="left" valign="bottom">Large deletion</td><td align="left" valign="bottom">76</td><td align="left" valign="bottom">17 <bold><italic>(0.6)</italic>*</bold></td><td align="left" valign="bottom">122 <bold><italic>(3.9)</italic>**</bold></td></tr></tbody></table><table-wrap-foot><fn><p>Values are counts of independent mutations. The neutrality index is shown in brackets in italic.</p></fn><fn><p>Significance testing Fisher‚Äôs Exact Test: p&lt;0.05; ** p&lt;0.005.</p></fn></table-wrap-foot></table-wrap><p>While large deletions were significantly more enriched in type I&gt;I variants (NI 4.0, p=1.1 √ó 10<sup>‚Äì15</sup>), the strongest evidence for enrichment (NI 19.9, p=1.6 √ó 10<sup>‚Äì42</sup>) was found for IS insertions. We and others have previously shown that new insertions of IS<italic>256</italic> may provide an efficient mechanism of genomic plasticity in invasive <italic>S. aureus</italic> strains (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Kuroda et al., 2019</xref>; <xref ref-type="bibr" rid="bib73">McEvoy et al., 2013</xref>). Here, we expand this observation in a larger dataset and show that this mechanism is not limited to IS<italic>256</italic> (<xref ref-type="fig" rid="fig2s5">Figure 2‚Äîfigure supplement 5</xref>). As shown in <xref ref-type="fig" rid="fig2">Figure 2C</xref>, two invasive strains exhibited a burst of &gt;10 new IS insertions (IS<italic>3</italic> and IS<italic>256</italic>, respectively). It has been shown that IS activation occurs under stress conditions, such as antibiotic exposure and oxidative stress (<xref ref-type="bibr" rid="bib96">Schreiber et al., 2013</xref>), which is consistent with the selection environment encountered by invasive strains. However, these bursts occurred only in 2/1068 adapted invasive strains.</p><p>Overall, these data support a model, where late infection-adapted strains show an enrichment for variants that are predicted to exert a stronger functional impact, either by producing a truncated protein or by potentially interfering with intergenic regulatory regions, through point mutations or IS insertions. This strong genome degradation signature appears to be specific to type I&gt;I variants and was absent in type C&gt;I variants, suggesting that the bottleneck effect upon blood or tissue invasion does not explain it. To assess whether this general enrichment of non-silent evolution represented a signature of positive selection or derived from within-host gene obsolescence occurring during invasive infection, we further investigated signals of gene, operon, and pathway specific enrichment across independent episodes of infection.</p></sec><sec id="s2-3"><title>Gene enrichment analysis identifies significant hotspots of adaptation</title><p>To identify signatures of adaptation, we first counted how many times each coding sequence was mutated independently across distinct colonisation/infection episodes (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="table" rid="table3">Table 3</xref>, <xref ref-type="table" rid="table4">Table 4</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). We considered all protein-modifying mutations either predicted to cause a gain or LOF to the locus: non-synonymous substitutions, truncations, IS insertions, or deletions. To ensure consistency across the dataset, we restricted our analysis to 1736 (74%) genes with a homologue in reference strain FPR3757 (excluding plasmid genes and phage genes). Mutations were considered independent if they arose in distinct colonisation/infection episodes. To assess whether the convergent signals were a reliable indication of adaptation, we applied a gene enrichment analysis for protein-altering mutations which computes a length-corrected gene-level enrichment of protein-modifying mutations. The significance of the enrichment for each gene was estimated by comparing gene-specific Poisson models of mutation counts with the null hypothesis, which indicates neutrality and assumes a constant mutation rate across all genes (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Top 20 genes with the most significant mutation enrichment across the entire dataset.</title><p>(<bold>A</bold>) Significance of the enrichment for protein-altering mutations. The dashed line depicts the Bonferroni-corrected significance threshold, and red circles and blue circles represent genes with p values below and above the Bonferroni threshold, respectively. (B) Bar plots of independent mutations separated in three panels according to the type of variant (type C&gt;C: colonising-colonising; type C&gt;I: colonising-invasive; type I&gt;I: invasive-invasive) and coloured according to the class of mutation. (C) Gene maps with type and positions of mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 1.</label><caption><title>Mapping of mutations in the 10 most significantly enriched mutated genes across the entire dataset.</title><p>The maximum-likelihood phylogenetic tree was inferred from the core genome alignment of 2590 isolates. The variants are annotated based on SnpEff (*: stop codon; fs: frameshift; ext*?: stop lost).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 2.</label><caption><title>dN/dS values for non-synonymous mutations (<bold>A</bold>), indels (<bold>B</bold>), and non-sense mutations (stop codons) (<bold>B</bold>) for FPR3757 genes.</title><p>Only the 20 most significant genes with positive selection (dN/dS for missense mutations &gt;1) are shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 3.</label><caption><title>Scatter plot representing in silico inferred functional impact of variants in the 20 most convergent loci.</title><p>On the x-axis are shown proportions of predicted deleterious mutations (protein-truncating substitutions with PROVEAN score &lt;‚Äì2.5, insertion sequences [IS] insertions), the y-axis shows protein-truncating mutations, the colour of the dots is based on the median PROVEAN score, and the size represents the total number of aggregated mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 4.</label><caption><title>Most frequently deleted genes in large deletions.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 5.</label><caption><title>Most frequently enriched genes in copy number variations.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp5-v2.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 6.</label><caption><title>Gene convergence analysis of all mutated genes (i.e. including both genes with FPR3757 homologue and no FPR3757 homologue).</title><p>Top 20 genes with the most significant mutation enrichment across the entire dataset. (<bold>A</bold>) Significance of the enrichment for protein-altering mutations. The dashed line depicts the Bonferroni-corrected significance threshold, and red circles and blue circles represent genes with and without FPR3757 homologue, respectively. (B) Bar plots of independent mutations separated in three panels according to the type of variant (type C&gt;C: colonising-colonising; type C&gt;I: colonising-invasive; type I&gt;I: invasive-invasive) and coloured according to the class of mutation. (C) Gene maps with type and positions of mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp6-v2.tif"/></fig><fig id="fig3s7" position="float" specific-use="child-fig"><label>Figure 3‚Äîfigure supplement 7.</label><caption><title>Gene convergence analysis after removing variants in strains included in <xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>, the largest collection of this analysis (1078 strains and 105 episodes).</title><p>Top 20 genes with the most significant mutation enrichment across the entire dataset. (<bold>A</bold>) Significance of the enrichment for protein-altering mutations. The dashed line depicts the Bonferroni-corrected significance threshold, and red circles and blue circles represent genes with p values below and above the Bonferroni threshold, respectively. (B) Bar plots of independent mutations separated in three panels according to the type of variant (type C&gt;C: colonising-colonising; type C&gt;I: colonising-invasive; type I&gt;I: invasive-invasive) and coloured according to the class of mutation. (C) Gene maps with type and positions of mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig3-figsupp7-v2.tif"/></fig></fig-group><table-wrap id="table3" position="float"><label>Table 3.</label><caption><title>Genome-wide significant gene signatures of within-host evolution.</title><p>The genes shown reached genome-wide significance in the entire dataset or in either colonising-colonising (type C&gt;C), colonising-invasive (type C&gt;I), or invasive-invasive (type I&gt;I) variants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Gene</th><th align="left" valign="bottom" rowspan="2">p value(whole dataset)</th><th align="left" valign="bottom" rowspan="2">Description</th><th align="left" valign="bottom" colspan="3">N independent mutations</th><th align="left" valign="bottom" rowspan="2">Significance</th></tr><tr><th align="left" valign="bottom">Type C&gt;C</th><th align="left" valign="bottom">Type C&gt;I</th><th align="left" valign="bottom">Type I&gt;I</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>agrA</italic><xref ref-type="table-fn" rid="table3fn1"><sup>*</sup></xref></td><td align="char" char="." valign="bottom">7.04 √ó 10<sup>‚Äì28</sup></td><td align="left" valign="bottom">Accessory gene regulator protein A</td><td align="char" char="." valign="bottom">5**</td><td align="char" char="." valign="bottom">9**</td><td align="char" char="." valign="bottom">8**</td><td align="left" valign="bottom">Part of the agr quorum sensing system, which is the master regulator of virulence factors expression in <italic>S. aureus</italic>. Recurrent mutations associated with invasive disease.</td></tr><tr><td align="left" valign="bottom"><italic>agrC</italic>**</td><td align="char" char="." valign="bottom">2.84 √ó 10<sup>‚Äì10</sup></td><td align="left" valign="bottom">Accessory gene regulator protein C</td><td align="char" char="." valign="bottom">4</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">6**</td><td align="left" valign="bottom">Histidine kinase, receptor for extracellular autoactivating peptide. Phosphorylates agrA.</td></tr><tr><td align="left" valign="bottom"><italic>stp1</italic>**</td><td align="char" char="." valign="bottom">1.13 √ó 10<sup>‚Äì7</sup></td><td align="left" valign="bottom">Protein phosphatase 2 C domain-containing protein</td><td align="char" char="." valign="bottom">3</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">Associated with vancomycin resistance.</td></tr><tr><td align="left" valign="bottom"><italic>mprF</italic>**</td><td align="char" char="." valign="bottom">4.55 √ó 10<sup>‚Äì6</sup></td><td align="left" valign="bottom">Oxacillin resistance-related FmtC protein</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">9**</td><td align="left" valign="bottom">Main determinant of daptomycin resistance. Association with persistence and immune evasion.</td></tr><tr><td align="left" valign="bottom"><italic>rpoB</italic></td><td align="char" char="." valign="bottom">7.24 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">DNA-directed RNA polymerase subunit beta</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">7**</td><td align="left" valign="bottom">Association with rifampicin resistance, but selection in the absence of rifampicin exposure can happen (R503H). Co-resistance to vancomycin, daptomycin, and oxacillin. Association with persistence.</td></tr></tbody></table><table-wrap-foot><fn id="table3fn1"><label>*</label><p>Significant enrichment (above the Bonferroni-corrected cut-off, see methods).</p></fn></table-wrap-foot></table-wrap><table-wrap id="table4" position="float"><label>Table 4.</label><caption><title>Gene signatures of within-host evolution with suggestive significant enrichment.</title><p>The genes shown reached the suggestive significance threshold in the entire dataset or in either type C&gt;C, type C&gt;I, or type I&gt;I variants.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Gene</th><th align="left" valign="bottom" rowspan="2">p value(whole dataset)</th><th align="left" valign="bottom" rowspan="2">Description</th><th align="left" valign="bottom" colspan="3">N independent mutations</th><th align="left" valign="bottom" rowspan="2">Significance</th></tr><tr><th align="left" valign="bottom">Type C&gt;C</th><th align="left" valign="bottom">Type C&gt;I</th><th align="left" valign="bottom">Type I&gt;I</th></tr></thead><tbody><tr><td align="left" valign="bottom"><italic>sucA</italic><xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">6.82 √ó 10<sup>‚Äì5</sup></td><td align="left" valign="bottom">2-oxoglutarate dehydrogenase E1 component</td><td align="char" char="." valign="bottom">6</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Encodes a subunit of the Œ±-ketoglutarate dehydrogenase of the tricarboxylic acid cycle.</td></tr><tr><td align="left" valign="bottom">saeR<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">1.83 √ó 10<sup>‚Äì4</sup></td><td align="left" valign="bottom">DNA-binding response regulator SaeR</td><td align="char" char="." valign="bottom">2</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">Regulator component of the saeRS two-component system. Virulence regulation.</td></tr><tr><td align="left" valign="bottom"><italic>accB</italic></td><td align="char" char="." valign="bottom">4.27 √ó 10<sup>‚Äì4</sup></td><td align="left" valign="bottom">Biotin carboxyl carrier protein of acetyl-CoA carboxylase</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Part of the fatty acid synthesis pathway of <italic>S. aureus.</italic></td></tr><tr><td align="left" valign="bottom">SAUSA300_1856</td><td align="char" char="." valign="bottom">6.41 √ó 10<sup>‚Äì4</sup></td><td align="left" valign="bottom">Hypothetical protein</td><td align="char" char="." valign="bottom">4<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Intracellular cysteine peptidase. Putative chaperone in <italic>S. aureus.</italic></td></tr><tr><td align="left" valign="bottom"><italic>xpaC</italic></td><td align="char" char="." valign="bottom">1.38 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">Hypothetical protein</td><td align="char" char="." valign="bottom">4<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Predicted 5-bromo-4-chloroindolyl phosphate hydrolysis protein, no data on <italic>S. aureus.</italic></td></tr><tr><td align="left" valign="bottom"><italic>rpsJ</italic></td><td align="char" char="." valign="bottom">1.58 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">30S ribosomal protein S10</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Mutations at residues 53‚Äì60 are associated with tigecycline resistance, at no apparent fitness cost.</td></tr><tr><td align="left" valign="bottom">SAUSA300_2399</td><td align="char" char="." valign="bottom">1.68 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">ABC transporter ATP-binding protein</td><td align="char" char="." valign="bottom">4<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Downregulated in the presence of fusidic acid</td></tr><tr><td align="left" valign="bottom"><italic>walR</italic></td><td align="char" char="." valign="bottom">2.10 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">DNA-binding response regulator</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">Part of walKR two-component response regulator. Associated with vancomycin resistance.</td></tr><tr><td align="left" valign="bottom"><italic>yjbH</italic></td><td align="char" char="." valign="bottom">3.55 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">Dsba-family protein</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">Negative regulator of spx (directs its ClpXP-dependent degradation). Association with antibiotic resistance, virulence regulation, and oxidative stress resistance.</td></tr><tr><td align="left" valign="bottom"><italic>purR</italic></td><td align="char" char="." valign="bottom">3.86 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">Pur operon repressor</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom"><italic>purR</italic> mutants: increased biofilm formation and virulence in animal model; higher capacity to invave epithelial cells.</td></tr><tr><td align="left" valign="bottom"><italic>era</italic></td><td align="char" char="." valign="bottom">5.34 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">GTP-binding protein Era</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">1</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">Involved in ribosome assembly and stringent response.</td></tr><tr><td align="left" valign="bottom"><italic>pbp2</italic></td><td align="char" char="." valign="bottom">7.75 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">Penicillin-binding protein 2</td><td align="char" char="." valign="bottom">6<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Role in methicillin resistance (PBP2a synergism). Increased expression after oxacillin exposure.</td></tr><tr><td align="left" valign="bottom"><italic>fakA</italic></td><td align="char" char="." valign="bottom">9.90 √ó 10<sup>‚Äì3</sup></td><td align="left" valign="bottom">Hypothetical protein</td><td align="char" char="." valign="bottom">5<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="left" valign="bottom">Fatty acid kinase. Deletion mutant displayed increased virulence in a murine model of skin infection.</td></tr><tr><td align="left" valign="bottom"><italic>sgtB</italic></td><td align="char" char="." valign="bottom">2.65 √ó 10<sup>‚Äì2</sup></td><td align="left" valign="bottom">Glycosyltransferase</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">0</td><td align="char" char="." valign="bottom">3<xref ref-type="table-fn" rid="table4fn1">*</xref></td><td align="left" valign="bottom">sgtB mutations in adaptive laboratory evolution experiments upon vancomycin exposure.</td></tr></tbody></table><table-wrap-foot><fn id="table4fn1"><label>*</label><p>suggestive significant enrichment (above the suggestive significance cut-off, adjusted for false-discovery, see methods).</p></fn></table-wrap-foot></table-wrap><p>When applying a Bonferroni-corrected significance threshold (4.6 √ó 10<sup>‚Äì5</sup>), mutations in <italic>agrA</italic> were highly significantly enriched across the entire dataset (45-fold enrichment, p=7.0 √ó 10<sup>‚Äì28</sup>). Other significantly enriched genes were <italic>agrC</italic> (13-fold enrichment, p=2.8 √ó 10<sup>‚Äì10</sup>), <italic>stp1</italic> (14-fold enrichment, p=1.1 √ó 10<sup>‚Äì7</sup>), and <italic>mprF</italic> (sixfold enrichment, p=4.6 √ó 10<sup>‚Äì6</sup>). The gene <italic>sucA</italic> reached near-significance (fivefold enrichment, p=6.8 √ó 10<sup>‚Äì5</sup>). Mutations in genes most significantly targeted by convergent evolution were evenly distributed across the <italic>S. aureus</italic> phylogeny, indicating that these adaptative mechanisms were not specific to selected lineages (<xref ref-type="fig" rid="fig3s1">Figure 3‚Äîfigure supplement 1</xref>). Using dN/dS analysis, we confirmed signatures of positive selection in the most significantly enriched genes, although only <italic>agrA</italic> reached statistical significance (<xref ref-type="fig" rid="fig3s2">Figure 3‚Äîfigure supplement 2</xref> and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>We found that several genes with the most significant enrichment (<italic>agrA</italic>, <italic>agrC, stp1</italic>, and <italic>sucA</italic>) were recurrently mutated across all three within-host evolutionary scenarios, implying a global role in <italic>S. aureus</italic> adaptation during colonisation and invasion. This suggests partial adaptation of <italic>S. aureus</italic> strains upon invasion. It has been previously shown that adaptive mutations, particularly within the quorum sensing accessory gene regulator (<italic>agr</italic>), are enriched in invasive <italic>S. aureus</italic> strains, suggesting that adapted strains are more prone to be involved in invasive disease (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>; <xref ref-type="bibr" rid="bib128">Young et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Altman et al., 2018</xref>; <xref ref-type="bibr" rid="bib104">Smyth et al., 2012</xref>). While the key role of <italic>agr</italic> was consistent with previous evidence from clinical and experimental studies, the high number of recurrent <italic>sucA</italic> mutations was surprising. This metabolic gene encodes for the Œ±-ketoglutarate dehydrogenase of the tricarboxylic acid cycle, and recent work has revealed the functional basis of its potential role in adaptation. Its inactivation was found to lead to a persister phenotypye (<xref ref-type="bibr" rid="bib121">Wang et al., 2018</xref>), and <italic>sucA</italic> was a hotspot of metabolic adaptation to antibiotics in a recent in vitro evolution study (<xref ref-type="bibr" rid="bib66">Lopatkin et al., 2021</xref>).</p><p>Adaptive mutations can cause both loss or gain of function of the gene affected; however, LOF is thought to be most frequent consequence of adaptation (<xref ref-type="bibr" rid="bib10">Behe, 2010</xref>). We inferred LOF when variants lead to protein truncation (including intragenic IS insertions) or non-synonymous substitutions were expected to be deleterious based on the degree of divergence in conserved sites of the protein <xref ref-type="bibr" rid="bib19">Choi et al., 2012</xref>. The majority (63%) of aggregated variants in adaptive loci were predicted to lead to LOF (<xref ref-type="fig" rid="fig3s3">Figure 3‚Äîfigure supplement 3</xref>), either because of accumulation of truncating mutations (<italic>agrA and agrC</italic>) or exclusively because of deleterious substitutions (<italic>walR</italic> and <italic>vraG</italic>). Because only LOF is inferred from the sequence, gain of function variants might be miss-classified as neutral (or even deleterious). We considered this hypothesis for genes with low frequency of truncations and expected adaptive advantage of gain of function mutations based on the literature. For example, <italic>mprF</italic> mutations associated with vancomycin or daptomycin resistance have been shown to be associated with increased enzymatic activity of the protein leading to decreased negative charge of the membrane (<xref ref-type="bibr" rid="bib24">Ernst and Peschel, 2019</xref>). Among within-host acquired <italic>mprF</italic> mutations in our dataset, we found that four of them were previously described and associated with antibiotic resistance through a gain of function mechanism (<xref ref-type="bibr" rid="bib24">Ernst and Peschel, 2019</xref>). A distinctive sign of these variants was convergence at position or mutation level, which has been described as a potential hallmark of gain of function mutations (<xref ref-type="bibr" rid="bib30">Gerasimavicius et al., 2021</xref>). Further supporting the evidence for gain of function, <italic>mprF</italic> was duplicated in one of the episodes, as reported previously (<xref ref-type="bibr" rid="bib28">Gao et al., 2015</xref>), while no other convergent gene was affected by within-host copy number variants. We also assessed <italic>accB</italic> because no variant in this genes was classified as deleterious; however, <italic>accB</italic> mutations have been previously described as LOF in strains that are auxotroph for fatty acids (<xref ref-type="bibr" rid="bib79">Morvan et al., 2016</xref>). Thus, based on in silico prediction and previous data, we hypothesise that variants in convergent loci were mostly expected to be LOF with the exception of <italic>mprF</italic>.</p><p>To confirm that our gene enrichment analysis (focused on point mutations and IS insertions and limited to genes with FPR3757 homologues) captured the large part of adaptation, we analysed variation due to large deletions and copy number variation, which were not included in the gene enrichment analysis. We observed multiple independent deletions and amplifications mainly in phage genes (<xref ref-type="fig" rid="fig3s4">Figure 3‚Äîfigure supplement 4</xref> and <xref ref-type="fig" rid="fig3s5">Figure 3‚Äîfigure supplement 5</xref>). We also repeated the gene enrichment analysis with all mutated genes (with and without FPR3757 homologues) and found very similar results, with only two hypothetical proteins with no FPR3757 homologue among the genes with most significant enrichment (<xref ref-type="fig" rid="fig3s6">Figure 3‚Äîfigure supplement 6</xref>).</p></sec><sec id="s2-4"><title>Combining multiple mechanisms of adaptation and multi-layered annotation increases the signal of convergent evolution</title><p>To increase our ability to capture signatures of adaptation from convergent evolution, we extended our analysis beyond coding sequences, to integrate the genetic variation signals issued from intergenic mutations and IS insertions in intergenic regions. This multi-layered annotation of mutated regions was shown to increase the amount of information gained from in vitro adaptive evolution experiments (<xref ref-type="bibr" rid="bib86">Phaneuf et al., 2020</xref>). Such methodology allows for an advanced classification of intergenic mutations based on regulatory sequences including promoters and transcription units based on data acquired from RNAseq experiments (<xref ref-type="bibr" rid="bib70">M√§der et al., 2016</xref>; <xref ref-type="bibr" rid="bib88">Prados et al., 2016</xref>).</p><p>Using this approach, we were able to assign 150/1237 (11%) of all intergenic mutations and IS insertions to a predicted regulatory region. We found that the <italic>agr</italic>, <italic>sucAB</italic>, and <italic>walKR</italic> operons had the strongest convergent evolution signal with 28, 13, and 13 independent mutations (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Mutations within these loci were significantly (<italic>agr</italic>, 12-fold enrichment, p=1.1e-21; <italic>sucAB</italic>, fourfold enrichment, p=4.5e-5) or near-significantly enriched (<italic>walKR</italic>, threefold enrichment, p=1.7e-4) (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Interestingly, promoter mutations represented 2/13 (15%) of the <italic>walKR</italic> operon mutations, indicating that potentially impactful intergenic variants may be missed when considering only coding regions. Furthermore, new IS insertions were found within type I&gt;I variants: three insertions into <italic>agrC</italic> (predicted to inactivate the gene, as shown previously in staphylococci [<xref ref-type="bibr" rid="bib12">Both et al., 2021</xref>; <xref ref-type="bibr" rid="bib108">Suligoy et al., 2020</xref>]) and an insertion 159 bp upstream of <italic>walR</italic>, in a region encompassing its cognate promoter. Together with the strong enrichment for IS insertions within type I&gt;I variants, the location of these insertions in recurrently mutated operons suggests that IS insertions contribute to the adaptive evolution of <italic>S. aureus</italic> during invasive infection.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Top 20 operons with the most significant mutation enrichment across all dataset.</title><p>(<bold>A</bold>) Significance of the enrichment for protein-altering mutations. The dashed line depicts the Bonferroni-corrected significance threshold, and red circles and blue circles represent operons with p values below and above the Bonferroni threshold, respectively. (B) Bar plots of independent mutations separated in three panels according to the type of variant (type C&gt;C: colonising-colonising; type C&gt;I: colonising-invasive; type I&gt;I: invasive-invasive) and coloured according to the class of mutation. Mutations were considered independent if they occurred in separate episodes of either colonisation or invasive infection. (C) Operon maps with positions of the mutations (relative to the start of the first gene of the operon). Operons are labelled with the names of the genes included, and longer labels were shorted for clarity (see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> for details).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig4-v2.tif"/></fig></sec><sec id="s2-5"><title>Adaptation within the invasive population is distinctive and strongly driven by antibiotics</title><p>The excess of non-silent evolution (and potentially function-altering) within invasive strains suggested that strong, specific selection pressure occurs within the invasive populations (type I&gt;I variants). We therefore assessed genes that appeared to be specifically mutated or inactivated during infection. We performed our gene- and operon-enrichment analysis for each type of within-host variants separately (i.e. within the colonising population, between colonising and invasive strains, and within the invasive population) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We found that <italic>agrA</italic> mutations were highly enriched in any group of variants, and particularly prevalent between colonising and invasive strains (type C&gt;I variants), consistent with a previous study that is included in this analysis (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>). Among type I&gt;I variants (between invasive strains), a significant enrichment was observed in <italic>mprF</italic> (18-fold enrichment, p=2.8 √ó 10<sup>‚Äì9</sup>), <italic>agrC</italic> (24-fold enrichment, p=2.1 √ó 10<sup>‚Äì7</sup>), and <italic>rpoB</italic> (10-fold enrichment, p=8.8 √ó 10<sup>‚Äì6</sup>). Other genes that were strongly enriched in type I&gt;I variants (below the Bonferroni-corrected threshold, but above the suggestive significance threshold, <xref ref-type="fig" rid="fig5">Figure 5</xref>) included <italic>walR</italic> (22-fold enrichment, p=3.5 √ó 10<sup>‚Äì4</sup>), <italic>stp1</italic> (20-fold enrichment, p=4.2 √ó 10<sup>‚Äì4</sup>), <italic>yjbH</italic> (19-fold enrichment, p=5.4 √ó 10<sup>‚Äì4</sup>), <italic>sgtB</italic> (19-fold enrichment, p=5.5 √ó 10<sup>‚Äì4</sup>), and <italic>purR</italic> (18-fold enrichment, p=5.8 √ó 10<sup>‚Äì4</sup>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Modified volcano plot displaying enrichment (x-axis) and significance of enrichment (y-axis) within colonising-colonising (type C&gt;C), colonising-invasive (type C&gt;I), and invasive-invasive (type I&gt;I) variants.</title><p>The horizontal dashed line depicts the Bonferroni-corrected significance threshold and dotted line shows the suggestive significance threshold. Labels indicate genes with significance of enrichment below the suggestive threshold. Genes are coloured in red if the p value is below the Bonferroni-corrected threshold and in blue otherwise.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5‚Äîfigure supplement 1.</label><caption><title>Modified volcano plot displaying enrichment (x-axis) and significance of enrichment (y-axis) for FPR3757 operons across the entire dataset, colonising-colonising (type CC), colonising-invasive (type CI), and invasive-invasive (type II) variants.</title><p>The horizontal line depicts the Bonferroni-corrected significance threshold. Genes are coloured in red if the p value is below the Bonferroni-corrected threshold and in blue otherwise. Operons are labelled if they were significantly enriched or reached near significance.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5‚Äîfigure supplement 2.</label><caption><title>Gene set enrichment analysis (GSEA) for protein-modifying mutations in colonising-colonising (type CC), colonising-invasive (type CI), and invasive-invasive (type II) variants.</title><p>(<bold>A</bold>) Gene ontologies (minimum set size 10 for a total of 110 categories) ordered by normalised enrichment score (NES). Ontologies with negative enrichment were excluded. Dark blue bars indicate a significant p value after false discovery rate correction (<bold>B</bold>) Dot plot of nine significantly enriched ontologies among type II variants.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig5-figsupp2-v2.tif"/></fig></fig-group><p>The enrichment for mutations in <italic>mprF, rpoB, stp1, sgtB,</italic> and in the <italic>walKR/yycH</italic> operon (11-fold enrichment, p=9 √ó 10<sup>‚Äì9</sup>, see <xref ref-type="fig" rid="fig5s1">Figure 5‚Äîfigure supplement 1</xref> for the operon enrichment analysis) highlights the role of antibiotic pressure in shaping adaptation within the invasive population, since these loci are hotspots of adaptation to key anti-staphylococcal antibiotics that are often used in invasive infections (rifampicin, daptomycin, and vancomycin). For example, the essential two-component regulator <italic>walKR/yycFG</italic> (and its associated genes <italic>walH</italic>/<italic>yycH</italic>) have been shown to have a key role in vancomycin resistance in one of the within-host evolution studies included in this analysis (<xref ref-type="bibr" rid="bib46">Howden et al., 2011</xref>), while mutations in both <italic>stp1</italic> and <italic>sgtB</italic> have been observed in vancomycin-adapted strains (<xref ref-type="bibr" rid="bib69">Machado et al., 2021</xref>).</p><p>Notably, the most significant gene signatures in invasive strains might have been selected in response to other selective pressures, including the host immune response during infection. For example, <italic>rpoB</italic> mutations have been associated with pleiotropic effects, including co-resistance to vancomycin, daptomycin, and oxacillin and immune evasion, suggesting a potential role in adaptation beyond the response to the selective pressure from rifampicin (<xref ref-type="bibr" rid="bib38">Gu√©rillot et al., 2018</xref>). This hypothesis is supported by the presence of mutations (such as the <italic>rpoB</italic> R503H substitution and N405 inframe deletion) outside the rifampicin-resistance determining region.</p><p>Pleiotropic phenotypes are also likely to underlie the enrichment of <italic>yjbH</italic> with invasive strains, which was mutated four times (of which three were truncations), yet only one mutation was found in colonising strains or early infection-adapted strains. This gene has a cysteine-rich domain that is homologous to <italic>dsbA</italic> in <italic>Escherichia coli</italic>. One of its roles in <italic>S. aureus</italic> is to facilitate the ClpXP-dependent degradation of the transcriptional regulator Spx (<xref ref-type="bibr" rid="bib5">Austin et al., 2019</xref>). Inactivation of <italic>yjbH</italic> has been associated with oxacillin (<xref ref-type="bibr" rid="bib33">G√∂hring et al., 2011</xref>) and vancomyin (<xref ref-type="bibr" rid="bib92">Renzoni et al., 2011</xref>) resistance, impaired growth (<xref ref-type="bibr" rid="bib23">Engman et al., 2012</xref>), and reduced virulence in animal models (<xref ref-type="bibr" rid="bib83">Paudel et al., 2021</xref>), indicating that <italic>yjbH</italic> mutations may influence both host-pathogen interaction and antibiotic resistance. Finally, <italic>purR</italic>, a purine biosynthesis repressor, has been recently characterised beyond its metabolic function: interestingly, it was shown to be a virulence regulator (<xref ref-type="bibr" rid="bib95">Sause et al., 2019</xref>), where <italic>purR</italic> mutants displayed higher bacterial counts following mice infection, increased biofilm formation (<xref ref-type="bibr" rid="bib35">Goncheva et al., 2019</xref>), and higher capacity to invade epithelial cells (<xref ref-type="bibr" rid="bib36">Goncheva et al., 2020</xref>).</p><p>We performed a gene set enrichment analysis (GSEA), using gene ontology and antibiotic resistance gene annotations (<xref ref-type="bibr" rid="bib25">Feldgarden et al., 2019</xref>). The GSEA, stratified by variant type, showed significant enrichment only in type I&gt;I variants, further underscoring the higher level of adaptation in this group (<xref ref-type="fig" rid="fig5s2">Figure 5‚Äîfigure supplement 2</xref> and <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>) and confirmed the broad functional implications of the most enriched genes and operons with the invasive populations, since among the ontologies that were significantly enriched within the invasive population, we found the categories ‚ÄòDNA binding‚Äô (normalised enrichment score [NES]=1.6, false discovery rate [FDR]-adjusted p=9 √ó 10<sup>‚Äì4</sup>), ‚Äòpathogenesis‚Äô (NES = 1.7, adjusted p=4 √ó 10<sup>‚Äì3</sup>), and ‚Äòantibiotic response‚Äô (NES = 1.8, adjusted p=7 √ó 10<sup>‚Äì3</sup>).</p><p>Taken together, these findings point to six key genetic loci that appear to have an important role in <italic>S. aureus</italic> adaptation during invasive infections. These loci are associated with either antibiotic resistance (<italic>mprF</italic>, <italic>rpoB</italic>, <italic>stp1</italic>, <italic>sgtB</italic>, and <italic>walKR</italic>), pathogenesis (<italic>agrAC</italic> and <italic>purR</italic>), or both (<italic>yjbH</italic>).</p></sec><sec id="s2-6"><title>A mutation‚Äôs co-occurrence network defines loci under within-host co-evolutionary pressure</title><p>Epistasis, defined as the interaction of multiple mutations on a given phenotype (<xref ref-type="bibr" rid="bib61">Levin-Reisman et al., 2019</xref>), plays a role in adaptive evolution in bacteria, particularly in antibiotic resistance (<xref ref-type="bibr" rid="bib103">Skwark et al., 2017</xref>; <xref ref-type="bibr" rid="bib120">Wadsworth et al., 2018</xref>; <xref ref-type="bibr" rid="bib127">Yokoyama et al., 2018</xref>). Whether epistatic interactions could promote <italic>S. aureus</italic> adaptation during infection remains unknown. Identifying these interactions would enable identification of combinations of mutations underlying bacterial adaption during infection and refine the prediction of infection outcomes. Here, we assessed co-occurrence of mutations and mutated genes across independent episodes of colonisation/infection. While co-occurrence may simply result from co-selection (e.g. simultaneous exposure to two different antibiotics), it may also indicate putative epistatic interactions that could be explored in terms of potential impact on adaptive phenotypes (<xref ref-type="bibr" rid="bib87">Phillips, 2008</xref>).</p><p>First, we explored co-occurrence of mutations and found only one case where the same mutations co-occurred in more than one independent episode. The two mutations were an inframe deletion within hypothetical protein SAUSA300_2068 and a A60D substitution of the gene <italic>ywlC</italic>. These genes are closely located in FPR3757. While the co-occurrence could be explained by recombination, recombination is expected to be rare amongst within-host <italic>S. aureus</italic> populations in general (<xref ref-type="bibr" rid="bib34">Golubchik et al., 2013</xref>) and even rarer within invasive strains. YwlC is a threonylcarbamoyl-AMP synthase <italic>in E. coli</italic>, thus it is possible that SAUSA300_2068 is also a ribosomal protein. Ribosomal proteins can display regulatory activity (<xref ref-type="bibr" rid="bib4">Aseev and Boni, 2011</xref>) and could plausibly be targets of adaptation to both antibiotics and the host/intracellular survival. This specific case of convergent co-occurrence of mutations was detected within type I&gt;I variants.</p><p>When assessing interactions at gene level (i.e. co-occurrence of the same altered protein sequences across independent episodes), we found the strongest interaction between the <italic>agrA</italic> and <italic>agrC</italic> genes (<xref ref-type="fig" rid="fig6">Figure 6</xref>). While this is consistent with the high convergence of mutations in the <italic>agr</italic> locus, this suggests that strains acquire multiple mutations within the locus, possibly further impacting <italic>agr</italic> activity. Interestingly, no convergent co-occurrence signature compatible with possible epistasis was observed within the <italic>walKR</italic> locus, the other operon with a high number of independent mutations; which could be due to the essentiality of <italic>walKR</italic> in <italic>S. aureus</italic> (<xref ref-type="bibr" rid="bib78">Monk et al., 2019</xref>). Collectively, <italic>agr</italic> locus mutations interacted with 17 other mutated genes, the strongest interaction being with <italic>stp1</italic>. Since <italic>stp1</italic> (a serine/threonine phosphatase) has been previously associated with virulence regulation (<xref ref-type="bibr" rid="bib16">Cameron et al., 2012</xref>), this interaction potentially indicates another mechanism by which adapted strains fine-tune the gene expression profile that is already altered by <italic>agr</italic> mutations.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Network of mutations co-occurrence.</title><p>The width and colour of the edges represent the strength of the co-occurrence of mutated genes on the same strain (thin and blue, two independent co-occurrences; thick and orange, three independent co-occurrences).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig6-v2.tif"/></fig><p>Another moderately strong interaction was observed between <italic>rpoB</italic> and <italic>parC</italic>, which were co-mutated in three independent episodes. Given the association of <italic>parC</italic> mutations with fluoroquinolone resistance (<xref ref-type="bibr" rid="bib116">Trong et al., 2005</xref>), this interaction is likely to be an example of co-selection due to co-exposure to fluoroquinolones and rifampicin.</p></sec><sec id="s2-7"><title>Clinical correlates of adaptive signatures within colonising and invasive populations</title><p>Genetic signatures of bacterial adaptation have been associated with infection extent, for example, enabling the prediction of extraintestinal infection with <italic>S. enterica</italic> (<xref ref-type="bibr" rid="bib124">Wheeler et al., 2018</xref>). We have previously shown that adaptive mutations are enriched in invasive infections; however, it is unclear whether bacterial adaptation is more likely to be associated with distinctive clinical syndromes. To identify clinical correlates of adaptive signatures, we classified colonisation and infection episodes based on the sites of collection and on clinical data obtained from the publications (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7‚Äîfigure supplement 1</xref>). We then used the Jaccard index and network analysis to compute node centrality as a global measure of adaptation for each independent episode. The Jaccard index can be used as a simple marker of the proportion of shared mutated genes between pairs of colonisation or infection episodes (<xref ref-type="bibr" rid="bib7">Bailey et al., 2017</xref>). Node centrality allows to similtuaneously take into account the strength of similarity between independent episodes (Jaccard index) and the number of pairs with shared mutated genes (number of connections). Hence, a node centrality of 0, indicates that the episode does not share any mutated genes with other episodes and appears as isolates node on the adaptation network (<xref ref-type="fig" rid="fig7s2">Figure 7‚Äîfigure supplement 2</xref>). Here, we limited the analysis to the 20 most significantly enriched genes with each type of variant.</p><p>Our network analysis showed that adaptation was present in only a minority of episodes within each type of variant (<xref ref-type="fig" rid="fig7s2">Figure 7‚Äîfigure supplement 2</xref>). With a definition of adaptation based on a centrality value of more than 0, we found that the proportion of adaptive episodes was 43, 20, and 22% with type C&gt;C, C&gt;I, and I&gt;I variants, respectively. In addition, certain clinical syndromes were more strongly associated with adaptation. Within the colonising population (type C&gt;C variants), almost 80% of cystic fibrosis episodes were adaptive, as opposed to one third of episodes of skin colonisation in atopic dermatitis (<xref ref-type="fig" rid="fig7">Figure 7AB</xref>). This is consistent with within-host evolution studies showing strong convergent evolution signals among bacterial populations colonising individuals with cystic fibrosis, not only in case of <italic>S. aureus</italic> colonisation (<xref ref-type="bibr" rid="bib65">Long et al., 2020</xref>) but also <italic>P. aeruginosa</italic> (<xref ref-type="bibr" rid="bib72">Marvig et al., 2015</xref>) and <italic>Mycobacterium abscessus</italic> (<xref ref-type="bibr" rid="bib13">Bryant et al., 2021</xref>); however, one study found adaptive evolution signals in atopic dermatitis (<xref ref-type="bibr" rid="bib50">Key et al., 2021</xref>). We also observed that adaptation among infection episodes correlated with infection extent. Episodes of infective endocarditis episodes displayed higher adaptation metrics (46% with centrality &gt;0) than bacteraemia with additional infection foci (28%) and bacteraemia without focus (17%) (<xref ref-type="fig" rid="fig7">Figure 7D‚ÄìE</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Clinical correlates of adaptive signatures within colonising (colonising-colonising [type C&gt;C,] panels A‚ÄìC) and invasive (invasive-invasive [type I&gt;I], panels D‚ÄìF) bacterial populations.</title><p>Adaptation was inferred by computing the Jaccard index of shared mutated genes between independent episodes, followed by network analysis of infection episodes pairs. The node centrality measure was used as an indicator of adaptation. To avoid overinflation of mutated genes, the calculation was limited to the 20 most significantly enriched genes within each group of mutations. (<bold>A, D</bold>) Density of centrality values across colonisation (panel A) and infection categories (panel D). (<bold>B, E</bold>) Number and proportion of adaptive episodes. An adaptive episode was defined by a centrality &gt;0. (<bold>C, F</bold>) Distribution of mutations in the 20 most significantly enriched genes across categories of colonisation (panel C) and infection (panel F).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7‚Äîfigure supplement 1.</label><caption><title>Clinical manifestations and infection sites of invasive episodes, grouped by the infection syndromes classification used for the adaptation analysis.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig7-figsupp1-v2.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7‚Äîfigure supplement 2.</label><caption><title>Network of colonisation/infection episodes for colonising-colonising (type CC) (panel A), colonising-invasive (type CI) (panel B), and invasive-invasive (type II) variants (panel C).</title><p>Nodes indicate independent episodes, coloured based on the clinical syndrome, edges show connections based on shared mutated genes (the width of the connection is proportional to the Jaccard index).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-77195-fig7-figsupp2-v2.tif"/></fig></fig-group><p>To explore the syndrome-specificity of adaptation signatures, we mapped mutations in the most significantly enriched adaptive genes to clinical syndromes of colonisation and infection (<xref ref-type="fig" rid="fig7">Figure 7</xref> panels C and F). As expected, syndromes with high prevalence of adaptation had higher numbers of episodes with adaptive mutations; however, some genes appeared to be preferentially mutated. For example, <italic>rpsJ</italic>, <italic>stp1,</italic> and SAUSA300_1230 were over-represented in cystic fibrosis, while no clear pattern of mutations was discernible for nasal carriage episodes. Within infection syndromes, <italic>mprF</italic> and <italic>purR</italic> mutations were more prevalent in endocarditis, and <italic>yjbH</italic> mutations were only found in severe infections (bacteraemias with additional foci and endocarditis). Some genes appeared to be distinctive for low adaptation groups (atopic dermatitis and skin infections); however, the low number of adaptative mutations prevented an accurate assessment of these profiles.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Within-host evolution of bacterial pathogens such as <italic>S. aureus</italic> is thought to be governed by a combination of positive selection for variants that confers an advantage within the host and random fixation of mutations (genetic drift) (<xref ref-type="bibr" rid="bib52">Klemm et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Didelot et al., 2016</xref>). Sudden changes in the effective population size (bottlenecks) can cause genetic drift, for example, when a single or few bacterial cells invade the bloodstream or when a secondary infection foci is established in tissues and organs. Consistent with this view, animal studies have shown that after infecting the blood with a polyclonal population, bacteraemic infection is established stochastically by a single clone (<xref ref-type="bibr" rid="bib74">McVicker et al., 2014</xref>; <xref ref-type="bibr" rid="bib39">Guerillot et al., 2018</xref>), although estimating the bottleneck size at invasion from clinical sequences has been more challenging (<xref ref-type="bibr" rid="bib2">Abel et al., 2015</xref>). On the other hand, several lines of evidence support the role of positive selection and adaptive evolution during <italic>S. aureus</italic> infection. First, adaptive phenotypic features appear to be acquired during infection. The most obvious adaptative phenotype is secondary resistance to antistaphylococcal antibiotics such as rifampicin, vancomycin (<xref ref-type="bibr" rid="bib45">Howden et al., 2006</xref>), daptomycin (<xref ref-type="bibr" rid="bib84">Peleg et al., 2012</xref>), and oxacillin (<xref ref-type="bibr" rid="bib32">Giulieri et al., 2020</xref>). Crucially, these resistance phenotypes can be associated with pleiotropic, pathoadaptative phenotypes such as small colony variant and immune evasion (<xref ref-type="bibr" rid="bib38">Gu√©rillot et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Jiang et al., 2019</xref>; <xref ref-type="bibr" rid="bib40">Gu√©rillot et al., 2019</xref>). Furthermore, phenotypic adaptation (e.g. loss of toxicity) has been observed upon transition from colonisation to infection (<xref ref-type="bibr" rid="bib56">Laabei et al., 2015</xref>), supporting the concept that invasive infection is linked to pathoadapted strains. At the molecular level, an excess of protein-truncating mutations in invasive strains (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>) and in late colonising strains leading to infection (<xref ref-type="bibr" rid="bib128">Young et al., 2012</xref>) have been noted. While this observation alone could be explained by relaxed constraint resulting from reduced population size (<xref ref-type="bibr" rid="bib22">Didelot et al., 2016</xref>), it has been suggested that loss of gene function might be a common adaptation mechanism of within-host evolution (<xref ref-type="bibr" rid="bib29">Gatt and Margalit, 2021</xref>), as supported by evidence of gene- or pathway-specific enrichment of mutations across independent infection episodes (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>).</p><p>Despite support for adaptive evolution from previous studies, it has been difficult to identify specific molecular signatures of adaptation during infection, due to the limited power of previous within-host studies of bacteraemia and other serious <italic>S. aureus</italic> infections that were often limited to a restricted number of episodes. To increase our ability to identify signatures of adaptation and find significantly enriched loci, we analysed multiple sources of genetic variation (point mutations, large deletions, IS insertions, and copy number variants) in a large collection of independent episodes of <italic>S. aureus</italic> colonisation and infection from 25 studies. We predicted that the main advantage of our approach would be to increase the ability of detecting convergence of genetic variants arising during invasive infections as opposed to those detected during the colonisation and upon transition from colonisation to infection. To test this hypothesis, we classified within-host variants based on their likely position in the within-host phylogeny (<xref ref-type="fig" rid="fig1">Figure 1D</xref>).</p><p>Bacterial adaptation is promoted by genomic plasticity; however, within-host evolution is characterised by low genetic variation (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>). Based on our previous genomic studies of <italic>S. aureus</italic> bacteraemia, we reasoned that chromosome structural variants may provide an additional mechanism to increase genetic variation during infection. Here, we found that new insertions of IS are strongly enriched during invasive infection. However, despite this 20-fold enrichment, IS insertions remained a rare source of variation even within invasive strains and appeared to have a selective contribution to adaptation (i.e. limited to specific loci such as <italic>agrC</italic>). Similarly, large deletions and copy number variants appeared to play a less prominent role in adaptation, although we did not include them in our enrichment analysis.</p><p>Together with the enrichment for LOF mutations, which is another feature of evolution within the invasive population in our analysis, these IS movements suggest that a pattern of reductive evolution (genome degradation through loss of genes or accumulation of LOF mutations) emerges during within-host evolution of invasive <italic>S. aureus</italic>. This genome degradation might be related to less effective purifying selection (loss of deleterious alleles) in the invasive population due to a decrease in effective population size and a shorter evolutionary timescale (<xref ref-type="bibr" rid="bib22">Didelot et al., 2016</xref>). However, our data indicate that these changes converge to specific genes, operons, and pathways, suggesting an adaptative benefit. Reductive evolution has been described in several ‚Äòcommensal-to-pathogen‚Äô settings (<xref ref-type="bibr" rid="bib112">Toft and Andersson, 2010</xref>). Although niche adaptation through reductive evolution has been described in extracellular pathogens (<xref ref-type="bibr" rid="bib105">Stinear et al., 2007</xref>), a smaller (reduced) genome is a hallmark of obligate intracellular endosymbiotic bacteria (<xref ref-type="bibr" rid="bib9">Batut et al., 2014</xref>). Since it appears that invasive <italic>S. aureus</italic> is able to reside intracellularly (promoting dissemination through mobile phagocytes during <italic>S. aureus</italic> sepsis [<xref ref-type="bibr" rid="bib111">Thwaites and Gant, 2011</xref>; <xref ref-type="bibr" rid="bib109">Surewaard et al., 2016</xref>], and immune evasion), it is plausible that this pattern of reductive evolution reflects an adaptation of invasive <italic>S. aureus</italic> to an invasive and intracellular lifestyle, as it has been shown for other facultative intracellular pathogens such as non-typhoidal <italic>Salmonella</italic> (<xref ref-type="bibr" rid="bib52">Klemm et al., 2016</xref>). However, it is possible that these signatures of reductive evolution might be only temporary, as genome degradation might be present only in a minority of strains or be reversible; moreover, LOF mutations are expected to be more likely than gain of function mutations.</p><p>Beside reductive evolution, another distinctive feature of within-host evolution during invasive infection was intergenic mutations (both point mutations and IS insertions). In a within-host evolution study of <italic>S. pneumoniae</italic> colonisation, it was shown that intergenic sites were under convergent evolution (<xref ref-type="bibr" rid="bib17">Chaguza et al., 2020</xref>). Mutations in promoter sequences of some core genes can play an important role in antibiotic resistance as it was repeatedly shown for <italic>pbp4</italic> and resistance to beta-lactam antibiotics (<xref ref-type="bibr" rid="bib8">Basuino et al., 2018</xref>). The role of intergenic mutations in within-host evolution was shown in a study of <italic>P. aeruginosa</italic> infection, where convergent evolution targeted several intergenic regulatory regions including upstream of antibiotic resistance genes (<xref ref-type="bibr" rid="bib51">Khademi et al., 2019</xref>).</p><p>Previous work on within-host evolution by our group (included in this analysis) has established that <italic>agrA</italic> mutations are significantly enriched upon transition from colonisation to infection (<xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>). In addition, we have shown through genomics and targeted mutagenesis that mutations in key genes such as <italic>walKR</italic> (<xref ref-type="bibr" rid="bib46">Howden et al., 2011</xref>) and <italic>rpoB</italic> (<xref ref-type="bibr" rid="bib27">Gao et al., 2013</xref>) play a key pathoadaptive role in selected cases of persistent <italic>S. aureus</italic> infections. In this study, we increased our ability to discover potential targets of adaptation by analysing several mechanisms of genetic variation and applying several layers of annotation. As compared to previous work on <italic>S. aureus</italic>, this approach provides a higher-resolution picture of within-host evolution and adaptation. Importantly, this analysis remains robust after removing more than 1000 sequences from the largest within-host study included (<xref ref-type="fig" rid="fig3s7">Figure 3‚Äîfigure supplement 7</xref>). We increase here the generalisability of our findings. We expand the list of genes targeted by convergent evolution and show that there are distinctive adaptation pathways in colonising and invasive populations. We confirm that the dominantly mutated loci belonged to the <italic>agr</italic> locus, in particular <italic>agrA</italic> and <italic>agrC</italic>. This finding is consistent with a large body of literature that predated the genomic era (<xref ref-type="bibr" rid="bib80">Novick and Geisinger, 2008</xref>) that supports the role of the <italic>agr</italic> locus as the master regulator of gene expression in <italic>S. aureus. Agr</italic>-mediated adaptation was so important that we found a highly significant enrichment of <italic>agr</italic> mutations arros all type variants, including within colonising strains (type C&gt;C variants). Shopsin et al. showed that ~10% of healthy <italic>S. aureus</italic> carriers held an agr-defective strain and that prior hospitalisation was significantly associated with agr-defective status, suggesting prior adaptive pressures (<xref ref-type="bibr" rid="bib102">Shopsin et al., 2008</xref>).</p><p>Consistent with the distinctive general patterns of evolution displayed during invasive infection, some genes and loci were specifically mutated within invasive strains. Some of these genes were emerging targets of <italic>S. aureus</italic> pathogenesis in vivo, such as <italic>purR</italic> and <italic>yjbH</italic> that were not singled out in previous within-host evolution investigations. Others were known determinants of antibiotic resistance, including <italic>mprF</italic>, <italic>rpoB,</italic> and the <italic>walKR</italic> operon. This underscores the crucial role of antibiotic exposure in shaping adaptive evolution during invasive infection. A recent study of within-host evolution during cystic fibrosis found that resistance genes were hotspots of convergent evolution in this population, which is frequently treated with antibiotics and shows features of phenotypic adaptation (<xref ref-type="bibr" rid="bib65">Long et al., 2020</xref>).</p><p>While most mutations in adaptive loci were substitutions within the coding sequence, about 40% of <italic>walKR</italic> operon mutations were located outside of the coding regions of <italic>walR</italic> and <italic>walk</italic>, emphasising the need to study intergenic mutations and mutations throughout an operon to capture adaptive signatures. This observation highlights the importance of expanding the analysis of intergenic mutations for the detection of adaptive mutations, in particular those linked to antibiotic resistance.</p><p>If within-host evolution represents adaptative evolution, it is possible that adaptation involved an accumulation of mutations and possibly epistatic mechanisms. Our data show that some mutations are specific for invasive strains; these mutations may reflect late adaptation, occurring after evolution during colonisation in the nose and upon transition from colonisation to infection, and thus occurring after adaptive mutations were acquired during earlier stages. This evolutionary pattern of stepwise adaptation (or adaptive continuum) encompassing the entire within-host evolutionary arch has been well described for cancer (<xref ref-type="bibr" rid="bib1">Abbosh et al., 2017</xref>) and has been also investigated in a study of transition from colonisation to infection (<xref ref-type="bibr" rid="bib128">Young et al., 2012</xref>). One way to capture this is mutation co-occurrence analysis. Here, we show mutation co-occurrence within the <italic>agr</italic> operon but also co-occurrence of the same mutations in two uncharacterised proteins in <italic>S. aureus</italic>. Our network of mutation co-occurrence linked to <italic>agrAC</italic> mutations might suggest a potential pathway of stepwise adaptation following initial mutations acquisition in the <italic>agr</italic> locus, an hypothesis that has been explored in one of studies included in our analysis (<xref ref-type="bibr" rid="bib3">Altman et al., 2018</xref>).</p><p>While combining multiple studies allowed us to increase statistical power in order to detect genome-wide convergent signals of adaptation, this approach has some limitations. The quality of the publicly available sequences and metadata can be heterogeneous, despite performing quality control assessment, for example, due to different read coverage across studies. Lack of consistent metadata might have impacted the clinical categorisations used here, including the distinction between colonising and invasive strains (however, 83% of the strains could be classified unambiguously based on the site of collection). In addition, detection of structural variants from short reads is not as accurate as from long reads; for example, chromosomal inversions can be missed if their inversion site span is larger than the insert site of the paired-end reads (<xref ref-type="bibr" rid="bib40">Gu√©rillot et al., 2019</xref>). Furthermore, the majority of the episodes included had low sampling density. More contemporary strategies leverage a multiplicity of samples and deep sequencing strategies to capture within-host diversity, allowing to detect minority variants that could be relevant for adaptation and to obtain a more accurate understanding of evolutionary dynamics within the host, including estimating bottlenecks (<xref ref-type="bibr" rid="bib41">Hall et al., 2019</xref>) and tracking the fall and rise of within-host lineages (<xref ref-type="bibr" rid="bib13">Bryant et al., 2021</xref>). Finally, while several adaptive loci identified here have been previously assessed experimentally, the functional impact of adaptive variants in less characterised genes and intergenic mutations warrants further exploration using targeted mutagenesis (<xref ref-type="bibr" rid="bib77">Monk et al., 2015</xref>).</p><p>Ultimately, the goal of detecting adaptive signals is to identify new mechanisms of pathogenesis or resistance to therapeutic targets and to inform prediction of clinical outcomes. So far, studies have failed to show consistent associations between specific clinical outcomes and genetic features of infecting (or colonising) <italic>S. aureus</italic> strains. This might be related to the dominance of host/environmental factors, but it could also be linked to the limited power of studies performed so far. By contrast, within-host evolution studies are an elegant approach to identify signatures of adaptation that might be candidate markers of important clinical outcomes, such as infection risk in case of colonisation or treatment failure in case of infection. Here, we show that adaptation signatures are at least partially specific to colonisation, infection, and upon transition from colonisation to infection and that adaptive changes are more frequent in distinctive infection episodes (complicated bacteraemia and endocarditis). These findings suggest that adaptive signatures might be indicative of important clinical outcomes. In the future, precision medicine in infectious diseases could follow the lead of cancer genomics, where within-host evolution studies have tracked the evolution of cancer clones and enabled the detection of high risk mutations early.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Literature search</title><p>We conducted a search of articles indexed in PubMed before the 11 August 2020 using the keyword ‚Äòaureus‚Äô in combination with either ‚Äògenomics‚Äô or ‚Äòwhole genome sequencing‚Äô and with either ‚Äòwithin-host evolution‚Äô, ‚Äò<italic>in vivo</italic> evolution‚Äô, ‚Äòadaptation‚Äô, or ‚Äòbacteraemia‚Äô. The records retrieved through this search were combined with additional citations identified through other sources. After removing duplicates, this resulted in 815 citations that were screened based on following inclusion criteria: (i) whole-genome sequencing of human <italic>S. aureus</italic> isolates; (ii) &gt;1 <italic>S</italic>. <italic>aureus</italic> isolates sequenced per individual; (iii) sequences (reads or assemblies) publicly available; and (iv) minimum sequences metadata available (either with the manuscript or linked to the sequences): patient ID, date of collection (or collection interval in reference to a baseline isolate), and source of the sample. After excluding studies not satisfying the inclusion criteria (730 based on the title, 46 based on the abstract, and 15 after reviewing the full text), we kept 24 within-host evolution studies.</p></sec><sec id="s4-2"><title>Extraction of sequence metadata</title><p>For each of the included studies, the following variables were extracted either from reads, metadata (when available) or from the publication/supplementary data: identifier linking the sequences to a patient or an episode of infection, date of collection (when available) or collection interval in reference to a baseline isolate, and site of collection of the isolate. Isolates were broadly categorised in ‚Äòcolonising‚Äô and ‚Äòinvasive‚Äô based on the site of collection, when the information was unambiguous (e.g. ‚Äònose‚Äô for ‚Äòcolonising‚Äô or ‚Äòblood‚Äô for ‚Äòinvasive‚Äô). When the information on the body site was not sufficient (e.g. ‚Äòskin‚Äô or ‚Äòlung‚Äô), the categorisation was based on further details provided in the publication. When available, phenotypic metadata and antibiotic treatments were also extracted from the publication. We used clinical and site data to classify colonisation episodes in ‚Äònasal carriage‚Äô, ‚Äòatopic dermatitis‚Äô, and ‚Äòcystic fibrosis‚Äô and infection episodes in ‚Äòskin infection‚Äô (skin infection site surgical site infection without other foci), ‚Äòosteoarticular infection‚Äô (bone/join infection without other foci), ‚Äòbacteraemia without focus‚Äô (bloodstream infection, no other foci, and expect for vascular catheter or skin), ‚Äòbacteraemia with focus‚Äô (bloodstream infection with other focus involving the lung, nervous system, bone and joints, or internal organs), and ‚Äòendocarditis‚Äô (based on diagnosis reported in the publication or in the clinical metadata).</p></sec><sec id="s4-3"><title>Sequence processing</title><p>Sequences (reads and assemblies) and metadata were downloaded from the European Nucleotide Archive and the National Center for Biotechnology Information (NCBI), respectively using the BioProject accession or the genome accession. Quality assessment of the reads was performed by calculating mean read depth and the fraction of <italic>S. aureus</italic> reads using Kraken 2, v2.0.9-beta (<xref ref-type="bibr" rid="bib125">Wood et al., 2019</xref>) and by extracting metrics from reads assemblies constructed using Shovill, v1.1.0 (<ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/shovill">https://github.com/tseemann/shovill</ext-link>, <xref ref-type="bibr" rid="bib100">Seemann, 2022c</xref>) and annotated using Prokka, v1.14.6 <xref ref-type="bibr" rid="bib97">Seemann, 2014</xref> . ST was inferred from the assembly using Mlst, v2.19.0 (<ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/mlst">https://github.com/tseemann/mlst</ext-link>, <xref ref-type="bibr" rid="bib99">Seemann, 2022b</xref>), and resistance genes were detected using Abricate, v1.0.1 (<ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/abricate">https://github.com/tseemann/abricate</ext-link>, <xref ref-type="bibr" rid="bib98">Seemann, 2022a</xref>). Reads were discarded if the mean coverage depth was below 35, the majority of reads were not <italic>S. aureus,</italic> or the size of the assembly was below 2.6 megabases. Assemblies downloaded from the NCBI repository were discarded if the genome size was below 2.6 megabases.</p></sec><sec id="s4-4"><title>Sequences from the CAMERA2 trial</title><p>We collected <italic>S. aureus</italic> strains from bacteraemia episodes included in the CAMERA2 trial (Combination Antibiotics for Methicillin Resistant <italic>S. aureus</italic>), where at least two strains per episode were available. The CAMERA2 trial was performed between 2015 and 2018 in Australia, New Zealand, Singapore, and Israel and randomised participants with methicillin-resistant <italic>S. aureus</italic> bacteraemia to either monotherapy with vancomycin or daptomycin or combination therapy with vancomycin or daptomycin plus an antistaphylococcal beta-lactam (flucloxacillin, cloxacillin, or cefazolin) (<xref ref-type="bibr" rid="bib114">Tong et al., 2020</xref>). Strains were isolated from ‚Äì80C glycerol onto horse-blood agar. Species were confirmed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Bacterial whole-genome sequencing was performed from single colonies on the Illumnina NextSeq platform. Reads were checked for quality, assembled, and annotated as described above.</p></sec><sec id="s4-5"><title>Global phylogeny</title><p>To generate a global alignment of all sequences, reads and shredded assemblies were mapped to reference genome USA300 FPR3757 (assembly accession: GCF_000013465.1) (using Snippy, v4.6.0) (<ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/snippy">https://github.com/tseemann/snippy</ext-link>; <xref ref-type="bibr" rid="bib101">Seemann, 2022d</xref>). The core genome alignment was obtained using Snippy; sites with &gt;10% gaps were removed using Goalign (<xref ref-type="bibr" rid="bib60">Lemoine and Gascuel, 2021</xref>) and constant sites were removed using SNP-sites (<xref ref-type="bibr" rid="bib81">Page et al., 2016</xref>), for a final length of 186,825 bp. A maximum-likelihood phylogenetic tree of 2590 sequences (those kept in the analysis after excluding genetically unrelated strains, see below) was inferred using IQ-TREE, v2.0.3 <xref ref-type="bibr" rid="bib76">Minh et al., 2020</xref>.</p></sec><sec id="s4-6"><title>Variant calling</title><p>We have previously shown that the accuracy of variant calling in within-host evolution analyses is improved when mapping reads to an internal draft assembly as opposed to a closely related closed genome (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>). Here, we applied the same approach, where we selected the internal reference among the sequences from the same patient or episode. When available, the oldest colonising strain was selected. When only sequences from invasive strains were available, the oldest strain (baseline strain) was selected. When multiple sequences were available per sample (e.g. multiple colonies sequenced per plate) or at the same date, the reference was randomly selected among them. Snippy with default parameters (minimum reads coverage 10, minimum read mapping quality 60, and minimum base quality 13) was used for variant calling. To further improve the accuracy of the calls, we masked variants called from reference reads and those at positions where reference reads had a coverage below 10 (using the BEDTools suite [<xref ref-type="bibr" rid="bib91">Quinlan and Hall, 2010</xref>]).</p></sec><sec id="s4-7"><title>Filtering of genetically unrelated sequences</title><p>The threshold for removing genetically unrelated sequences was set empirically at 100 episode-specific variants based on the upper Tukey‚Äôs fence of the distribution of the number of variants in same-episode isolates belonging to the same ST (<xref ref-type="fig" rid="fig2s1">Figure 2‚Äîfigure supplement 1</xref>).</p></sec><sec id="s4-8"><title>Estimation of within-host mutation rates</title><p>To estimate within-host mutation rates within colonising and invasive populations, a linear regression was fitted to model the relationship between sampling time (in years after the first isolate) and number of mutations relative to the internal reference. Only episodes with at least two strains collected at least one day apart were included in this analysis. The mutation rate Œº was computed as follows Œº = Œ≤/g, where Œ≤ is the regression parameter and g is the mean genome size of the internal references (2.79 Mb). Regression diagnostics were performed using the R package performance (<xref ref-type="bibr" rid="bib68">L√ºdecke et al., 2021</xref>).</p></sec><sec id="s4-9"><title>Detection of chromosome structural variants</title><p>Using BWA-MEM (<xref ref-type="bibr" rid="bib62">Li, 2013</xref>), reads and shredded contigs were aligned to the closest available complete genome (either internal to the dataset or selected from the NCBI repository based on the mash distance). To detect large deletions ( ‚â• 500 bp), reads coverage was computed using BEDTools, as described in <xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>. To detect new IS insertions, split reads were extracted, filtered, and annotated as described in <xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>. We used the R package CNOGpro (<xref ref-type="bibr" rid="bib14">Brynildsrud et al., 2015</xref>) to detect 1000 bp windows with an estimated copy number above one as compared to the internal reference. The package calculates the reads coverage per sliding windows of the chromosome, performs a G+C bias normalisation, and infers copy number state using a Hidden Markow Model. We ran the package with default parameters, with the exception of the length of the sliding window that was set at 1000 bp. For each class of structural variant and within each episode, we used BEDTools to mask regions where the variant was already present in internal reference.</p></sec><sec id="s4-10"><title>Prediction of functional impact of variants</title><p>Functional impact of variants was extracted from the Snippy output, which uses SnpEff to infer the functional effect of the detected mutations (<xref ref-type="bibr" rid="bib20">Cingolani et al., 2012</xref>). SnpEff categories for coding regions were aggregated in ‚Äòtruncating‚Äô (frameshift, stop codons, and start codons), ‚Äònon-synonymous substitutions‚Äô, and ‚Äòsynonymous substitutions‚Äô. Non-synonymous substitutions were further investigated using PROVEAN, v1.1.5 (58) using the non-redundant protein database provides on the PROVEAN repository (<ext-link ext-link-type="uri" xlink:href="ftp://ftp.jcvi.org/pub/data/provean/nr_Aug_2011/">ftp://ftp.jcvi.org/pub/data/provean/nr_Aug_2011/</ext-link>). Substitutions were classified as ‚Äòdeleterious‚Äô if the PROVEAN score was ‚Äì2.5 or less and ‚Äòneutral‚Äô otherwise.</p></sec><sec id="s4-11"><title>Internal variant annotation</title><p>To ensure a consistent annotation of mutated genes across independent episodes, we clustered amino-acid sequences using CD-HIT, v4.8.1 with an identity threshold of 0.9. The BEDTools suite was used to annotate mutated intergenic regions with upstream and downstream coding regions and the distance separating the mutation from the start or the end of the gene. For the operon analysis, intergenic mutations were classified according to their location within a presumed promoter based on blasting the sequence of unique promoters (as determined in [<xref ref-type="bibr" rid="bib88">Prados et al., 2016</xref>]) on the draft assembly of the internal reference. Phage genes were annotated using blastp and the PhageWeb database (<ext-link ext-link-type="uri" xlink:href="http://computationalbiology.ufpa.br/phageweb/">http://computationalbiology.ufpa.br/phageweb/</ext-link>).</p></sec><sec id="s4-12"><title>Variant annotation using reference strain FPR3757</title><p>To compare mutated genes across separated episodes, we used blastp to identify homologues of each CD-HIT cluster of mutated genes in USA300 FPR3757. Genes in FPR3757 were further annotated using the database provided in the AureoWiki repository (<xref ref-type="bibr" rid="bib26">Fuchs et al., 2018</xref>), and operon annotations of FPR3757 were retrieved from Microbes Online (<xref ref-type="bibr" rid="bib21">Dehal et al., 2010</xref>). In addition, we used the text mining tool PaperBLAST to search for publications containing data on homologues of uncharacterised FPR3757 proteins (<xref ref-type="bibr" rid="bib89">Price et al., 2017</xref>). Only protein-altering variants in genes with FPR3757 homologues (excluding plasmid genes and phage genes) were kept for the analysis of convergence at gene and operon level and the gene enrichment analysis.</p></sec><sec id="s4-13"><title>Classification of variants</title><p>Mutational and structural variants were classified in to type C&gt;C (within colonising strains), type C&gt;I (between colonising and invasive strains), and type I&gt;I (within invasive strains) as follows: all variants arising in colonising strains were classified as type C&gt;C, while variants among invasive strains were classified as type C&gt;I if they were found in a baseline invasive strain (defined as the oldest invasive strain; when multiple sequences were available at same time, the baseline invasive strain was selected randomly), and as type I&gt;I if they were found between invasive strains but not on the baseline invasive strain. This approach is based on the assumption that co-infection or superinfection is rare, as we have shown previously for bacteraemia (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>).</p></sec><sec id="s4-14"><title>Calculation of the Neutrality Index (NI)</title><p>A modified McDonald-Kreitman table was compiled a described in <xref ref-type="bibr" rid="bib106">Stoletzki and Eyre-Walker, 2011</xref>, where a ratio was calculated between non-synonymous, protein-truncating, IS insertions, intergenic and deletion variants, and synonymous variants. The NI was obtained by dividing the ratio calculated above for type C&gt;I and type I&gt;I by the ratio for type C&gt;C variants that were used as reference group. Significance was tested by Fisher‚Äôs Exact test.</p></sec><sec id="s4-15"><title>dN/dS analysis</title><p>We used the R package dNdScv (<xref ref-type="bibr" rid="bib71">Martincorena et al., 2017</xref>) to obtain dN/dS ratios for non-synonymous mutations, indels, and missense mutations (stop codons) for all FPR3757 genes, based on variants called when mapping all reads on FPR3757 and after subtracting variants from the internal reference reads and variants in positive where internal reference reads had a low coverage. Since this analysis could be hampered by potential false-positive variants resulting from mapping reads on a single reference (<xref ref-type="bibr" rid="bib31">Giulieri et al., 2018</xref>), we also used our curated list of within-host mutations obtained from episode-specific variant calling to calculate crude dN/dS ratios by dividing the number of protein modifying mutations by the number non-synonymous mutations and computed p values by Fisher exact test as in <xref ref-type="bibr" rid="bib65">Long et al., 2020</xref>.</p></sec><sec id="s4-16"><title>Gene and operon enrichment analysis</title><p>We calculated the enrichment of protein-altering mutations across all coding regions of FPR3757 (excluding plasmid genes and phage genes) using the approach described in <xref ref-type="bibr" rid="bib129">Young et al., 2017</xref>. The variant enrichment per gene <italic>i</italic> was calculated as follows: (N<sub>i</sub>/L<sub>i</sub>)/(Œ£<sub>n</sub>/Œ£<sub>l</sub>), where N<sub>i</sub> is the number of variants per gene <italic>i</italic>, L<sub>i</sub> is the length of gene <italic>i</italic>, Œ£<sub>n</sub> is the total number of variants, and Œ£<sub>l</sub> is the total length of the genes. We used Poisson regression to model the number of variants per gene <italic>j</italic> under the null hypothesis (no enrichment), as defined by the equation Œª<sub>0</sub>L<sub>j</sub>, where Œª<sub>0</sub> is the expected number of variants in any gene and L<sub>j</sub> is the gene length. Under the alternative hypothesis (enrichment of variant in gene <italic>i</italic>), the estimated number of variants is Œª<sub>i</sub>L<sub>i</sub> for gene <italic>i,</italic> and Œª<sub>1</sub>L<sub>j</sub> for any other gene <italic>j</italic>. The model parameters Œª<sub>0</sub>, Œª<sub>1</sub>, and Œª<sub>I</sub> were obtained using maximum likelihood and tested for significance using the likelihood ratio test. The genome-wide significance cut-off was calculated using the Bonferroni correction (0.05 divided by the number of unique genes or operons) and the suggestive significance cut-off (1 divided by the number of unique genes or operons), as implemented for bacterial genome-wide associated studies in <xref ref-type="bibr" rid="bib58">Lees et al., 2017a</xref>.</p></sec><sec id="s4-17"><title>Gene set enrichment analysis</title><p>We used the PANNZER platform (<xref ref-type="bibr" rid="bib115">T√∂r√∂nen et al., 2018</xref>), to retrieve a gene ontology annotation of FPR3757 based on the GO terms. We modified the ‚Äòantibiotic response‚Äô category by adding a curated list of antibiotic resistance genes downloaded from the NCBI Anti-Microbial Resistance (AMR) gene reference database (<xref ref-type="bibr" rid="bib25">Feldgarden et al., 2019</xref>). The GSEA was performed as implemented in the R package clusterProfile (<xref ref-type="bibr" rid="bib130">Yu et al., 2012</xref>). Genes with a FPR3757 homologue were ranked according to the significance of the enrichment of protein-modifying mutations (gene enrichment analysis, see above), and the GSEA was carried out with a minimum gene set size of 10 and using the FDR method for adjustment for multiple testing.</p></sec><sec id="s4-18"><title>Mutation co-occurrence analysis</title><p>To detect co-occurrence of mutations and mutated genes across independent episodes, we constructed a co-occurrence matrix using the R package co-occur (<xref ref-type="bibr" rid="bib37">Griffith et al., 2016</xref>). A co-occurrence of mutations or mutated genes in at least two independent episodes was interpreted as convergent and as a sign of potential epistatic interaction. The network of co-occurrence of mutated genes was visualised using the R package ggraph (<ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/ggraph/index.html">https://cran.r-project.org/web/packages/ggraph/index.html</ext-link>).</p></sec><sec id="s4-19"><title>Network analysis of adaptation signatures</title><p>The pairwise calculation of the Jaccard index between set of mutated genes was performed in R. The calculations were performed both with the entire set of mutated FPR3757 genes and with the 20 most significantly enriched genes in each group of variants. A network of shared mutated genes between independent episodes was constructed using ggraph, where edges represented episode connections based on the Jaccard index. We used the R package tidygraph to extract the node centrality (function centrality_degree) as a summary measure of the degree of adaptation of the episodes. The network graph and analysis were performed for each group of variants separately.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Methodology, Visualization, Writing ‚Äì original draft, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Formal analysis, Methodology, Software, Supervision, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Software, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Investigation, Project administration</p></fn><fn fn-type="con" id="con6"><p>Methodology, Software, Supervision</p></fn><fn fn-type="con" id="con7"><p>Investigation, Resources, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Investigation, Resources</p></fn><fn fn-type="con" id="con9"><p>Methodology, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con10"><p>Methodology, Software, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Methodology, Supervision, Writing ‚Äì review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Funding acquisition, Supervision, Writing ‚Äì review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Ethics approval was obtained at each partecipating site to the CAMERA2 trial and written informed onsent was obtained from each participant or surrogate decision maker.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of colonisation/infection episodes included with publication data (first author, year, PubMed id), number of strains, sites of collection, clinical characterstics, classification of colonisation, and infection episodes.</title></caption><media xlink:href="elife-77195-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>List of strains included with site and date of collection, sequence type, presence of the <italic>mecA</italic> gene, information on whether the strain was designed as internal reference or baseline index strain, mash distance to the internal reference, number of variants called (as compared to the internal reference), and sequencing metrics.</title></caption><media xlink:href="elife-77195-supp2-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>List of variants identified annotated with gene, gene sequence, FPR3757 homologue, and FPR3757 operon.</title><p>Point mutations, insertion sequences insertions, large deletions, and copy number variants are presented separately.</p></caption><media xlink:href="elife-77195-supp3-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Gene enrichment analysis for all mutated genes with a FPR3757 homologue with number of mutations, gene length, mutation enrichment, and p value based on a Poisson regression to model the number of variants per gene.</title><p>Results are presented separately for the complete dataset and for colonising-colonising (type C&gt;C), colonising-invasive (type C&gt;I), and invasive-invasive (type I&gt;I) variants.</p></caption><media xlink:href="elife-77195-supp4-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Operon enrichment analysis for all FPR3757 operons (i.e. mutated genes that could be assigned to a FPR3757 operon) with number of mutations, operon length, mutation enrichment, and p value based on a Poisson regression to model the number of variants per operon.</title><p>Results are presented separately for the complete dataset and for colonising-colonising (type C&gt;C), colonising-invasive (type C&gt;I), and invasive-invasive (type I&gt;I) variants.</p></caption><media xlink:href="elife-77195-supp5-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Gene set enrichment analysis for mutations in genes aggregated in gene ontologies (GO) categories with enrichment score, normalsied enrichment score (NES), and unadjusted and false-discovery rate (FDR) adjusted p value.</title><p>Results are presented separately for the complete dataset and for colonising-colonising (type C&gt;C), colonising-invasive (type C&gt;I), and invasive-invasive (type I&gt;I) variants.</p></caption><media xlink:href="elife-77195-supp6-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-77195-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting file 1-6. The code to call, filter and annotated within-host variants and to perform the enrichment analysis is available on github at <ext-link ext-link-type="uri" xlink:href="https://github.com/stefanogg/staph_adaptation_paper">https://github.com/stefanogg/staph_adaptation_paper</ext-link>, (copy archived at <ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:f7d4fa33bd94730b08bc384831701f2b3edbbfd9;origin=https://github.com/stefanogg/staph_adaptation_paper;visit=swh:1:snp:6703eaf27f624a5ffa779a316bcf79b663b76799;anchor=swh:1:rev:6ec5132855405e1c759fedadb4c70e295c1c1974">swh:1:rev:6ec5132855405e1c759fedadb4c70e295c1c1974</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Giulieri</surname><given-names>SG</given-names></name><name><surname>Daniel</surname><given-names>D</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Davis</surname><given-names>JS</given-names></name><name><surname>Tong</surname><given-names>SYC</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Within-host evolution analysis of <italic>S. aureus</italic> bacteraemias included in the CAMERA-2 trial</data-title><source>European Nucleotide Archive</source><pub-id pub-id-type="accession" xlink:href="https://github.com/stefanogg/staph_adaptation_paper">PRJEB50796</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Tobias</surname><given-names>NJ</given-names></name><name><surname>Gladman</surname><given-names>SL</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Large tandem chromosome duplications facilitate niche adaptation during persistent infection with drug-resistant <italic>Staphylococcus aureus</italic></data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB9193">PRJEB9193</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Evolution of Multidrug Resistance during <italic>Staphylococcus aureus</italic> Infection Involves Mutation of the Essential Two Component Regulator WalKR</data-title><source>NCBI Sequence Read Archive</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/sra/?term=SRA027352">SRA027352</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Evolution of Multidrug Resistance during <italic>Staphylococcus aureus</italic> Infection Involves Mutation of the Essential Two Component Regulator WalKR</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA29567">PRJNA29567</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>McEvoy</surname><given-names>CR</given-names></name><name><surname>Allen</surname><given-names>DL</given-names></name><name><surname>Chua</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name><name><surname>Bell</surname><given-names>J</given-names></name><name><surname>Coombs</surname><given-names>G</given-names></name><name><surname>Bennett-Wood</surname><given-names>V</given-names></name><name><surname>Porter</surname><given-names>JL</given-names></name><name><surname>Robins-Browne</surname><given-names>R</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2011">2011</year><data-title>Evolution of Multidrug Resistance during <italic>Staphylococcus aureus</italic> Infection Involves Mutation of the Essential Two Component Regulator WalKR</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA29569">PRJNA29569</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset6"><person-group person-group-type="author"><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Golubchik</surname><given-names>T</given-names></name><name><surname>Batty</surname><given-names>EM</given-names></name><name><surname>Fung</surname><given-names>R</given-names></name><name><surname>Larner-Svensson</surname><given-names>H</given-names></name><name><surname>Votintseva</surname><given-names>AA</given-names></name><name><surname>Miller</surname><given-names>RR</given-names></name><name><surname>Godwin</surname><given-names>H</given-names></name><name><surname>Knox</surname><given-names>K</given-names></name><name><surname>Everitt</surname><given-names>RG</given-names></name><name><surname>Iqbal</surname><given-names>Z</given-names></name><name><surname>Rimmer</surname><given-names>AJ</given-names></name><name><surname>Cule</surname><given-names>M</given-names></name><name><surname>Ip</surname><given-names>CLC</given-names></name><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Harding</surname><given-names>RM</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Peto</surname><given-names>TE</given-names></name><name><surname>Crook</surname><given-names>DW</given-names></name><name><surname>Bowden</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Evolutionary dynamics of <italic>Staphylococcus aureus</italic> during progression from carriage to disease</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2862">PRJEB2862</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset7"><person-group person-group-type="author"><name><surname>Golubchik</surname><given-names>T</given-names></name><name><surname>Batty</surname><given-names>EM</given-names></name><name><surname>Miller</surname><given-names>RR</given-names></name><name><surname>Farr</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Larner-Svensson</surname><given-names>H</given-names></name><name><surname>Fung</surname><given-names>R</given-names></name><name><surname>Godwin</surname><given-names>H</given-names></name><name><surname>Knox</surname><given-names>K</given-names></name><name><surname>Votintseva</surname><given-names>A</given-names></name><name><surname>Everitt</surname><given-names>RG</given-names></name><name><surname>Street</surname><given-names>T</given-names></name><name><surname>Cule</surname><given-names>M</given-names></name><name><surname>CL</surname><given-names>Ip</given-names></name><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Peto</surname><given-names>TE</given-names></name><name><surname>Harding</surname><given-names>RM</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name><name><surname>Crook</surname><given-names>DW</given-names></name><name><surname>Bowden</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><data-title>Within-host evolution of <italic>Staphylococcus aureus</italic> during asymptomatic carriage</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB2881">PRJEB2881</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset8"><person-group person-group-type="author"><name><surname>Burd</surname><given-names>EM</given-names></name><name><surname>Alam</surname><given-names>MT</given-names></name><name><surname>Passalacqua</surname><given-names>KD</given-names></name><name><surname>Kalokhe</surname><given-names>AS</given-names></name><name><surname>Eaton</surname><given-names>ME</given-names></name><name><surname>Satola</surname><given-names>SW</given-names></name><name><surname>Kraft</surname><given-names>CS</given-names></name><name><surname>Read</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Development of oxacillin resistance in a patient with recurrent <italic>Staphylococcus aureus</italic> bacteremia</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA248678">PRJNA248678</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset9"><person-group person-group-type="author"><name><surname>Rishishwar</surname><given-names>L</given-names></name><name><surname>Kraft</surname><given-names>CS</given-names></name><name><surname>Jordan</surname><given-names>IK</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Population Genomics of Reduced Vancomycin Susceptibility in <italic>Staphylococcus aureus</italic></data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA259799">PRJNA259799</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset10"><person-group person-group-type="author"><name><surname>Trouillet-Assant</surname><given-names>S</given-names></name><name><surname>Leli√®vre</surname><given-names>L</given-names></name><name><surname>Martins-Sim√µes</surname><given-names>P</given-names></name><name><surname>Gonzaga</surname><given-names>L</given-names></name><name><surname>Tasse</surname><given-names>J</given-names></name><name><surname>Valour</surname><given-names>F</given-names></name><name><surname>Rasigade</surname><given-names>JP</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><name><surname>Muniz Guedes</surname><given-names>RL</given-names></name><name><surname>Ribeiro de Vasconcelos</surname><given-names>AT</given-names></name><name><surname>Caillon</surname><given-names>J</given-names></name><name><surname>Lustig</surname><given-names>S</given-names></name><name><surname>Ferry</surname><given-names>T</given-names></name><name><surname>Jacqueline</surname><given-names>C</given-names></name><name><surname>Loss de Morais</surname><given-names>G</given-names></name><name><surname>Laurent</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Adaptive processes of <italic>Staphylococcus aureus</italic> isolates during the progression from acute to chronic bone and joint infections in patients</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA298748">PRJNA298748</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset11"><person-group person-group-type="author"><name><surname>Rouard</surname><given-names>C</given-names></name><name><surname>Garnier</surname><given-names>F</given-names></name><name><surname>Leraut</surname><given-names>J</given-names></name><name><surname>Lepainteur</surname><given-names>M</given-names></name><name><surname>Rahajamananav</surname><given-names>L</given-names></name><name><surname>Languepin</surname><given-names>J</given-names></name><name><surname>Ploy</surname><given-names>MC</given-names></name><name><surname>Bourgeois-Nicolaos</surname><given-names>N</given-names></name><name><surname>Doucet-Populaire</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Emergence and Within-Host Genetic Evolution of Methicillin-Resistant <italic>Staphylococcus aureus</italic> Resistant to Linezolid in a Cystic Fibrosis Patient</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA434495">PRJNA434495</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset12"><person-group person-group-type="author"><name><surname>Langhanki</surname><given-names>L</given-names></name><name><surname>Berger</surname><given-names>P</given-names></name><name><surname>Treffon</surname><given-names>J</given-names></name><name><surname>Catania</surname><given-names>F</given-names></name><name><surname>Kahl</surname><given-names>BC</given-names></name><name><surname>Mellmann</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>In vivo competition and horizontal gene transfer among distinct <italic>Staphylococcus aureus</italic> lineages as major drivers for adaptational changes during long-term persistence in humans</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB22600">PRJEB22600</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset13"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Genome Plasticity of agr-Defective <italic>Staphylococcus aureus</italic> during Clinical Infection</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA393749">PRJNA393749</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset14"><person-group person-group-type="author"><name><surname>Giulieri</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent <italic>Staphylococcus aureus</italic> bacteraemia</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB27932">PRJEB27932</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset15"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>JB</given-names></name><name><surname>Frank</surname><given-names>DN</given-names></name><name><surname>Bessesen</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Genomic evolution of <italic>Staphylococcus aureus</italic> isolates colonizing the nares and progressing to bacteremia</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA414752">PRJNA414752</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset16"><person-group person-group-type="author"><name><surname>Suligoy</surname><given-names>CM</given-names></name><name><surname>Lattar</surname><given-names>SM</given-names></name><name><surname>Noto Llana</surname><given-names>M</given-names></name><name><surname>Gonz√°lez</surname><given-names>CD</given-names></name><name><surname>Alvarez</surname><given-names>LP</given-names></name><name><surname>Robinson</surname><given-names>DA</given-names></name><name><surname>G√≥mez</surname><given-names>MI</given-names></name><name><surname>Buzzola</surname><given-names>FR</given-names></name><name><surname>Sordelli</surname><given-names>DO</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Mutation of Agr Is Associated with the Adaptation of <italic>Staphylococcus aureus</italic> to the Host during Chronic Osteomyelitis</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA414566">PRJNA414566</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset17"><person-group person-group-type="author"><name><surname>Harkins</surname><given-names>CP</given-names></name><name><surname>Pettigrew</surname><given-names>KA</given-names></name><name><surname>Oravcov√°</surname><given-names>K</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Hearn</surname><given-names>RMR</given-names></name><name><surname>Rice</surname><given-names>D</given-names></name><name><surname>Mather</surname><given-names>AE</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>SJ</given-names></name><name><surname>Proby</surname><given-names>CM</given-names></name><name><surname>Holden</surname><given-names>MTG</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>The Microevolution and Epidemiology of <italic>Staphylococcus aureus</italic> Colonization during Atopic Eczema Disease Flare</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJEB20148">PRJEB20148</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset18"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Chronic <italic>Staphylococcus aureus</italic> Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA446073">PRJNA446073</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset19"><person-group person-group-type="author"><name><surname>Loss</surname><given-names>G</given-names></name><name><surname>Sim√µes</surname><given-names>PM</given-names></name><name><surname>Valour</surname><given-names>F</given-names></name><name><surname>Cort√™s</surname><given-names>MF</given-names></name><name><surname>Gonzaga</surname><given-names>L</given-names></name><name><surname>Bergot</surname><given-names>M</given-names></name><name><surname>Trouillet-Assant</surname><given-names>S</given-names></name><name><surname>Josse</surname><given-names>J</given-names></name><name><surname>Diot</surname><given-names>A</given-names></name><name><surname>Ricci</surname><given-names>E</given-names></name><name><surname>Vasconcelos</surname><given-names>AT</given-names></name><name><surname>Laurent</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title><italic>Staphylococcus aureus</italic> Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA497214">PRJNA497214</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset20"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Sekizuka</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Ohsuga</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Hanaki</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>IS256-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a <italic>Staphylococcus aureus</italic> Clinical Isolate</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJDB8056">PRJDB8056</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset21"><person-group person-group-type="author"><name><surname>Azarian</surname><given-names>T</given-names></name><name><surname>Ridgway</surname><given-names>JP</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>David</surname><given-names>MZ</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Long-Term Intrahost Evolution of Methicillin Resistant <italic>Staphylococcus aureus</italic> Among Cystic Fibrosis Patients With Respiratory Carriage</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA527261">PRJNA527261</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset22"><person-group person-group-type="author"><name><surname>W√ºthrich</surname><given-names>D</given-names></name><name><surname>Cu√©nod</surname><given-names>A</given-names></name><name><surname>Hinic</surname><given-names>V</given-names></name><name><surname>Morgenstern</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Egli</surname><given-names>A</given-names></name><name><surname>Kuehl</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA488707">PRJNA488707</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset23"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant <italic>Staphylococcus aureus</italic> Strains From Three Endocarditis Patients</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA577181">PRJNA577181</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset24"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>CR</given-names></name><name><surname>Dey</surname><given-names>S</given-names></name><name><surname>Smolenski</surname><given-names>PD</given-names></name><name><surname>Kulkarni</surname><given-names>PS</given-names></name><name><surname>Monk</surname><given-names>JM</given-names></name><name><surname>Szubin</surname><given-names>R</given-names></name><name><surname>Sakoulas</surname><given-names>G</given-names></name><name><surname>Berti</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Distinct Subpopulations of Intravalvular Methicillin-Resistant <italic>Staphylococcus aureus</italic> with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA544229">PRJNA544229</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset25"><person-group person-group-type="author"><name><surname>Petrovic Fabijan</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>RCY</given-names></name><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Maddocks</surname><given-names>S</given-names></name><name><surname>Ben Zakour</surname><given-names>NL</given-names></name><name><surname>Iredell</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Safety of bacteriophage therapy in severe <italic>Staphylococcus aureus</italic> infection</data-title><source>NCBI BioProject</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/PRJNA541589">PRJNA541589</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors declare that they have no competing interests. All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. This work was supported by a Research Fellowship to BPH and TPS from the National Health and Medical Research Council, Australia. SGG was supported by a PhD scholarship of the University of Melbourne. We acknowledge the CAMERA2 Study Group for sharing sequences and clinical metadata of trial participants with multiple sequential bacteraemia strains: Nick Anagostou, David Andresen, Sophia Archuleta, Narin Bak, Alan Cass, Mark Chatfield, Alan Cheng, Jane Davies, Joshua Davis, Yael Dishon, Ravindra Dotel, Patricia Ferguson, Hong Foo, Vance Fowler, Niladri Ghosh, Timothy Gray, Stephen Guy, Natasha Holmes, Benjamin Howden, Sandra Johnson, Shirin Kalimuddin, David Lye, Stephen McBride, Genevieve McKew, Niamh Meagher, Jane Nelson, Matthew O‚ÄôSullivan, David Paterson, Mical Paul, David Price, Anna Ralph, Matthew Roberts, Owen Robinson, Ben Rogers, Naomi Runnegar, Simon Smith, Archana Sud, Steven Tong, Adrian Tramontana, Sebastian Van Hal, Genevieve Walls, Morgyn Warner, Dafna Yahav, and Barnaby Young.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abbosh</surname><given-names>C</given-names></name><name><surname>Birkbak</surname><given-names>NJ</given-names></name><name><surname>Wilson</surname><given-names>GA</given-names></name><name><surname>Jamal-Hanjani</surname><given-names>M</given-names></name><name><surname>Constantin</surname><given-names>T</given-names></name><name><surname>Salari</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution</article-title><source>Nature</source><volume>545</volume><fpage>446</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.1038/nature22364</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>S</given-names></name><name><surname>Abel zur Wiesch</surname><given-names>P</given-names></name><name><surname>Davis</surname><given-names>BM</given-names></name><name><surname>Waldor</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Analysis of Bottlenecks in Experimental Models of Infection</article-title><source>PLOS Pathogens</source><volume>11</volume><elocation-id>e1004823</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1004823</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altman</surname><given-names>DR</given-names></name><name><surname>Sullivan</surname><given-names>MJ</given-names></name><name><surname>Chacko</surname><given-names>KI</given-names></name><name><surname>Balasubramanian</surname><given-names>D</given-names></name><name><surname>Pak</surname><given-names>TR</given-names></name><name><surname>Sause</surname><given-names>WE</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Sebra</surname><given-names>R</given-names></name><name><surname>Deikus</surname><given-names>G</given-names></name><name><surname>Attie</surname><given-names>O</given-names></name><name><surname>Rose</surname><given-names>H</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><name><surname>Fulmer</surname><given-names>Y</given-names></name><name><surname>Bashir</surname><given-names>A</given-names></name><name><surname>Kasarskis</surname><given-names>A</given-names></name><name><surname>Schadt</surname><given-names>EE</given-names></name><name><surname>Richardson</surname><given-names>AR</given-names></name><name><surname>Torres</surname><given-names>VJ</given-names></name><name><surname>Shopsin</surname><given-names>B</given-names></name><name><surname>van Bakel</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genome Plasticity of <italic>agr</italic>-Defective <italic>Staphylococcus aureus</italic> during Clinical Infection</article-title><source>Infection and Immunity</source><volume>86</volume><elocation-id>e00331-18</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00331-18</pub-id><pub-id pub-id-type="pmid">30061376</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aseev</surname><given-names>LV</given-names></name><name><surname>Boni</surname><given-names>IV</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Extraribosomal functions of bacterial ribosomal proteins</article-title><source>Molekuliarnaia Biologiia</source><volume>45</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1134/S0026893311050025</pub-id><pub-id pub-id-type="pmid">22393776</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Austin</surname><given-names>CM</given-names></name><name><surname>Garabaglu</surname><given-names>S</given-names></name><name><surname>Krute</surname><given-names>CN</given-names></name><name><surname>Ridder</surname><given-names>MJ</given-names></name><name><surname>Seawell</surname><given-names>NA</given-names></name><name><surname>Markiewicz</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Contribution of YjbIH to Virulence Factor Expression and Host Colonization in <italic>Staphylococcus aureus</italic></article-title><source>Infection and Immunity</source><volume>87</volume><elocation-id>e00155-19</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00155-19</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azarian</surname><given-names>T</given-names></name><name><surname>Ridgway</surname><given-names>JP</given-names></name><name><surname>Yin</surname><given-names>Z</given-names></name><name><surname>David</surname><given-names>MZ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Long-Term Intrahost Evolution of Methicillin Resistant <italic>Staphylococcus aureus</italic> Among Cystic Fibrosis Patients With Respiratory Carriage</article-title><source>Frontiers in Genetics</source><volume>10</volume><elocation-id>546</elocation-id><pub-id pub-id-type="doi">10.3389/fgene.2019.00546</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>SF</given-names></name><name><surname>Blanquart</surname><given-names>F</given-names></name><name><surname>Bataillon</surname><given-names>T</given-names></name><name><surname>Kassen</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>What drives parallel evolution?: How population size and mutational variation contribute to repeated evolution</article-title><source>BioEssays‚ÄØ: News and Reviews in Molecular, Cellular and Developmental Biology</source><volume>39</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1002/bies.201600176</pub-id><pub-id pub-id-type="pmid">27859467</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basuino</surname><given-names>L</given-names></name><name><surname>Jousselin</surname><given-names>A</given-names></name><name><surname>Alexander</surname><given-names>JAN</given-names></name><name><surname>Strynadka</surname><given-names>NCJ</given-names></name><name><surname>Pinho</surname><given-names>MG</given-names></name><name><surname>Chambers</surname><given-names>HF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PBP4 activity and its overexpression are necessary for PBP4-mediated high-level Œ≤-lactam resistance</article-title><source>The Journal of Antimicrobial Chemotherapy</source><volume>73</volume><fpage>1177</fpage><lpage>1180</lpage><pub-id pub-id-type="doi">10.1093/jac/dkx531</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batut</surname><given-names>B</given-names></name><name><surname>Knibbe</surname><given-names>C</given-names></name><name><surname>Marais</surname><given-names>G</given-names></name><name><surname>Daubin</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reductive genome evolution at both ends of the bacterial population size spectrum</article-title><source>Nature Reviews. Microbiology</source><volume>12</volume><fpage>841</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1038/nrmicro3331</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behe</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Experimental evolution, loss-of-function mutations, and ‚Äúthe first rule of adaptive evolution.‚Äù</article-title><source>The Quarterly Review of Biology</source><volume>85</volume><fpage>419</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1086/656902</pub-id><pub-id pub-id-type="pmid">21243963</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benoit</surname><given-names>JB</given-names></name><name><surname>Frank</surname><given-names>DN</given-names></name><name><surname>Bessesen</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic evolution of <italic>Staphylococcus aureus</italic> isolates colonizing the nares and progressing to bacteremia</article-title><source>PLOS ONE</source><volume>13</volume><elocation-id>e0195860</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0195860</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Both</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>M</given-names></name><name><surname>Lausmann</surname><given-names>C</given-names></name><name><surname>Wei√üelberg</surname><given-names>S</given-names></name><name><surname>B√ºttner</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Distinct clonal lineages and within-host diversification shape invasive <italic>Staphylococcus epidermidis</italic> populations</article-title><source>PLOS Pathogens</source><volume>17</volume><elocation-id>e1009304</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009304</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>JM</given-names></name><name><surname>Brown</surname><given-names>KP</given-names></name><name><surname>Burbaud</surname><given-names>S</given-names></name><name><surname>Everall</surname><given-names>I</given-names></name><name><surname>Belardinelli</surname><given-names>JM</given-names></name><name><surname>Rodriguez-Rincon</surname><given-names>D</given-names></name><name><surname>Grogono</surname><given-names>DM</given-names></name><name><surname>Peterson</surname><given-names>CM</given-names></name><name><surname>Verma</surname><given-names>D</given-names></name><name><surname>Evans</surname><given-names>IE</given-names></name><name><surname>Ruis</surname><given-names>C</given-names></name><name><surname>Weimann</surname><given-names>A</given-names></name><name><surname>Arora</surname><given-names>D</given-names></name><name><surname>Malhotra</surname><given-names>S</given-names></name><name><surname>Bannerman</surname><given-names>B</given-names></name><name><surname>Passemar</surname><given-names>C</given-names></name><name><surname>Templeton</surname><given-names>K</given-names></name><name><surname>MacGregor</surname><given-names>G</given-names></name><name><surname>Jiwa</surname><given-names>K</given-names></name><name><surname>Fisher</surname><given-names>AJ</given-names></name><name><surname>Blundell</surname><given-names>TL</given-names></name><name><surname>Ordway</surname><given-names>DJ</given-names></name><name><surname>Jackson</surname><given-names>M</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Floto</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Stepwise pathogenic evolution of <italic>Mycobacterium abscessus</italic></article-title><source>Science (New York, N.Y.)</source><volume>372</volume><elocation-id>eabb8699</elocation-id><pub-id pub-id-type="doi">10.1126/science.abb8699</pub-id><pub-id pub-id-type="pmid">33926925</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brynildsrud</surname><given-names>O</given-names></name><name><surname>Snipen</surname><given-names>LG</given-names></name><name><surname>Bohlin</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>CNOGpro: detection and quantification of CNVs in prokaryotic whole-genome sequencing data</article-title><source>Bioinformatics (Oxford, England)</source><volume>31</volume><fpage>1708</fpage><lpage>1715</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btv070</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burd</surname><given-names>EM</given-names></name><name><surname>Alam</surname><given-names>MT</given-names></name><name><surname>Passalacqua</surname><given-names>KD</given-names></name><name><surname>Kalokhe</surname><given-names>AS</given-names></name><name><surname>Eaton</surname><given-names>ME</given-names></name><name><surname>Satola</surname><given-names>SW</given-names></name><name><surname>Kraft</surname><given-names>CS</given-names></name><name><surname>Read</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Development of oxacillin resistance in a patient with recurrent <italic>Staphylococcus aureus</italic> bacteremia</article-title><source>Journal of Clinical Microbiology</source><volume>52</volume><fpage>3114</fpage><lpage>3117</lpage><pub-id pub-id-type="doi">10.1128/JCM.00615-14</pub-id><pub-id pub-id-type="pmid">24850355</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cameron</surname><given-names>DR</given-names></name><name><surname>Ward</surname><given-names>DV</given-names></name><name><surname>Kostoulias</surname><given-names>X</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Moellering RC</surname><given-names>J</given-names></name><name><surname>Eliopoulos</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in <italic>Staphylococcus aureus</italic></article-title><source>The Journal of Infectious Diseases</source><volume>205</volume><fpage>1677</fpage><lpage>1687</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis252</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaguza</surname><given-names>C</given-names></name><name><surname>Senghore</surname><given-names>M</given-names></name><name><surname>Bojang</surname><given-names>E</given-names></name><name><surname>Gladstone</surname><given-names>RA</given-names></name><name><surname>Lo</surname><given-names>SW</given-names></name><name><surname>Tientcheu</surname><given-names>PE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Within-host microevolution of Streptococcus pneumoniae is rapid and adaptive during natural colonisation</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>3442</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-17327-w</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chilambi</surname><given-names>GS</given-names></name><name><surname>Nordstrom</surname><given-names>HR</given-names></name><name><surname>Evans</surname><given-names>DR</given-names></name><name><surname>Ferrolino</surname><given-names>JA</given-names></name><name><surname>Hayden</surname><given-names>RT</given-names></name><name><surname>Mar√≥n</surname><given-names>GM</given-names></name><name><surname>Vo</surname><given-names>AN</given-names></name><name><surname>Gilmore</surname><given-names>MS</given-names></name><name><surname>Wolf</surname><given-names>J</given-names></name><name><surname>Rosch</surname><given-names>JW</given-names></name><name><surname>Van Tyne</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Evolution of vancomycin-resistant <italic>Enterococcus faecium</italic> during colonization and infection in immunocompromised pediatric patients</article-title><source>PNAS</source><volume>117</volume><fpage>11703</fpage><lpage>11714</lpage><pub-id pub-id-type="doi">10.1073/pnas.1917130117</pub-id><pub-id pub-id-type="pmid">32393645</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>Y</given-names></name><name><surname>Sims</surname><given-names>GE</given-names></name><name><surname>Murphy</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>JR</given-names></name><name><surname>Chan</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Predicting the functional effect of amino acid substitutions and indels</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e46688</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0046688</pub-id><pub-id pub-id-type="pmid">23056405</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>P</given-names></name><name><surname>Platts</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Coon</surname><given-names>M</given-names></name><name><surname>Nguyen</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff</article-title><source>Fly</source><volume>6</volume><fpage>80</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.4161/fly.19695</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehal</surname><given-names>PS</given-names></name><name><surname>Joachimiak</surname><given-names>MP</given-names></name><name><surname>Price</surname><given-names>MN</given-names></name><name><surname>Bates</surname><given-names>JT</given-names></name><name><surname>Baumohl</surname><given-names>JK</given-names></name><name><surname>Chivian</surname><given-names>D</given-names></name><name><surname>Friedland</surname><given-names>GD</given-names></name><name><surname>Huang</surname><given-names>KH</given-names></name><name><surname>Keller</surname><given-names>K</given-names></name><name><surname>Novichkov</surname><given-names>PS</given-names></name><name><surname>Dubchak</surname><given-names>IL</given-names></name><name><surname>Alm</surname><given-names>EJ</given-names></name><name><surname>Arkin</surname><given-names>AP</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MicrobesOnline: an integrated portal for comparative and functional genomics</article-title><source>Nucleic Acids Research</source><volume>38</volume><fpage>D396</fpage><lpage>D400</lpage><pub-id pub-id-type="doi">10.1093/nar/gkp919</pub-id><pub-id pub-id-type="pmid">19906701</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Walker</surname><given-names>AS</given-names></name><name><surname>Peto</surname><given-names>TE</given-names></name><name><surname>Crook</surname><given-names>DW</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Within-host evolution of bacterial pathogens</article-title><source>Nature Reviews. Microbiology</source><volume>14</volume><fpage>150</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2015.13</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engman</surname><given-names>J</given-names></name><name><surname>Rogstam</surname><given-names>A</given-names></name><name><surname>Frees</surname><given-names>D</given-names></name><name><surname>Ingmer</surname><given-names>H</given-names></name><name><surname>von Wachenfeldt</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The YjbH adaptor protein enhances proteolysis of the transcriptional regulator Spx in <italic>Staphylococcus aureus</italic></article-title><source>Journal of Bacteriology</source><volume>194</volume><fpage>1186</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.1128/JB.06414-11</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>CM</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>MprF-mediated daptomycin resistance</article-title><source>International Journal of Medical Microbiology</source><volume>309</volume><fpage>359</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2019.05.010</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldgarden</surname><given-names>M</given-names></name><name><surname>Brover</surname><given-names>V</given-names></name><name><surname>Haft</surname><given-names>DH</given-names></name><name><surname>Prasad</surname><given-names>AB</given-names></name><name><surname>Slotta</surname><given-names>DJ</given-names></name><name><surname>Tolstoy</surname><given-names>I</given-names></name><name><surname>Tyson</surname><given-names>GH</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Hsu</surname><given-names>C-H</given-names></name><name><surname>McDermott</surname><given-names>PF</given-names></name><name><surname>Tadesse</surname><given-names>DA</given-names></name><name><surname>Morales</surname><given-names>C</given-names></name><name><surname>Simmons</surname><given-names>M</given-names></name><name><surname>Tillman</surname><given-names>G</given-names></name><name><surname>Wasilenko</surname><given-names>J</given-names></name><name><surname>Folster</surname><given-names>JP</given-names></name><name><surname>Klimke</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Validating the AMRFinder Tool and Resistance Gene Database by Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of Isolates</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>e00483-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00483-19</pub-id><pub-id pub-id-type="pmid">31427293</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Mehlan</surname><given-names>H</given-names></name><name><surname>Bernhardt</surname><given-names>J</given-names></name><name><surname>Hennig</surname><given-names>A</given-names></name><name><surname>Michalik</surname><given-names>S</given-names></name><name><surname>Surmann</surname><given-names>K</given-names></name><name><surname>Pan√©-Farr√©</surname><given-names>J</given-names></name><name><surname>Giese</surname><given-names>A</given-names></name><name><surname>Weiss</surname><given-names>S</given-names></name><name><surname>Backert</surname><given-names>L</given-names></name><name><surname>Herbig</surname><given-names>A</given-names></name><name><surname>Nieselt</surname><given-names>K</given-names></name><name><surname>Hecker</surname><given-names>M</given-names></name><name><surname>V√∂lker</surname><given-names>U</given-names></name><name><surname>M√§der</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>AureoWiki Ãµ The repository of the <italic>Staphylococcus aureus</italic> research and annotation community</article-title><source>International Journal of Medical Microbiology</source><volume>308</volume><fpage>558</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1016/j.ijmm.2017.11.011</pub-id><pub-id pub-id-type="pmid">29198880</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Cameron</surname><given-names>DR</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name><name><surname>Kostoulias</surname><given-names>X</given-names></name><name><surname>Stepnell</surname><given-names>J</given-names></name><name><surname>Tuck</surname><given-names>KL</given-names></name><name><surname>Yeaman</surname><given-names>MR</given-names></name><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The RpoB H‚ÇÑ‚Çà‚ÇÅY rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in <italic>Staphylococcus aureus</italic></article-title><source>The Journal of Infectious Diseases</source><volume>207</volume><fpage>929</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis772</pub-id><pub-id pub-id-type="pmid">23255563</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Tobias</surname><given-names>NJ</given-names></name><name><surname>Gladman</surname><given-names>SL</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Large tandem chromosome expansions facilitate niche adaptation during persistent infection with drug-resistant <italic>Staphylococcus aureus</italic></article-title><source>Microbial Genomics</source><volume>1</volume><elocation-id>e000026</elocation-id><pub-id pub-id-type="doi">10.1099/mgen.0.000026</pub-id><pub-id pub-id-type="pmid">28348811</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatt</surname><given-names>YE</given-names></name><name><surname>Margalit</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Common Adaptive Strategies Underlie Within-Host Evolution of Bacterial Pathogens</article-title><source>Molecular Biology and Evolution</source><volume>38</volume><fpage>1101</fpage><lpage>1121</lpage><pub-id pub-id-type="doi">10.1093/molbev/msaa278</pub-id><pub-id pub-id-type="pmid">33118035</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Gerasimavicius</surname><given-names>L</given-names></name><name><surname>Livesey</surname><given-names>BJ</given-names></name><name><surname>Marsh</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss-of-Function, Gain-of-Function and Dominant-Negative Mutations Have Profoundly Different Effects on Protein Structure: Implications for Variant Effect Prediction</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.10.23.465554</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giulieri</surname><given-names>SG</given-names></name><name><surname>Baines</surname><given-names>SL</given-names></name><name><surname>Guerillot</surname><given-names>R</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Gon√ßalves da Silva</surname><given-names>A</given-names></name><name><surname>Schultz</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent <italic>Staphylococcus aureus</italic> bacteraemia</article-title><source>Genome Medicine</source><volume>10</volume><elocation-id>65</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-018-0574-x</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giulieri</surname><given-names>SG</given-names></name><name><surname>Gu√©rillot</surname><given-names>R</given-names></name><name><surname>Kwong</surname><given-names>JC</given-names></name><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Hayes</surname><given-names>AS</given-names></name><name><surname>Daniel</surname><given-names>D</given-names></name><name><surname>Baines</surname><given-names>S</given-names></name><name><surname>Sherry</surname><given-names>NL</given-names></name><name><surname>Holmes</surname><given-names>NE</given-names></name><name><surname>Ward</surname><given-names>P</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Comprehensive Genomic Investigation of Adaptive Mutations Driving the Low-Level Oxacillin Resistance Phenotype in <italic>Staphylococcus aureus</italic></article-title><source>MBio</source><volume>11</volume><elocation-id>e02882-20</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02882-20</pub-id><pub-id pub-id-type="pmid">33293382</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G√∂hring</surname><given-names>N</given-names></name><name><surname>Fedtke</surname><given-names>I</given-names></name><name><surname>Xia</surname><given-names>G</given-names></name><name><surname>Jorge</surname><given-names>AM</given-names></name><name><surname>Pinho</surname><given-names>MG</given-names></name><name><surname>Bertsche</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>New role of the disulfide stress effector YjbH in Œ≤-lactam susceptibility of <italic>Staphylococcus aureus</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>55</volume><fpage>5452</fpage><lpage>5458</lpage><pub-id pub-id-type="doi">10.1128/AAC.00286-11</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golubchik</surname><given-names>T</given-names></name><name><surname>Batty</surname><given-names>EM</given-names></name><name><surname>Miller</surname><given-names>RR</given-names></name><name><surname>Farr</surname><given-names>H</given-names></name><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Larner-Svensson</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Within-host evolution of <italic>Staphylococcus aureus</italic> during asymptomatic carriage</article-title><source>PLOS ONE</source><volume>8</volume><elocation-id>e61319</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0061319</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Sterling</surname><given-names>BE</given-names></name><name><surname>Laakso</surname><given-names>HA</given-names></name><name><surname>Friedrich</surname><given-names>NC</given-names></name><name><surname>Kaiser</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Stress-induced inactivation of the <italic>Staphylococcus aureus</italic> purine biosynthesis repressor leads to hypervirulence</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>775</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-08724-x</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncheva</surname><given-names>MI</given-names></name><name><surname>Flannagan</surname><given-names>RS</given-names></name><name><surname>Heinrichs</surname><given-names>DE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>De Novo Purine Biosynthesis Is Required for Intracellular Growth of <italic>Staphylococcus aureus</italic> and for the Hypervirulence Phenotype of a purR Mutant</article-title><source>Infection and Immunity</source><volume>88</volume><elocation-id>e00104-20</elocation-id><pub-id pub-id-type="doi">10.1128/IAI.00104-20</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>DM</given-names></name><name><surname>Veech</surname><given-names>JA</given-names></name><name><surname>Marsh</surname><given-names>CJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>cooccur: Probabilistic Species Co-Occurrence Analysis in R</article-title><source>Journal of Statistical Software, Code Snippets</source><volume>69</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.18637/jss.v069.c02</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu√©rillot</surname><given-names>R</given-names></name><name><surname>Gon√ßalves da Silva</surname><given-names>A</given-names></name><name><surname>Monk</surname><given-names>I</given-names></name><name><surname>Giulieri</surname><given-names>S</given-names></name><name><surname>Tomita</surname><given-names>T</given-names></name><name><surname>Alison</surname><given-names>E</given-names></name><name><surname>Porter</surname><given-names>J</given-names></name><name><surname>Pidot</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant <italic>Staphylococcus aureus</italic></article-title><source>MSphere</source><volume>3</volume><elocation-id>e00550-17</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.00550-17</pub-id><pub-id pub-id-type="pmid">29404415</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guerillot</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Baines</surname><given-names>S</given-names></name><name><surname>Howden</surname><given-names>B</given-names></name><name><surname>Schultz</surname><given-names>MB</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Comprehensive antibiotic-linked mutation assessment by resistance mutation sequencing (RM-seq</article-title><source>Genome Medicine</source><volume>10</volume><elocation-id>63</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-018-0572-z</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu√©rillot</surname><given-names>R</given-names></name><name><surname>Kostoulias</surname><given-names>X</given-names></name><name><surname>Donovan</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Carter</surname><given-names>GP</given-names></name><name><surname>Hachani</surname><given-names>A</given-names></name><name><surname>Vandelannoote</surname><given-names>K</given-names></name><name><surname>Giulieri</surname><given-names>S</given-names></name><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Kunimoto</surname><given-names>M</given-names></name><name><surname>Starrs</surname><given-names>L</given-names></name><name><surname>Burgio</surname><given-names>G</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Unstable chromosome rearrangements in <italic>Staphylococcus aureus</italic> cause phenotype switching associated with persistent infections</article-title><source>PNAS</source><volume>116</volume><fpage>20135</fpage><lpage>20140</lpage><pub-id pub-id-type="doi">10.1073/pnas.1904861116</pub-id><pub-id pub-id-type="pmid">31527262</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>MD</given-names></name><name><surname>Holden</surname><given-names>MT</given-names></name><name><surname>Srisomang</surname><given-names>P</given-names></name><name><surname>Mahavanakul</surname><given-names>W</given-names></name><name><surname>Wuthiekanun</surname><given-names>V</given-names></name><name><surname>Limmathurotsakul</surname><given-names>D</given-names></name><name><surname>Fountain</surname><given-names>K</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Nickerson</surname><given-names>EK</given-names></name><name><surname>Peacock</surname><given-names>SJ</given-names></name><name><surname>Fraser</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Improved characterisation of MRSA transmission using within-host bacterial sequence diversity</article-title><source>eLife</source><volume>8</volume><elocation-id>e46402</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46402</pub-id><pub-id pub-id-type="pmid">31591959</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harkins</surname><given-names>CP</given-names></name><name><surname>Pettigrew</surname><given-names>KA</given-names></name><name><surname>Oravcova</surname><given-names>K</given-names></name><name><surname>Gardner</surname><given-names>J</given-names></name><name><surname>Hearn</surname><given-names>RMR</given-names></name><name><surname>Rice</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The Microevolution and Epidemiology of <italic>Staphylococcus aureus</italic> Colonization during Atopic Eczema Disease Flare</article-title><source>The Journal of Investigative Dermatology</source><volume>138</volume><fpage>336</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.jid.2017.09.023</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkey</surname><given-names>J</given-names></name><name><surname>Monk</surname><given-names>JM</given-names></name><name><surname>Billman-Jacobe</surname><given-names>H</given-names></name><name><surname>Palsson</surname><given-names>B</given-names></name><name><surname>Holt</surname><given-names>KE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Impact of insertion sequences on convergent evolution of Shigella species</article-title><source>PLOS Genetics</source><volume>16</volume><elocation-id>e1008931</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1008931</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hood</surname><given-names>MI</given-names></name><name><surname>Skaar</surname><given-names>EP</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nutritional immunity: transition metals at the pathogen-host interface</article-title><source>Nature Reviews. Microbiology</source><volume>10</volume><fpage>525</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2836</pub-id><pub-id pub-id-type="pmid">22796883</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Johnson</surname><given-names>PD</given-names></name><name><surname>Ward</surname><given-names>PB</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Davies</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant <italic>Staphylococcus aureus</italic> bacteremia</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>50</volume><fpage>3039</fpage><lpage>3047</lpage><pub-id pub-id-type="doi">10.1128/AAC.00422-06</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>McEvoy</surname><given-names>CR</given-names></name><name><surname>Allen</surname><given-names>DL</given-names></name><name><surname>Chua</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>PF</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Evolution of multidrug resistance during <italic>Staphylococcus aureus</italic> infection involves mutation of the essential two component regulator WalKR</article-title><source>PLOS Pathogens</source><volume>7</volume><elocation-id>e1002359</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1002359</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>S</given-names></name><name><surname>Jiang</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>In-Host Evolution of Daptomycin Resistance and Heteroresistance in Methicillin-Resistant <italic>Staphylococcus aureus</italic> Strains From Three Endocarditis Patients</article-title><source>The Journal of Infectious Diseases</source><volume>221</volume><fpage>S243</fpage><lpage>S252</lpage><pub-id pub-id-type="doi">10.1093/infdis/jiz571</pub-id><pub-id pub-id-type="pmid">32176794</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>JH</given-names></name><name><surname>Dexter</surname><given-names>C</given-names></name><name><surname>Cameron</surname><given-names>DR</given-names></name><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Baines</surname><given-names>SL</given-names></name><name><surname>Abbott</surname><given-names>IJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>63</volume><elocation-id>e01926-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.01926-18</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennemann</surname><given-names>L</given-names></name><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Aebischer</surname><given-names>T</given-names></name><name><surname>Kuhn</surname><given-names>S</given-names></name><name><surname>Drescher</surname><given-names>B</given-names></name><name><surname>Droege</surname><given-names>M</given-names></name><name><surname>Reinhardt</surname><given-names>R</given-names></name><name><surname>Correa</surname><given-names>P</given-names></name><name><surname>Meyer</surname><given-names>TF</given-names></name><name><surname>Josenhans</surname><given-names>C</given-names></name><name><surname>Falush</surname><given-names>D</given-names></name><name><surname>Suerbaum</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Helicobacter pylori genome evolution during human infection</article-title><source>PNAS</source><volume>108</volume><fpage>5033</fpage><lpage>5038</lpage><pub-id pub-id-type="doi">10.1073/pnas.1018444108</pub-id><pub-id pub-id-type="pmid">21383187</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Key</surname><given-names>FM</given-names></name><name><surname>Khadka</surname><given-names>VD</given-names></name><name><surname>Romo-Gonz√°lez</surname><given-names>C</given-names></name><name><surname>Blake</surname><given-names>KJ</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Lynn</surname><given-names>TC</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Chiu</surname><given-names>IM</given-names></name><name><surname>Garc√≠a-Romero</surname><given-names>MT</given-names></name><name><surname>Lieberman</surname><given-names>TD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>On-Person Adaptive Evolution of <italic>Staphylococcus aureus</italic> during Treatment for Atopic Dermatitis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.03.24.436824</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khademi</surname><given-names>SMH</given-names></name><name><surname>Sazinas</surname><given-names>P</given-names></name><name><surname>Jelsbak</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Within-Host Adaptation Mediated by Intergenic Evolution in <italic>Pseudomonas aeruginosa</italic></article-title><source>Genome Biology and Evolution</source><volume>11</volume><fpage>1385</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.1093/gbe/evz083</pub-id><pub-id pub-id-type="pmid">30980662</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klemm</surname><given-names>EJ</given-names></name><name><surname>Gkrania-Klotsas</surname><given-names>E</given-names></name><name><surname>Hadfield</surname><given-names>J</given-names></name><name><surname>Forbester</surname><given-names>JL</given-names></name><name><surname>Harris</surname><given-names>SR</given-names></name><name><surname>Hale</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Emergence of host-adapted Salmonella Enteritidis through rapid evolution in an immunocompromised host</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>e15023</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2015.23</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krismer</surname><given-names>B</given-names></name><name><surname>Weidenmaier</surname><given-names>C</given-names></name><name><surname>Zipperer</surname><given-names>A</given-names></name><name><surname>Peschel</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The commensal lifestyle of <italic>Staphylococcus aureus</italic> and its interactions with the nasal microbiota</article-title><source>Nature Reviews. Microbiology</source><volume>15</volume><fpage>675</fpage><lpage>687</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.104</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuehl</surname><given-names>R</given-names></name><name><surname>Morata</surname><given-names>L</given-names></name><name><surname>Meylan</surname><given-names>S</given-names></name><name><surname>Mensa</surname><given-names>J</given-names></name><name><surname>Soriano</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>When antibiotics fail: a clinical and microbiological perspective on antibiotic tolerance and persistence of <italic>Staphylococcus aureus</italic></article-title><source>The Journal of Antimicrobial Chemotherapy</source><volume>75</volume><fpage>1071</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1093/jac/dkz559</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Sekizuka</surname><given-names>T</given-names></name><name><surname>Matsui</surname><given-names>H</given-names></name><name><surname>Ohsuga</surname><given-names>J</given-names></name><name><surname>Ohshima</surname><given-names>T</given-names></name><name><surname>Hanaki</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>IS<italic>256</italic>-Mediated Overexpression of the WalKR Two-Component System Regulon Contributes to Reduced Vancomycin Susceptibility in a <italic>Staphylococcus aureus</italic> Clinical Isolate</article-title><source>Frontiers in Microbiology</source><volume>10</volume><elocation-id>1882</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2019.01882</pub-id><pub-id pub-id-type="pmid">31474962</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laabei</surname><given-names>M</given-names></name><name><surname>Uhlemann</surname><given-names>AC</given-names></name><name><surname>Lowy</surname><given-names>FD</given-names></name><name><surname>Austin</surname><given-names>ED</given-names></name><name><surname>Yokoyama</surname><given-names>M</given-names></name><name><surname>Ouadi</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Evolutionary Trade-Offs Underlie the Multi-faceted Virulence of <italic>Staphylococcus aureus</italic></article-title><source>PLOS Biology</source><volume>13</volume><elocation-id>e1002229</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002229</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langhanki</surname><given-names>L</given-names></name><name><surname>Berger</surname><given-names>P</given-names></name><name><surname>Treffon</surname><given-names>J</given-names></name><name><surname>Catania</surname><given-names>F</given-names></name><name><surname>Kahl</surname><given-names>BC</given-names></name><name><surname>Mellmann</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>In vivo competition and horizontal gene transfer among distinct <italic>Staphylococcus aureus</italic> lineages as major drivers for adaptational changes during long-term persistence in humans</article-title><source>BMC Microbiology</source><volume>18</volume><elocation-id>152</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-018-1308-3</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>JA</given-names></name><name><surname>Croucher</surname><given-names>NJ</given-names></name><name><surname>Goldblatt</surname><given-names>D</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Turner</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>P</given-names></name><name><surname>Bentley</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration</article-title><source>eLife</source><volume>6</volume><elocation-id>e26255</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.26255</pub-id><pub-id pub-id-type="pmid">28742023</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>JA</given-names></name><name><surname>Kremer</surname><given-names>PHC</given-names></name><name><surname>Manso</surname><given-names>AS</given-names></name><name><surname>Croucher</surname><given-names>NJ</given-names></name><name><surname>Ferwerda</surname><given-names>B</given-names></name><name><surname>Ser√≥n</surname><given-names>MV</given-names></name><name><surname>Oggioni</surname><given-names>MR</given-names></name><name><surname>Parkhill</surname><given-names>J</given-names></name><name><surname>Brouwer</surname><given-names>MC</given-names></name><name><surname>van der Ende</surname><given-names>A</given-names></name><name><surname>van de Beek</surname><given-names>D</given-names></name><name><surname>Bentley</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>Large scale genomic analysis shows no evidence for pathogen adaptation between the blood and cerebrospinal fluid niches during bacterial meningitis</article-title><source>Microbial Genomics</source><volume>3</volume><elocation-id>e000103</elocation-id><pub-id pub-id-type="doi">10.1099/mgen.0.000103</pub-id><pub-id pub-id-type="pmid">28348877</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Lemoine</surname><given-names>F</given-names></name><name><surname>Gascuel</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Gotree/Goalign: Toolkit and Go API to Facilitate the Development of Phylogenetic Workflows</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.06.09.447704</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin-Reisman</surname><given-names>I</given-names></name><name><surname>Brauner</surname><given-names>A</given-names></name><name><surname>Ronin</surname><given-names>I</given-names></name><name><surname>Balaban</surname><given-names>NQ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Epistasis between antibiotic tolerance, persistence, and resistance mutations</article-title><source>PNAS</source><volume>116</volume><fpage>14734</fpage><lpage>14739</lpage><pub-id pub-id-type="doi">10.1073/pnas.1906169116</pub-id><pub-id pub-id-type="pmid">31262806</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Aligning Sequence Reads, Clone Sequences and Assembly CContigs with BWA-MEM</article-title><source>arXiv</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.48550/arXiv.1303.3997">https://doi.org/10.48550/arXiv.1303.3997</ext-link></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>TD</given-names></name><name><surname>Wilson</surname><given-names>D</given-names></name><name><surname>Misra</surname><given-names>R</given-names></name><name><surname>Xiong</surname><given-names>LL</given-names></name><name><surname>Moodley</surname><given-names>P</given-names></name><name><surname>Cohen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genomic diversity in autopsy samples reveals within-host dissemination of HIV-associated Mycobacterium tuberculosis</article-title><source>Nature Medicine</source><volume>22</volume><fpage>1470</fpage><lpage>1474</lpage><pub-id pub-id-type="doi">10.1038/nm.4205</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Gefen</surname><given-names>O</given-names></name><name><surname>Ronin</surname><given-names>I</given-names></name><name><surname>Bar-Meir</surname><given-names>M</given-names></name><name><surname>Balaban</surname><given-names>NQ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Effect of tolerance on the evolution of antibiotic resistance under drug combinations</article-title><source>Science (New York, N.Y.)</source><volume>367</volume><fpage>200</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1126/science.aay3041</pub-id><pub-id pub-id-type="pmid">31919223</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>DR</given-names></name><name><surname>Wolter</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>M</given-names></name><name><surname>Precit</surname><given-names>M</given-names></name><name><surname>McLean</surname><given-names>K</given-names></name><name><surname>Holmes</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Polyclonality, Shared Strains, and Convergent Evolution in Chronic CF <italic>S. aureus</italic> Airway Infection</article-title><source>American Journal of Respiratory and Critical Care Medicine</source><volume>203</volume><fpage>1127</fpage><lpage>1137</lpage><pub-id pub-id-type="doi">10.1164/rccm.202003-0735OC</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopatkin</surname><given-names>AJ</given-names></name><name><surname>Bening</surname><given-names>SC</given-names></name><name><surname>Manson</surname><given-names>AL</given-names></name><name><surname>Stokes</surname><given-names>JM</given-names></name><name><surname>Kohanski</surname><given-names>MA</given-names></name><name><surname>Badran</surname><given-names>AH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Clinically relevant mutations in core metabolic genes confer antibiotic resistance</article-title><source>Science (New York, N.Y.)</source><volume>371</volume><elocation-id>eaba0862</elocation-id><pub-id pub-id-type="doi">10.1126/science.aba0862</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loss</surname><given-names>G</given-names></name><name><surname>Simoes</surname><given-names>PM</given-names></name><name><surname>Valour</surname><given-names>F</given-names></name><name><surname>Cortes</surname><given-names>MF</given-names></name><name><surname>Gonzaga</surname><given-names>L</given-names></name><name><surname>Bergot</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title><italic>Staphylococcus aureus</italic> Small Colony Variants (SCVs): News From a Chronic Prosthetic Joint Infection</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>9</volume><elocation-id>363</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2019.00363</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L√ºdecke</surname><given-names>D</given-names></name><name><surname>Ben-Shachar</surname><given-names>MS</given-names></name><name><surname>Patil</surname><given-names>I</given-names></name><name><surname>Waggoner</surname><given-names>P</given-names></name><name><surname>Makowski</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>performance: An R Package for Assessment, Comparison and Testing of Statistical Models</article-title><source>J. Journal of Open Source Software</source><volume>6</volume><elocation-id>3139</elocation-id><pub-id pub-id-type="doi">10.21105/joss.03139</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>H</given-names></name><name><surname>Seif</surname><given-names>Y</given-names></name><name><surname>Sakoulas</surname><given-names>G</given-names></name><name><surname>Olson</surname><given-names>CA</given-names></name><name><surname>Hefner</surname><given-names>Y</given-names></name><name><surname>Anand</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Environmental conditions dictate differential evolution of vancomycin resistance in <italic>Staphylococcus aureus</italic></article-title><source>Communications Biology</source><volume>4</volume><elocation-id>e793</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-021-02339-z</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M√§der</surname><given-names>U</given-names></name><name><surname>Nicolas</surname><given-names>P</given-names></name><name><surname>Depke</surname><given-names>M</given-names></name><name><surname>Pan√©-Farr√©</surname><given-names>J</given-names></name><name><surname>Debarbouille</surname><given-names>M</given-names></name><name><surname>van der Kooi-Pol</surname><given-names>MM</given-names></name><name><surname>Gu√©rin</surname><given-names>C</given-names></name><name><surname>D√©rozier</surname><given-names>S</given-names></name><name><surname>Hiron</surname><given-names>A</given-names></name><name><surname>Jarmer</surname><given-names>H</given-names></name><name><surname>Leduc</surname><given-names>A</given-names></name><name><surname>Michalik</surname><given-names>S</given-names></name><name><surname>Reilman</surname><given-names>E</given-names></name><name><surname>Schaffer</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>F</given-names></name><name><surname>Bessi√®res</surname><given-names>P</given-names></name><name><surname>Noirot</surname><given-names>P</given-names></name><name><surname>Hecker</surname><given-names>M</given-names></name><name><surname>Msadek</surname><given-names>T</given-names></name><name><surname>V√∂lker</surname><given-names>U</given-names></name><name><surname>van Dijl</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Staphylococcus aureus</italic> Transcriptome Architecture: From Laboratory to Infection-Mimicking Conditions</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1005962</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005962</pub-id><pub-id pub-id-type="pmid">27035918</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Raine</surname><given-names>KM</given-names></name><name><surname>Gerstung</surname><given-names>M</given-names></name><name><surname>Dawson</surname><given-names>KJ</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Universal Patterns of Selection in Cancer and Somatic Tissues</article-title><source>Cell</source><volume>171</volume><fpage>1029</fpage><lpage>1041</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.09.042</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marvig</surname><given-names>RL</given-names></name><name><surname>Sommer</surname><given-names>LM</given-names></name><name><surname>Molin</surname><given-names>S</given-names></name><name><surname>Johansen</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Convergent evolution and adaptation of <italic>Pseudomonas aeruginosa</italic> within patients with cystic fibrosis</article-title><source>Nature Genetics</source><volume>47</volume><fpage>57</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1038/ng.3148</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEvoy</surname><given-names>CRE</given-names></name><name><surname>Tsuji</surname><given-names>B</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Porter</surname><given-names>JL</given-names></name><name><surname>Doig</surname><given-names>K</given-names></name><name><surname>Ngo</surname><given-names>D</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Decreased vancomycin susceptibility in <italic>Staphylococcus aureus</italic> caused by IS256 tempering of WalKR expression</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>3240</fpage><lpage>3249</lpage><pub-id pub-id-type="doi">10.1128/AAC.00279-13</pub-id><pub-id pub-id-type="pmid">23629723</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McVicker</surname><given-names>G</given-names></name><name><surname>Prajsnar</surname><given-names>TK</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Wagner</surname><given-names>NL</given-names></name><name><surname>Boots</surname><given-names>M</given-names></name><name><surname>Renshaw</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clonal expansion during <italic>Staphylococcus aureus</italic> infection dynamics reveals the effect of antibiotic intervention</article-title><source>PLOS Pathogens</source><volume>10</volume><elocation-id>e1003959</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1003959</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>CR</given-names></name><name><surname>Dey</surname><given-names>S</given-names></name><name><surname>Smolenski</surname><given-names>PD</given-names></name><name><surname>Kulkarni</surname><given-names>PS</given-names></name><name><surname>Monk</surname><given-names>JM</given-names></name><name><surname>Szubin</surname><given-names>R</given-names></name><name><surname>Sakoulas</surname><given-names>G</given-names></name><name><surname>Berti</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Distinct Subpopulations of Intravalvular Methicillin-Resistant <italic>Staphylococcus aureus</italic> with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>64</volume><elocation-id>e01593-19</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.01593-19</pub-id><pub-id pub-id-type="pmid">31932377</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minh</surname><given-names>BQ</given-names></name><name><surname>Schmidt</surname><given-names>HA</given-names></name><name><surname>Chernomor</surname><given-names>O</given-names></name><name><surname>Schrempf</surname><given-names>D</given-names></name><name><surname>Woodhams</surname><given-names>MD</given-names></name><name><surname>von Haeseler</surname><given-names>A</given-names></name><name><surname>Lanfear</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>IQ-TREE 2: New Models and Efficient Methods for Phylogenetic Inference in the Genomic Era</article-title><source>Molecular Biology and Evolution</source><volume>37</volume><fpage>1530</fpage><lpage>1534</lpage><pub-id pub-id-type="doi">10.1093/molbev/msaa015</pub-id><pub-id pub-id-type="pmid">32011700</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Tree</surname><given-names>JJ</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Foster</surname><given-names>TJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Complete Bypass of Restriction Systems for Major <italic>Staphylococcus aureus</italic> Lineages</article-title><source>MBio</source><volume>6</volume><elocation-id>e00308-15</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00308-15</pub-id><pub-id pub-id-type="pmid">26015493</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monk</surname><given-names>IR</given-names></name><name><surname>Shaikh</surname><given-names>N</given-names></name><name><surname>Begg</surname><given-names>SL</given-names></name><name><surname>Gajdiss</surname><given-names>M</given-names></name><name><surname>Sharkey</surname><given-names>LKR</given-names></name><name><surname>Lee</surname><given-names>JYH</given-names></name><name><surname>Pidot</surname><given-names>SJ</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Kuiper</surname><given-names>M</given-names></name><name><surname>Winnen</surname><given-names>B</given-names></name><name><surname>Hvorup</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>BM</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name><name><surname>Udagedara</surname><given-names>SR</given-names></name><name><surname>Morey</surname><given-names>JR</given-names></name><name><surname>Pulyani</surname><given-names>N</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Maher</surname><given-names>MJ</given-names></name><name><surname>McDevitt</surname><given-names>CA</given-names></name><name><surname>King</surname><given-names>GF</given-names></name><name><surname>Stinear</surname><given-names>TP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Zinc-binding to the cytoplasmic PAS domain regulates the essential WalK histidine kinase of <italic>Staphylococcus aureus</italic></article-title><source>Nature Communications</source><volume>10</volume><elocation-id>3067</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-10932-4</pub-id><pub-id pub-id-type="pmid">31296851</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morvan</surname><given-names>C</given-names></name><name><surname>Halpern</surname><given-names>D</given-names></name><name><surname>K√©nanian</surname><given-names>G</given-names></name><name><surname>Hays</surname><given-names>C</given-names></name><name><surname>Anba-Mondoloni</surname><given-names>J</given-names></name><name><surname>Brinster</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Environmental fatty acids enable emergence of infectious <italic>Staphylococcus aureus</italic> resistant to FASII-targeted antimicrobials</article-title><source>Nature Communications</source><volume>7</volume><elocation-id>12944</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms12944</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novick</surname><given-names>RP</given-names></name><name><surname>Geisinger</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Quorum sensing in staphylococci</article-title><source>Annual Review of Genetics</source><volume>42</volume><fpage>541</fpage><lpage>564</lpage><pub-id pub-id-type="doi">10.1146/annurev.genet.42.110807.091640</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>AJ</given-names></name><name><surname>Taylor</surname><given-names>B</given-names></name><name><surname>Delaney</surname><given-names>AJ</given-names></name><name><surname>Soares</surname><given-names>J</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Keane</surname><given-names>JA</given-names></name><name><surname>Harris</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>SNP-sites</italic>: rapid efficient extraction of SNPs from multi-FASTA alignments</article-title><source>Microbial Genomics</source><volume>2</volume><elocation-id>e000056</elocation-id><pub-id pub-id-type="doi">10.1099/mgen.0.000056</pub-id><pub-id pub-id-type="pmid">28348851</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paterson</surname><given-names>GK</given-names></name><name><surname>Harrison</surname><given-names>EM</given-names></name><name><surname>Murray</surname><given-names>GGR</given-names></name><name><surname>Welch</surname><given-names>JJ</given-names></name><name><surname>Warland</surname><given-names>JH</given-names></name><name><surname>Holden</surname><given-names>MTG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Capturing the cloud of diversity reveals complexity and heterogeneity of MRSA carriage, infection and transmission</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>6560</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms7560</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paudel</surname><given-names>A</given-names></name><name><surname>Panthee</surname><given-names>S</given-names></name><name><surname>Hamamoto</surname><given-names>H</given-names></name><name><surname>Grunert</surname><given-names>T</given-names></name><name><surname>Sekimizu</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>YjbH regulates virulence genes expression and oxidative stress resistance in <italic>Staphylococcus aureus</italic></article-title><source>Virulence</source><volume>12</volume><fpage>470</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1080/21505594.2021.1875683</pub-id><pub-id pub-id-type="pmid">33487122</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peleg</surname><given-names>AY</given-names></name><name><surname>Miyakis</surname><given-names>S</given-names></name><name><surname>Ward</surname><given-names>DV</given-names></name><name><surname>Earl</surname><given-names>AM</given-names></name><name><surname>Rubio</surname><given-names>A</given-names></name><name><surname>Cameron</surname><given-names>DR</given-names></name><name><surname>Pillai</surname><given-names>S</given-names></name><name><surname>Moellering</surname><given-names>RC</given-names></name><name><surname>Eliopoulos</surname><given-names>GM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of <italic>Staphylococcus aureus</italic></article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e28316</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0028316</pub-id><pub-id pub-id-type="pmid">22238576</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrovic Fabijan</surname><given-names>A</given-names></name><name><surname>Lin</surname><given-names>RCY</given-names></name><name><surname>Ho</surname><given-names>J</given-names></name><name><surname>Maddocks</surname><given-names>S</given-names></name><name><surname>Ben Zakour</surname><given-names>NL</given-names></name><name><surname>Iredell</surname><given-names>JR</given-names></name><collab>Westmead Bacteriophage Therapy Team</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Safety of bacteriophage therapy in severe <italic>Staphylococcus aureus</italic> infection</article-title><source>Nature Microbiology</source><volume>5</volume><fpage>465</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/s41564-019-0634-z</pub-id><pub-id pub-id-type="pmid">32066959</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phaneuf</surname><given-names>PV</given-names></name><name><surname>Yurkovich</surname><given-names>JT</given-names></name><name><surname>Heckmann</surname><given-names>D</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name><name><surname>Sandberg</surname><given-names>TE</given-names></name><name><surname>King</surname><given-names>ZA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Causal mutations from adaptive laboratory evolution are outlined by multiple scales of genome annotations and condition-specificity</article-title><source>BMC Genomics</source><volume>21</volume><elocation-id>514</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-020-06920-4</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Epistasis ‚Äî the essential role of gene interactions in the structure and evolution of genetic systems</article-title><source>Nature Reviews Genetics</source><volume>9</volume><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1038/nrg2452</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prados</surname><given-names>J</given-names></name><name><surname>Linder</surname><given-names>P</given-names></name><name><surname>Redder</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TSS-EMOTE, a refined protocol for a more complete and less biased global mapping of transcription start sites in bacterial pathogens</article-title><source>BMC Genomics</source><volume>17</volume><elocation-id>849</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-016-3211-3</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>MN</given-names></name><name><surname>Arkin</surname><given-names>AP</given-names></name><name><surname>Langille</surname><given-names>MGI</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>PaperBLAST: Text Mining Papers for Information about Homologs</article-title><source>MSystems</source><volume>2</volume><elocation-id>e00039-17</elocation-id><pub-id pub-id-type="doi">10.1128/mSystems.00039-17</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proctor</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Immunity to <italic>Staphylococcus aureus</italic>: Implications for Vaccine Development</article-title><source>Microbiology Spectrum</source><volume>7</volume><elocation-id>e0037-2018</elocation-id><pub-id pub-id-type="doi">10.1128/microbiolspec.GPP3-0037-2018</pub-id><pub-id pub-id-type="pmid">31298209</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname><given-names>AR</given-names></name><name><surname>Hall</surname><given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics (Oxford, England)</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renzoni</surname><given-names>A</given-names></name><name><surname>Andrey</surname><given-names>DO</given-names></name><name><surname>Jousselin</surname><given-names>A</given-names></name><name><surname>Barras</surname><given-names>C</given-names></name><name><surname>Monod</surname><given-names>A</given-names></name><name><surname>Vaudaux</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in <italic>Staphylococcus aureus</italic></article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e21577</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021577</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rishishwar</surname><given-names>L</given-names></name><name><surname>Kraft</surname><given-names>CS</given-names></name><name><surname>Jordan</surname><given-names>IK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Population Genomics of Reduced Vancomycin Susceptibility in <italic>Staphylococcus aureus</italic></article-title><source>MSphere</source><volume>1</volume><elocation-id>e00094</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.00094-16</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rouard</surname><given-names>C</given-names></name><name><surname>Garnier</surname><given-names>F</given-names></name><name><surname>Leraut</surname><given-names>J</given-names></name><name><surname>Lepainteur</surname><given-names>M</given-names></name><name><surname>Rahajamananav</surname><given-names>L</given-names></name><name><surname>Languepin</surname><given-names>J</given-names></name><name><surname>Ploy</surname><given-names>M-C</given-names></name><name><surname>Bourgeois-Nicolaos</surname><given-names>N</given-names></name><name><surname>Doucet-Populaire</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Emergence and Within-Host Genetic Evolution of Methicillin-Resistant <italic>Staphylococcus aureus</italic> Resistant to Linezolid in a Cystic Fibrosis Patient</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>62</volume><elocation-id>e00720-18</elocation-id><pub-id pub-id-type="doi">10.1128/AAC.00720-18</pub-id><pub-id pub-id-type="pmid">30275089</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sause</surname><given-names>WE</given-names></name><name><surname>Balasubramanian</surname><given-names>D</given-names></name><name><surname>Irnov</surname><given-names>I</given-names></name><name><surname>Copin</surname><given-names>R</given-names></name><name><surname>Sullivan</surname><given-names>MJ</given-names></name><name><surname>Sommerfield</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The purine biosynthesis regulator PurR moonlights as a virulence regulator in <italic>Staphylococcus aureus</italic></article-title><source>PNAS</source><volume>116</volume><fpage>13563</fpage><lpage>13572</lpage><pub-id pub-id-type="doi">10.1073/pnas.1904280116</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>F</given-names></name><name><surname>Szekat</surname><given-names>C</given-names></name><name><surname>Josten</surname><given-names>M</given-names></name><name><surname>Sahl</surname><given-names>HG</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antibiotic-induced autoactivation of IS256 in <italic>Staphylococcus aureus</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>6381</fpage><lpage>6384</lpage><pub-id pub-id-type="doi">10.1128/AAC.01585-13</pub-id><pub-id pub-id-type="pmid">24080654</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Prokka: rapid prokaryotic genome annotation</article-title><source>Bioinformatics (Oxford, England)</source><volume>30</volume><fpage>2068</fpage><lpage>2069</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu153</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022a</year><data-title>ABRicate</data-title><version designator="955d402">955d402</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/abricate">https://github.com/tseemann/abricate</ext-link></element-citation></ref><ref id="bib99"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022b</year><data-title>mlst</data-title><version designator="09851e9">09851e9</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/mlst">https://github.com/tseemann/mlst</ext-link></element-citation></ref><ref id="bib100"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022c</year><data-title>Shovill</data-title><version designator="f64d19e">f64d19e</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/shovill">https://github.com/tseemann/shovill</ext-link></element-citation></ref><ref id="bib101"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Seemann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022d</year><data-title>snippy</data-title><version designator="2af674c">2af674c</version><source>Github</source><ext-link ext-link-type="uri" xlink:href="https://github.com/tseemann/snippy">https://github.com/tseemann/snippy</ext-link></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shopsin</surname><given-names>B</given-names></name><name><surname>Drlica-Wagner</surname><given-names>A</given-names></name><name><surname>Mathema</surname><given-names>B</given-names></name><name><surname>Adhikari</surname><given-names>RP</given-names></name><name><surname>Kreiswirth</surname><given-names>BN</given-names></name><name><surname>Novick</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Prevalence of agr dysfunction among colonizing <italic>Staphylococcus aureus</italic> strains</article-title><source>The Journal of Infectious Diseases</source><volume>198</volume><fpage>1171</fpage><lpage>1174</lpage><pub-id pub-id-type="doi">10.1086/592051</pub-id><pub-id pub-id-type="pmid">18752431</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skwark</surname><given-names>MJ</given-names></name><name><surname>Croucher</surname><given-names>NJ</given-names></name><name><surname>Puranen</surname><given-names>S</given-names></name><name><surname>Chewapreecha</surname><given-names>C</given-names></name><name><surname>Pesonen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Interacting networks of resistance, virulence and core machinery genes identified by genome-wide epistasis analysis</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006508</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006508</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>DS</given-names></name><name><surname>Kafer</surname><given-names>JM</given-names></name><name><surname>Wasserman</surname><given-names>GA</given-names></name><name><surname>Velickovic</surname><given-names>L</given-names></name><name><surname>Mathema</surname><given-names>B</given-names></name><name><surname>Holzman</surname><given-names>RS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Nasal carriage as a source of agr-defective <italic>Staphylococcus aureus</italic> bacteremia</article-title><source>The Journal of Infectious Diseases</source><volume>206</volume><fpage>1168</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1093/infdis/jis483</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinear</surname><given-names>TP</given-names></name><name><surname>Seemann</surname><given-names>T</given-names></name><name><surname>Pidot</surname><given-names>S</given-names></name><name><surname>Frigui</surname><given-names>W</given-names></name><name><surname>Reysset</surname><given-names>G</given-names></name><name><surname>Garnier</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer</article-title><source>Genome Research</source><volume>17</volume><fpage>192</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1101/gr.5942807</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoletzki</surname><given-names>N</given-names></name><name><surname>Eyre-Walker</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Estimation of the neutrality index</article-title><source>Molecular Biology and Evolution</source><volume>28</volume><fpage>63</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1093/molbev/msq249</pub-id><pub-id pub-id-type="pmid">20837603</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suligoy</surname><given-names>CM</given-names></name><name><surname>Lattar</surname><given-names>SM</given-names></name><name><surname>Noto Llana</surname><given-names>M</given-names></name><name><surname>Gonzalez</surname><given-names>CD</given-names></name><name><surname>Alvarez</surname><given-names>LP</given-names></name><name><surname>Robinson</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mutation of Agr Is Associated with the Adaptation of <italic>Staphylococcus aureus</italic> to the Host during Chronic Osteomyelitis</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>8</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2018.00018</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suligoy</surname><given-names>CM</given-names></name><name><surname>D√≠az</surname><given-names>RE</given-names></name><name><surname>Gehrke</surname><given-names>AK</given-names></name><name><surname>Ring</surname><given-names>N</given-names></name><name><surname>Yebra</surname><given-names>G</given-names></name><name><surname>Alves</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Acapsular <italic>Staphylococcus aureus</italic> with a non-functional agr regains capsule expression after passage through the bloodstream in a bacteremia mouse model</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>14108</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-70671-1</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Surewaard</surname><given-names>BGJ</given-names></name><name><surname>Deniset</surname><given-names>JF</given-names></name><name><surname>Zemp</surname><given-names>FJ</given-names></name><name><surname>Amrein</surname><given-names>M</given-names></name><name><surname>Otto</surname><given-names>M</given-names></name><name><surname>Conly</surname><given-names>J</given-names></name><name><surname>Omri</surname><given-names>A</given-names></name><name><surname>Yates</surname><given-names>RM</given-names></name><name><surname>Kubes</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification and treatment of the <italic>Staphylococcus aureus</italic> reservoir in vivo</article-title><source>The Journal of Experimental Medicine</source><volume>213</volume><fpage>1141</fpage><lpage>1151</lpage><pub-id pub-id-type="doi">10.1084/jem.20160334</pub-id><pub-id pub-id-type="pmid">27325887</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>X</given-names></name><name><surname>Coureuil</surname><given-names>M</given-names></name><name><surname>Ramond</surname><given-names>E</given-names></name><name><surname>Euphrasie</surname><given-names>D</given-names></name><name><surname>Dupuis</surname><given-names>M</given-names></name><name><surname>Tros</surname><given-names>F</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Nemazanyy</surname><given-names>I</given-names></name><name><surname>Chhuon</surname><given-names>C</given-names></name><name><surname>Guerrera</surname><given-names>IC</given-names></name><name><surname>Ferroni</surname><given-names>A</given-names></name><name><surname>Sermet-Gaudelus</surname><given-names>I</given-names></name><name><surname>Nassif</surname><given-names>X</given-names></name><name><surname>Charbit</surname><given-names>A</given-names></name><name><surname>Jamet</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Chronic <italic>Staphylococcus aureus</italic> Lung Infection Correlates With Proteogenomic and Metabolic Adaptations Leading to an Increased Intracellular Persistence</article-title><source>Clinical Infectious Diseases</source><volume>69</volume><fpage>1937</fpage><lpage>1945</lpage><pub-id pub-id-type="doi">10.1093/cid/ciz106</pub-id><pub-id pub-id-type="pmid">30753350</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thwaites</surname><given-names>GE</given-names></name><name><surname>Gant</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Are bloodstream leukocytes Trojan Horses for the metastasis of <italic>Staphylococcus aureus</italic>?</article-title><source>Nature Reviews. Microbiology</source><volume>9</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2508</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toft</surname><given-names>C</given-names></name><name><surname>Andersson</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evolutionary microbial genomics: insights into bacterial host adaptation</article-title><source>Nature Reviews. Genetics</source><volume>11</volume><fpage>465</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1038/nrg2798</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>SYC</given-names></name><name><surname>Davis</surname><given-names>JS</given-names></name><name><surname>Eichenberger</surname><given-names>E</given-names></name><name><surname>Holland</surname><given-names>TL</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title><italic>Staphylococcus aureus</italic> infections: epidemiology, pathophysiology, clinical manifestations, and management</article-title><source>Clinical Microbiology Reviews</source><volume>28</volume><fpage>603</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1128/CMR.00134-14</pub-id><pub-id pub-id-type="pmid">26016486</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>SYC</given-names></name><name><surname>Lye</surname><given-names>DC</given-names></name><name><surname>Yahav</surname><given-names>D</given-names></name><name><surname>Sud</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>JO</given-names></name><name><surname>Nelson</surname><given-names>J</given-names></name><name><surname>Archuleta</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>MA</given-names></name><name><surname>Cass</surname><given-names>A</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name><name><surname>Foo</surname><given-names>H</given-names></name><name><surname>Paul</surname><given-names>M</given-names></name><name><surname>Guy</surname><given-names>SD</given-names></name><name><surname>Tramontana</surname><given-names>AR</given-names></name><name><surname>Walls</surname><given-names>GB</given-names></name><name><surname>McBride</surname><given-names>S</given-names></name><name><surname>Bak</surname><given-names>N</given-names></name><name><surname>Ghosh</surname><given-names>N</given-names></name><name><surname>Rogers</surname><given-names>BA</given-names></name><name><surname>Ralph</surname><given-names>AP</given-names></name><name><surname>Davies</surname><given-names>J</given-names></name><name><surname>Ferguson</surname><given-names>PE</given-names></name><name><surname>Dotel</surname><given-names>R</given-names></name><name><surname>McKew</surname><given-names>GL</given-names></name><name><surname>Gray</surname><given-names>TJ</given-names></name><name><surname>Holmes</surname><given-names>NE</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name><name><surname>Warner</surname><given-names>MS</given-names></name><name><surname>Kalimuddin</surname><given-names>S</given-names></name><name><surname>Young</surname><given-names>BE</given-names></name><name><surname>Runnegar</surname><given-names>N</given-names></name><name><surname>Andresen</surname><given-names>DN</given-names></name><name><surname>Anagnostou</surname><given-names>NA</given-names></name><name><surname>Johnson</surname><given-names>SA</given-names></name><name><surname>Chatfield</surname><given-names>MD</given-names></name><name><surname>Cheng</surname><given-names>AC</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name><name><surname>Howden</surname><given-names>BP</given-names></name><name><surname>Meagher</surname><given-names>N</given-names></name><name><surname>Price</surname><given-names>DJ</given-names></name><name><surname>van Hal</surname><given-names>SJ</given-names></name><name><surname>O‚ÄôSullivan</surname><given-names>MVN</given-names></name><name><surname>Davis</surname><given-names>JS</given-names></name><collab>Australasian Society for Infectious Diseases Clinical Research Network</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal Œ≤-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial</article-title><source>JAMA</source><volume>323</volume><fpage>527</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1001/jama.2020.0103</pub-id><pub-id pub-id-type="pmid">32044943</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>T√∂r√∂nen</surname><given-names>P</given-names></name><name><surname>Medlar</surname><given-names>A</given-names></name><name><surname>Holm</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>PANNZER2: a rapid functional annotation web server</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>W84</fpage><lpage>W88</lpage><pub-id pub-id-type="doi">10.1093/nar/gky350</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trong</surname><given-names>HNG</given-names></name><name><surname>Prunier</surname><given-names>AL</given-names></name><name><surname>Leclercq</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hypermutable and fluoroquinolone-resistant clinical isolates of <italic>Staphylococcus aureus</italic></article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>49</volume><fpage>2098</fpage><lpage>2101</lpage><pub-id pub-id-type="doi">10.1128/AAC.49.5.2098-2101.2005</pub-id><pub-id pub-id-type="pmid">15855537</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trouillet-Assant</surname><given-names>S</given-names></name><name><surname>Leli√®vre</surname><given-names>L</given-names></name><name><surname>Martins-Sim√µes</surname><given-names>P</given-names></name><name><surname>Gonzaga</surname><given-names>L</given-names></name><name><surname>Tasse</surname><given-names>J</given-names></name><name><surname>Valour</surname><given-names>F</given-names></name><name><surname>Rasigade</surname><given-names>JP</given-names></name><name><surname>Vandenesch</surname><given-names>F</given-names></name><name><surname>Muniz Guedes</surname><given-names>RL</given-names></name><name><surname>Ribeiro de Vasconcelos</surname><given-names>AT</given-names></name><name><surname>Caillon</surname><given-names>J</given-names></name><name><surname>Lustig</surname><given-names>S</given-names></name><name><surname>Ferry</surname><given-names>T</given-names></name><name><surname>Jacqueline</surname><given-names>C</given-names></name><name><surname>Loss de Morais</surname><given-names>G</given-names></name><name><surname>Laurent</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Adaptive processes of <italic>Staphylococcus aureus</italic> isolates during the progression from acute to chronic bone and joint infections in patients</article-title><source>Cellular Microbiology</source><volume>18</volume><fpage>1405</fpage><lpage>1414</lpage><pub-id pub-id-type="doi">10.1111/cmi.12582</pub-id><pub-id pub-id-type="pmid">26918656</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Tyne</surname><given-names>D</given-names></name><name><surname>Manson</surname><given-names>AL</given-names></name><name><surname>Huycke</surname><given-names>MM</given-names></name><name><surname>Karanicolas</surname><given-names>J</given-names></name><name><surname>Earl</surname><given-names>AM</given-names></name><name><surname>Gilmore</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Impact of antibiotic treatment and host innate immune pressure on enterococcal adaptation in the human bloodstream</article-title><source>Science Translational Medicine</source><volume>11</volume><elocation-id>eaat8418</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aat8418</pub-id><pub-id pub-id-type="pmid">30971455</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargas</surname><given-names>R</given-names></name><name><surname>Freschi</surname><given-names>L</given-names></name><name><surname>Marin</surname><given-names>M</given-names></name><name><surname>Epperson</surname><given-names>LE</given-names></name><name><surname>Smith</surname><given-names>M</given-names></name><name><surname>Oussenko</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In-host population dynamics of Mycobacterium tuberculosis complex during active disease</article-title><source>eLife</source><volume>10</volume><elocation-id>e61805</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.61805</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadsworth</surname><given-names>CB</given-names></name><name><surname>Arnold</surname><given-names>BJ</given-names></name><name><surname>Sater</surname><given-names>MRA</given-names></name><name><surname>Grad</surname><given-names>YH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Azithromycin Resistance through Interspecific Acquisition of an Epistasis-Dependent Efflux Pump Component and Transcriptional Regulator in Neisseria gonorrhoeae</article-title><source>MBio</source><volume>9</volume><elocation-id>e01419-18</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01419-18</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bojer</surname><given-names>MS</given-names></name><name><surname>George</surname><given-names>SE</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Jensen</surname><given-names>PR</given-names></name><name><surname>Wolz</surname><given-names>C</given-names></name><name><surname>Ingmer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inactivation of TCA cycle enhances <italic>Staphylococcus aureus</italic> persister cell formation in stationary phase</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>10849</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-29123-0</pub-id><pub-id pub-id-type="pmid">30022089</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wertheim</surname><given-names>HF</given-names></name><name><surname>Melles</surname><given-names>DC</given-names></name><name><surname>Vos</surname><given-names>MC</given-names></name><name><surname>van Leeuwen</surname><given-names>W</given-names></name><name><surname>van Belkum</surname><given-names>A</given-names></name><name><surname>Verbrugh</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>The role of nasal carriage in <italic>Staphylococcus aureus</italic> infections</article-title><source>The Lancet. Infectious Diseases</source><volume>5</volume><fpage>751</fpage><lpage>762</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(05)70295-4</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheatley</surname><given-names>R</given-names></name><name><surname>Diaz Caballero</surname><given-names>J</given-names></name><name><surname>Kapel</surname><given-names>N</given-names></name><name><surname>de Winter</surname><given-names>FHR</given-names></name><name><surname>Jangir</surname><given-names>P</given-names></name><name><surname>Quinn</surname><given-names>A</given-names></name><name><surname>Del Barrio-Tofi√±o</surname><given-names>E</given-names></name><name><surname>L√≥pez-Causap√©</surname><given-names>C</given-names></name><name><surname>Hedge</surname><given-names>J</given-names></name><name><surname>Torrens</surname><given-names>G</given-names></name><name><surname>Van der Schalk</surname><given-names>T</given-names></name><name><surname>Xavier</surname><given-names>BB</given-names></name><name><surname>Fern√°ndez-Cuenca</surname><given-names>F</given-names></name><name><surname>Arenzana</surname><given-names>A</given-names></name><name><surname>Recanatini</surname><given-names>C</given-names></name><name><surname>Timbermont</surname><given-names>L</given-names></name><name><surname>Sifakis</surname><given-names>F</given-names></name><name><surname>Ruzin</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>O</given-names></name><name><surname>Lammens</surname><given-names>C</given-names></name><name><surname>Goossens</surname><given-names>H</given-names></name><name><surname>Kluytmans</surname><given-names>J</given-names></name><name><surname>Kumar-Singh</surname><given-names>S</given-names></name><name><surname>Oliver</surname><given-names>A</given-names></name><name><surname>Malhotra-Kumar</surname><given-names>S</given-names></name><name><surname>MacLean</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute <italic>Pseudomonas aeruginosa</italic> infection</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>2460</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-22814-9</pub-id><pub-id pub-id-type="pmid">33911082</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheeler</surname><given-names>NE</given-names></name><name><surname>Gardner</surname><given-names>PP</given-names></name><name><surname>Barquist</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Machine learning identifies signatures of host adaptation in the bacterial pathogen <italic>Salmonella enterica</italic></article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007333</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007333</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>DE</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Langmead</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Improved metagenomic analysis with Kraken 2</article-title><source>Genome Biology</source><volume>20</volume><elocation-id>257</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-019-1891-0</pub-id><pub-id pub-id-type="pmid">31779668</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wuthrich</surname><given-names>D</given-names></name><name><surname>Cuenod</surname><given-names>A</given-names></name><name><surname>Hinic</surname><given-names>V</given-names></name><name><surname>Morgenstern</surname><given-names>M</given-names></name><name><surname>Khanna</surname><given-names>N</given-names></name><name><surname>Egli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline</article-title><source>The Journal of Antimicrobial Chemotherapy</source><volume>74</volume><fpage>1452</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.1093/jac/dkz003</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>M</given-names></name><name><surname>Stevens</surname><given-names>E</given-names></name><name><surname>Laabei</surname><given-names>M</given-names></name><name><surname>Bacon</surname><given-names>L</given-names></name><name><surname>Heesom</surname><given-names>K</given-names></name><name><surname>Bayliss</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Epistasis analysis uncovers hidden antibiotic resistance-associated fitness costs hampering the evolution of MRSA</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>94</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1469-2</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Golubchik</surname><given-names>T</given-names></name><name><surname>Batty</surname><given-names>EM</given-names></name><name><surname>Fung</surname><given-names>R</given-names></name><name><surname>Larner-Svensson</surname><given-names>H</given-names></name><name><surname>Votintseva</surname><given-names>AA</given-names></name><name><surname>Miller</surname><given-names>RR</given-names></name><name><surname>Godwin</surname><given-names>H</given-names></name><name><surname>Knox</surname><given-names>K</given-names></name><name><surname>Everitt</surname><given-names>RG</given-names></name><name><surname>Iqbal</surname><given-names>Z</given-names></name><name><surname>Rimmer</surname><given-names>AJ</given-names></name><name><surname>Cule</surname><given-names>M</given-names></name><name><surname>Ip</surname><given-names>CLC</given-names></name><name><surname>Didelot</surname><given-names>X</given-names></name><name><surname>Harding</surname><given-names>RM</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name><name><surname>Peto</surname><given-names>TE</given-names></name><name><surname>Crook</surname><given-names>DW</given-names></name><name><surname>Bowden</surname><given-names>R</given-names></name><name><surname>Wilson</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Evolutionary dynamics of <italic>Staphylococcus aureus</italic> during progression from carriage to disease</article-title><source>PNAS</source><volume>109</volume><fpage>4550</fpage><lpage>4555</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113219109</pub-id><pub-id pub-id-type="pmid">22393007</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>BC</given-names></name><name><surname>Gordon</surname><given-names>NC</given-names></name><name><surname>Cole</surname><given-names>K</given-names></name><name><surname>Price</surname><given-names>JR</given-names></name><name><surname>Liu</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Severe infections emerge from commensal bacteria by adaptive evolution</article-title><source>eLife</source><volume>6</volume><elocation-id>e30637</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30637</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>L-G</given-names></name><name><surname>Han</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>Q-Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>clusterProfiler: an R package for comparing biological themes among gene clusters</article-title><source>OMICS‚ÄØ: A Journal of Integrative Biology</source><volume>16</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1089/omi.2011.0118</pub-id><pub-id pub-id-type="pmid">22455463</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77195.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><related-object id="sa0ro1" link-type="continued-by" object-id="10.1101/2022.02.11.480068" object-id-type="id" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.11.480068"/></front-stub><body><p>This study offers a comprehensive examination of <italic>Staphylococcus aureus</italic> evolution during infection. It provides a useful analysis of select genetic signatures during bacterial adaptation. A combination of multiple layers of genome annotation and point mutation variant detection compellingly supports the correlation of infection outcomes with adaptation signatures in <italic>S. aureus</italic>.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77195.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03rp50x72</institution-id><institution>University of the Witwatersrand</institution></institution-wrap><country>South Africa</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Van Tyne</surname><given-names>Daria</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01an3r305</institution-id><institution>University of Pittsburgh</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Zheng</surname><given-names>Meiqin</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.02.11.480068">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.02.11.480068v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Niche-specific genome degradation and convergent evolution shaping <italic>Staphylococcus aureus</italic> adaptation during severe infections&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Bavesh Kana as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Daria Van Tyne (Reviewer #1); Meiqin Zheng (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. One weakness of the study is a lack of a classification of the variants detected in convergent loci. For example, which genes do the authors think are acquiring gain-of-function versus loss-of-function mutations? One other weakness is a lack of functional studies exploring some of the more novel signals detected (such as hypothetical proteins with &quot;no data on S. aureus&quot;). Can the authors comment or provide data on this?</p><p>2. Line 130-131: Was there any association between sampling frequency and variant accumulation in patients between early vs. late adapted populations? Can the available data be used to estimate mutation rates or bottleneck sizes in moving from colonization-&gt;early infection-&gt;late infection?</p><p>Other comments that must be addressed</p><p>1. Line 78: Reference 13 is a study in E. faecalis, not E. faecium. Chilambi et al., 2020 PNAS examine colonization vs. infection in VREfm.</p><p>2. Lines 143-145: Please define &quot;early stage,&quot; &quot;late infection stage,&quot; &quot;persistence,&quot; and &quot;treatment failure&quot; here. These terms are not defined in the methods or anywhere else in the paper.</p><p>3. Line 153 should reference Figure 2B.</p><p>4. Line 183 should reference Figure 2 ‚Äîfigure supplement 2.</p><p>5. Lines 207-208: How many genes had a homolog in the reference strain? What percentage of the genome was this?</p><p>6. Was the definition of &quot;colonization&quot; vs. &quot;infection&quot; consistent across all studies compiled here? If not this should be acknowledged and discussed.</p><p>7. Figure 1: Panels B and D are somewhat confusing. Consider revising panel D, or moving it to the supplement.</p><p>8. Figure 3 and others like it: the triangles corresponding to &quot;2&quot; vs. &quot;3&quot; independent acquisitions do not look noticeably different on the figures.</p><p>9. Figure 3 ‚Äîfigure supplement 1: what does &quot;ext*?&quot; mean?</p><p>10. Line 416: what is the reference base of the definition about adaptation based on a centrality value of more than 0?</p><p>11. Line 712-714 and 722-723: These two sentences could be integrated into one.</p><p>12. In general, the article should be written with greater readability for the generalist audience of <italic>eLife</italic>.</p><p>13. Please check the whole article again and modify some mistakes such as Line 240, line 259, line 289, line 784, Figure 3 ‚Äîfigure supplement 5, and so on.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.77195.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. One weakness of the study is a lack of a classification of the variants detected in convergent loci. For example, which genes do the authors think are acquiring gain-of-function versus loss-of-function mutations?</p></disp-quote><p>We agree with the reviewer that our classification system doesn‚Äôt account for the predicted functional impact of amino acid substitutions. This is especially important for convergent loci where most or all aggregated mutations are substitutions such as <italic>mprF</italic> and <italic>sucA.</italic> To address this shortcoming, we used PROVEAN to predict the impact of amino acid substitution on the protein function (lines 915-923). We used a Œ¥ score of -2.5 to differentiate between deleterious and neutral substitutions. The results are presented in Figure 3 ‚Äì supplement 3 (new) and in the manuscript (lines 295-322). The output of PROVEAN is also provided with Supplementary file 3.</p><p>Based on <italic>in silico</italic> predictions (protein-truncations, low PROVEAN scores) we hypothesise that most convergent loci carry loss-of-function mutations. However, gain-of-function mutations are hard to predict from the sequence. We reviewed the literature on genes with low prevalence of truncations and higher PROVEAN scores and only confirmed gain-of-function mutations for <italic>mprF</italic>.</p><disp-quote content-type="editor-comment"><p>One other weakness is a lack of functional studies exploring some of the more novel signals detected (such as hypothetical proteins with &quot;no data on S. aureus&quot;). Can the authors comment or provide data on this?</p></disp-quote><p>Following the reviewer‚Äôs suggestion, we have performed a review of hypothetical proteins: we searched for homologs and functional domains and used PaperBlast to identify relevant papers (lines 947-948). We have revised tables 3/4 and added some relevant references that can provide more background information on the novel adaptive loci. We also agree with the reviewer that functional studies of candidate adaptive loci of unknown function will be important. Detection of previously described pathoadaptive loci such as <italic>agr</italic>, <italic>stp1</italic>, <italic>saeR</italic>, <italic>vraR</italic> and <italic>walR</italic> (Figure 3), underscores the validity of our approach. However, determining roles for genes in transition from colonising to invasive (and other pathoadaptive phenotypes) is non-trivial and of course represent substantial, stand-alone studies. We are planning to conduct these investigations and we hope that our work will encourage others to also dive into such studies (see also discussion, lines 750-754).</p><disp-quote content-type="editor-comment"><p>2. Line 130-131: Was there any association between sampling frequency and variant accumulation in patients between early vs. late adapted populations?</p></disp-quote><p>We assessed the correlation between number of samples and mean mutation counts per episode and stage of infection (colonisation, early, late). No correlation was found, except for early infections, where there was a weak association between number of sequences and mean mutation counts (R<sup>2</sup> = 0.042, p = 0.001). This analysis is presented in Figure 2 ‚Äîfigure supplement 2 and mentioned in the manuscript (lines 172-175).</p><disp-quote content-type="editor-comment"><p>Can the available data be used to estimate mutation rates or bottleneck sizes in moving from colonization-&gt;early infection-&gt;late infection?</p></disp-quote><p>We investigated mutation counts and rates within colonising and invasive populations by fitting a linear regression of mutation counts in response to the collection time. The regression suggests that mutation rates are higher in the invasive population, however this analysis should be taken with caution given that we are using multiple studies and sampling strategies and that the models displayed heteroskedasticity and non-linear distribution (results, lines 177-184 and methods 886-893). As hypothesised by the reviewer, this is a consequence of the heterogenous sampling approaches across the studies included in the analysis. Because of these limitations, the regression is presented in the supplementary data (Figure 2 ‚Äîfigure supplement 3 and 4).</p><p>We agree with the reviewers‚Äô that there is an interest in inferring bottleneck size at invasion from clinical data. Data from animal experiments suggest that there is a narrow bottleneck at the transition from colonisation to infection and upon organ seeding during bacteraemia. These analyses have used molecular markers and experimental design to infer the size of the bottleneck in animal models of bacteraemia and are therefore difficult to replicate with clinical sequences. Alternatively, the bottleneck size can be calculated using population genomics approaches, provided sufficient diversity and sampling depth is present, as it is the case in deep sequencing studies of viral infections. A few studies have also used deep sequencing approaches to calculate the size of the transmission bottleneck in bacterial infections. In a study by Hall <italic>et al.,</italic> (<italic>eLife</italic> 2019;8:e46402), the size of the transmission bottleneck was assessed using a Bayesian phylogenetic method in six colonisation pairs that fulfilled strict criteria in terms of statistical support and sampling depth (95% posterior trees and &gt; 5 tips [i.e. individual sequences] supporting the direction of transmission). Our dataset does not provide sufficient sampling coverage to apply one of the above approaches. The rate of coinfections with genetically distant lineages can be used to obtain a first rough estimate. Using this approach, we found evidence of coinfection for 4/336 (1%) episodes with at least two invasive sequences obtained at &lt; 3 days interval. By contrast evidence of co-colonisation was found in 11/167 (7%) episodes with at least two colonising sequences obtained at &lt; 3 days interval. This seems to confirm the prevailing opinion that there is a narrow bottleneck at invasion, however more subtle coinfections are missed with this approach and as mentioned above the estimate is heavily dependent on the density of sampling and sequencing depth. We have added the coinfection estimates to the Results section of the manuscript (lines 127-129) and mentioned the issues around the estimation of the bottleneck size in the discussion (lines 567-569 and lines 745-750).</p><disp-quote content-type="editor-comment"><p>Other comments that must be addressed</p><p>1. Line 78: Reference 13 is a study in E. faecalis, not E. faecium. Chilambi et al., 2020 PNAS examine colonization vs. infection in VREfm.</p></disp-quote><p>We have corrected the mistake and added the reference on within-host evolution of VRE (lines 75-77).</p><disp-quote content-type="editor-comment"><p>2. Lines 143-145: Please define &quot;early stage,&quot; &quot;late infection stage,&quot; &quot;persistence,&quot; and &quot;treatment failure&quot; here. These terms are not defined in the methods or anywhere else in the paper.</p></disp-quote><p>We have added a definition for these terms (lines 161-162). In addition, we replace the term ‚Äútreatment failure‚Äù with recurrence. Persistence and recurrence are the commonly used to define microbiological failure in <italic>Staphylococcus aureus</italic> bacteraemia, the main syndrome analysed in our study. When revising the manuscript, we have elected not to use the term ‚Äútreatment failure‚Äù as it is not well defined and may include outcomes that are not necessarily linked to bacterial adaptation.</p><disp-quote content-type="editor-comment"><p>3. Line 153 should reference Figure 2B.</p></disp-quote><p>We have modified the figure reference (line 171).</p><disp-quote content-type="editor-comment"><p>4. Line 183 should reference Figure 2 ‚Äîfigure supplement 2.</p></disp-quote><p>We have carefully reviewed figure references for IS insertions: 1) Figure 2 ‚Äîfigure supplement 5 (Figure 2 ‚Äîfigure supplement 2 in the older version) is referenced at line 220, to illustrate the diversity of IS families involved. 2) Figure 2C is referenced in the following sentence, at lines 220-221, to specify that the burst of IS insertions is visible when considering the accumulation of IS insertions within invasive strains (type I&gt;I) in panel C. 2) We hope that this clarifies how the two IS insertions figures are references in the text.</p><disp-quote content-type="editor-comment"><p>5. Lines 207-208: How many genes had a homolog in the reference strain? What percentage of the genome was this?</p></disp-quote><p>A total of 1,736 genes had a FPR3757 homolog (74%). We have added this information to the result section (lines 254-255).</p><disp-quote content-type="editor-comment"><p>6. Was the definition of &quot;colonization&quot; vs. &quot;infection&quot; consistent across all studies compiled here? If not this should be acknowledged and discussed.</p></disp-quote><p>The categorisation of ‚Äúcolonising‚Äù or ‚Äúinvasive‚Äù was based the following 2-steps assessment of the metadata (lines 799-803): 1) We first checked if the collection site was unambiguously associated with one of the two categories (e.g. ‚Äúnose‚Äù: colonising; ‚Äúblood‚Äù or ‚Äúbone‚Äù: invasive); 2) For sites that could be associated with both colonisation or infection (e.g. ‚Äúlung‚Äù or ‚Äúskin‚Äù) we considered the available details provided in the publication including the categorisation provided by the authors and the clinical histories, if available. While 2,151 sequences (83%) were unambiguous and could be assessed at the first step, we acknowledge that this second categorisation relies on the authors‚Äô assessment. This is now mentioned in the discussion (lines 739-742).</p><disp-quote content-type="editor-comment"><p>7. Figure 1: Panels B and D are somewhat confusing. Consider revising panel D, or moving it to the supplement.</p></disp-quote><p>Following the reviewers‚Äô suggestions we have modified figure 1: panel C is now a ‚Äúworkflow‚Äù figure showing the within-host evolution analysis process. We have replaced panel D with a simplified version of the statistical model we used.</p><disp-quote content-type="editor-comment"><p>8. Figure 3 and others like it: the triangles corresponding to &quot;2&quot; vs. &quot;3&quot; independent acquisitions do not look noticeably different on the figures.</p></disp-quote><p>We have modified the figures to improve the readability of panel C (Figure 3, Figure 3 ‚Äîfigure supplements 6 and 7, Figure 4).</p><disp-quote content-type="editor-comment"><p>9. Figure 3 ‚Äîfigure supplement 1: what does &quot;ext*?&quot; mean?</p></disp-quote><p>This is the SnpEff annotation for a stop_lost&amp;splice_region_variant. We have now added an explanation to the legend of Figure 3 ‚Äîfigure supplement 1 (lines 1137-1138).</p><disp-quote content-type="editor-comment"><p>10. Line 416: what is the reference base of the definition about adaptation based on a centrality value of more than 0?</p></disp-quote><p>A centrality value of 0 means that the episode (node) doesn‚Äôt have any connection to other episodes. Since connections are based on the Jaccard index, this means that a node with a centrality value of 0 doesn‚Äôt share any mutated genes with other episodes. In other words, within-host mutations for these nodes are only found in non-convergent loci (lines 520-522).</p><disp-quote content-type="editor-comment"><p>11. Line 712-714 and 722-723: These two sentences could be integrated into one.</p></disp-quote><p>We have modified this paragraph as suggested (lines 911-913).</p><disp-quote content-type="editor-comment"><p>12. In general, the article should be written with greater readability for the generalist audience of eLife.</p></disp-quote><p>We agree with the reviewer that readability is important, but this is a very broad criticism and therefore somewhat difficult to address. We have re-read the manuscript carefully with an eye to accessibility to a broad scientific audience. In this vein, we preface each section of the results with a rationale for a particular experiment, we define key terms and try to summarise the particular method(s) being deployed. Examples are at lines 177-184 (brief explanation of the regression analysis of mutation rates), lines 186-195 (rationale for the investigation of genome degradation signatures) and lines 208-209 (definition of the neutrality index); lines 295-299 (rationale and approach to infer functional consequences of substitutions); lines 452-464 (rationale and approach to the epistasis analysis); lines 503-523 (rationale and approach to the adaptation network analysis). We have made every effort to explain our implementation of leading-edge statistical and computational techniques as clearly as possible (examples lines 257-265).</p><disp-quote content-type="editor-comment"><p>13. Please check the whole article again and modify some mistakes such as Line 240, line 259, line 289, line 784, Figure 3 ‚Äîfigure supplement 5, and so on.</p></disp-quote><p>We have revised the manuscript and corrected mistakes.</p></body></sub-article></article>